Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
      EC 2.7.1
      EC 2.7.2
      EC 2.7.3
      EC 2.7.4
      EC 2.7.5
      EC 2.7.6
      EC 2.7.7
      EC 2.7.8
      EC 2.7.9
      EC 2.7.10
      EC 2.7.11
        EC 2.7.11.1
        EC 2.7.11.2
        EC 2.7.11.3
        EC 2.7.11.4
        EC 2.7.11.6
        EC 2.7.11.7
        EC 2.7.11.8
        EC 2.7.11.9
        EC 2.7.11.10
        EC 2.7.11.11
        EC 2.7.11.12
        EC 2.7.11.13
        EC 2.7.11.14
        EC 2.7.11.15
        EC 2.7.11.16
        EC 2.7.11.17
        EC 2.7.11.18
        EC 2.7.11.19
        EC 2.7.11.20
        EC 2.7.11.21
        EC 2.7.11.22
        EC 2.7.11.23
        EC 2.7.11.24
        EC 2.7.11.25
        EC 2.7.11.26
        EC 2.7.11.27
        EC 2.7.11.28
        EC 2.7.11.29
        EC 2.7.11.30
        EC 2.7.11.31
      EC 2.7.12
      EC 2.7.13
      EC 2.7.14
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.7.11.1 - ATP:protein phosphotransferase (non- specific) (non- specific serine/threonine protein kinase)



3D structures of EC 2.7.11.1 - non-specific serine/threonine protein kinase in Protein Data Bank

updated: 22 January 2021, 10:46

In total: 2443 PDB structures of EC 2.7.11.1 - non-specific serine/threonine protein kinase:
  1. 1e0a: Cdc42 Complexed with The Gtpase Binding Domain of P21 Activated Kinase
  2. 1h1w: High Resolution Crystal Structure of The Human Pdk1 Catalytic Domain
  3. 3p1a: Structure of Human Membrane-associated Tyrosine- and Threonine- Specific Cdc2-inhibitory Kinase Myt1 (pkmyt1)
  4. 3ow4: Discovery of Dihydrothieno- and Dihydrofuropyrimidines as Potent Pan Akt Inhibitors
  5. 3ot8: X-ray Crystal Structure of Compound 17r Bound to Human Chk1 Kinase Domain
  6. 3ot3: X-ray Crystal Structure of Compound 22k Bound to Human Chk1 Kinase Domain
  7. 3op5: Human Vaccinia-related Kinase 1
  8. 3omv: Crystal Structure of C-raf (raf-1)
  9. 3og7: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx4032
  10. 3o96: Crystal Structure of Human Akt1 with an Allosteric Inhibitor
  11. 3o51: Crystal Structure of Anthranilamide 10 Bound to Auroraa
  12. 3o50: Crystal Structure of Benzamide 9 Bound to Auroraa
  13. 3ny5: Crystal Structure of The Rbd Domain of Serine/threonine-protein Kinase B-raf from Homo Sapiens. Northeast Structural Genomics Consortium Target HR4694F
  14. 3nrm: Imidazo[1,2-a]pyrazine-based Aurora Kinase Inhibitors
  15. 3nkx: Impaired Binding of 14-3-3 to Raf1 Is Linked to Noonan and Leopard Syndrome
  16. 3nay: Pdk1 in Complex with Inhibitor Mp6
  17. 3nax: Pdk1 in Complex with Inhibitor Mp7
  18. 3myg: Aurora a Kinase Complexed with Sch 1473759
  19. 3mvh: Crystal Structure of Akt-1-inhibitor Complexes
  20. 3mv5: Crystal Structure of Akt-1-inhibitor Complexes
  21. 3mop: The Ternary Death Domain Complex of Myd88, Irak4, and Irak2
  22. 3mn3: An Inhibited Conformation for The Protein Kinase Domain of The Saccharomyces Cerevisiae Ampk Homolog Snf1
  23. 1mry: Crystal Structure of an Inactive Akt2 Kinase Domain
  24. 3mfu: Cask-4m Cam Kinase Domain, Amppnp-mn2+
  25. 3mft: Cask-4m Cam Kinase Domain, Mn2+
  26. 3mfs: Cask-4m Cam Kinase Domain, Amppnp
  27. 3mfr: Cask-4m Cam Kinase Domain, Native
  28. 3mb7: Human Ck2 Catalytic Domain in Complex with a Difurane Derivative Inhibitor (amr)
  29. 3mb6: Human Ck2 Catalytic Domain in Complex with a Difurane Derivative Inhibitor (cpa)
  30. 3ma3: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Naphtho-difuran Ligand
  31. 3m9g: Crystal Structure of The Three-pasta-domain of a Ser/thr Kinase from Staphylococcus Aureus
  32. 3m2w: Crystal Structure of Mapkak Kinase 2 (mk2) Complexed with a Spiroazetidine-tetracyclic Atp Site Inhibitor
  33. 3lm5: Crystal Structure of Human Serine/threonine Kinase 17b (STK17B) in Complex with Quercetin
  34. 3lm0: Crystal Structure of Human Serine/threonine Kinase 17b (STK17B)
  35. 3lj2: Ire1 Complexed with Jak Inhibitor I
  36. 3lj1: Ire1 Complexed with Cdk1/2 Inhibitor III
  37. 3lj0: Ire1 Complexed with Adp and Quercetin
  38. 3lau: Crystal Structure of Aurora2 Kinase in Complex with a GSK3BETA Inhibitor
  39. 3kxn: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor Tetraiodobenzimidazole (k88)
  40. 3kxm: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor K74
  41. 3kxh: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor (2-dymethylammino-4,5,6,7-tetrabromobenzoimidazol-1yl- Acetic Acid (k66)
  42. 3kxg: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor 3,4,5,6,7-pentabromo-1h-indazole (k64)
  43. 3kud: Complex of Ras-gdp with RAFRBD(A85K)
  44. 3kuc: Complex of RAP1A(E30D/K31E)GDP with RAFRBD(A85K/N71R)
  45. 1o6y: Catalytic Domain of Pknb Kinase from Mycobacterium Tuberculosis
  46. 3knb: Crystal Structure of The Titin C-terminus in Complex with Obscurin- like 1
  47. 3kn6: Crystal Structure of The C-terminal Kinase Domain of Msk1
  48. 3kn5: Crystal Structure of The C-terminal Kinase Domain of Msk1 in Complex with Amp-pnp
  49. 3khf: The Crystal Structure of The Pdz Domain of Human Microtubule Associated Serine/threonine Kinase 3 (mast3)
  50. 3kgv: Crystal Structure of Human Dna-dependent Protein Kinase Catalytic Subunit (dna-pkcs)
  51. 3kga: Crystal Structure of Mapkap Kinase 2 (mk2) Complexed with a Potent 3-aminopyrazole Atp Site Inhibitor
  52. 3kc3: Mk2 Complexed to Inhibitor N4-(7-(benzofuran-2-yl)-1h-indazol-5-yl) Pyrimidine-2,4-diamine
  53. 3ka0: Mk2 Complex with Inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2- Hydroxyphenyl)-n-methylbenzo[b]thiophene-2-carboxamide
  54. 3k5u: Identification, Sar Studies and X-ray Cocrystal Analysis of a Novel Furano-pyrimidine Aurora Kinase a Inhibitor
  55. 3k21: Crystal Structure of Carboxy-terminus of PFC0420W.
  56. 3k0e: Crystal Structure of The Phosphorylation-site Mutant T426N of The Kaic Circadian Clock Protein
  57. 3k0c: Crystal Structure of The Phosphorylation-site Double Mutant S431A/T432E of The Kaic Circadian Clock Protein
  58. 3k0a: Crystal Structure of The Phosphorylation-site Mutant S431A of The Kaic Circadian Clock Protein
  59. 3k09: Crystal Structure of The Phosphorylation-site Mutant S431D of The Kaic Circadian Clock Protein
  60. 3jzm: Crystal Structure of The Phosphorylation-site Mutant T432A of The Kaic Circadian Clock Protein
  61. 3jya: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
  62. 3jy0: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
  63. 3jxw: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
  64. 3jvs: Characterization of The Chk1 Allosteric Inhibitor Binding Site
  65. 3jvr: Characterization of The Chk1 Allosteric Inhibitor Binding Site
  66. 3juh: Crystal Structure of a Mutant of Human Protein Kinase CK2ALPHA with Altered Cosubstrate Specificity
  67. 3jpv: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Pyrrolo[2,3-a]carbazole Ligand
  68. 3ixe: Structural Basis of Competition between Pinch1 and Pinch2 for Binding to The Ankyrin Repeat Domain of Integrin-linked Kinase
  69. 3iq7: Crystal Structure of Human Haspin in Complex with 5-iodotubercidin
  70. 3iop: Pdk-1 in Complex with The Inhibitor Compound-8i
  71. 3ion: Pdk1 in Complex with Compound 8h
  72. 3ii5: The Complex of Wild-type B-raf with Pyrazolo Pyrimidine Inhibitor
  73. 3iec: Helicobacter Pylori Caga Inhibits Par1/mark Family Kinases by Mimicking Host Substrates
  74. 3idp: B-raf V600E Kinase Domain in Complex with an Aminoisoquinoline Inhibitor
  75. 3i6w: Structure and Activation Mechanism of The Chk2 Dna-damage Checkpoint Kinase
  76. 3i6u: Structure and Activation Mechanism of The Chk2 Dna-damage Checkpoint Kinase
  77. 3hyh: Crystal Structure of The Protein Kinase Domain of Yeast Amp- Activated Protein Kinase Snf1
  78. 3hrc: Crystal Structure of a Mutant of Human Pdk1 Kinase Domain in Complex with Atp
  79. 3hdn: Crystal Structure of Serum and Glucocorticoid-regulated Kinase 1 in Complex with Compound 2
  80. 3hdm: Crystal Structure of Serum and Glucocorticoid-regulated Kinase 1 in Complex with Compound 1
  81. 3ha6: Crystal Structure of Aurora a in Complex with Tpx2 and Compound 10
  82. 3h9o: Phosphoinositide-dependent Protein Kinase 1 (pdk-1) in Complex with Compound 9
  83. 3h4j: Crystal Structure of Pombe Ampk Kdaid Fragment
  84. 3h30: Crystal Structure of The Catalytic Subunit of Human Protein Kinase Ck2 with 5,6-dichloro-1-beta-d- Ribofuranosylbenzimidazole
  85. 3h10: Aurora a Inhibitor Complex
  86. 3h0z: Aurora a in Complex with a Bisanilinopyrimidine
  87. 3h0y: Aurora a in Complex with a Bisanilinopyrimidine
  88. 3gub: Crystal Structure of DAPKL93G Complexed with N6-(2- Phenylethyl)adenosine
  89. 3gu8: Crystal Structure of DAPKL93G with N6-cyclopentyladenosine
  90. 3gu7: Crystal Structure of DAPKQ23V-ADP-MG2+
  91. 3gu6: Crystal Structure of DAPKQ23V-ADP
  92. 3gu5: Crystal Structure of DAPKQ23V-AMPPNP-MG2+
  93. 3gu4: Crystal Structure of DAPKQ23V-AMPPNP
  94. 3gre: Crystal Structure of Saccharomyces Cerevisiae Vps15 Wd Repeat Domain
  95. 3gok: Binding Site Mapping of Protein Ligands
  96. 3ggf: Crystal Structure of Human Serine/threonine-protein Kinase Mst4 in Complex with an Quinazolin
  97. 3g51: Structural Diversity of The Active Conformation of The N- Terminal Kinase Domain of P90 Ribosomal S6 Kinase 2
  98. 3fyk: Crystal Structure of a Benzthiophene Lead Bound to Mapkap Kinase-2 (mk-2)
  99. 3fyj: Crystal Structure of an Optimzied Benzothiophene Inhibitor Bound to Mapkap Kinase-2 (mk-2)
  100. 3fy0: Crystal Structure of Pak1 Kinase Domain with Ruthenium Complex Dw1
  101. 3fxz: Crystal Structure of Pak1 Kinase Domain with Ruthenium Complex Lambda-fl172
  102. 3fxw: High Resolution Crystal Structure of Mitogen-activated Protein Kinase-activated Protein Kinase 3/inhibitor 2 Complex
  103. 3fwq: Inactive Conformation of Human Protein Kinase Ck2 Catalytic Subunit
  104. 3fpm: Crystal Structure of a Squarate Inhibitor Bound to Mapkap Kinase-2
  105. 3fmd: Crystal Structure of Human Haspin with an Isoquinoline Ligand
  106. 3fl5: Protein Kinase Ck2 in Complex with The Inhibitor Quinalizarin
  107. 3fhr: High Resolution Crystal Structure of Mitogen-activated Protein Kinase-activated Protein Kinase 3 (mk3)-inhibitor Complex
  108. 3fe3: Crystal Structure of The Kinase Mark3/par-1: T211A-S215A Double Mutant
  109. 3fdn: Structure-based Drug Design of Novel Aurora Kinase a Inhibitors: Structure Basis for Potency and Specificity
  110. 3fbv: Crystal Structure of The Oligomer Formed by The Kinase- Ribonuclease Domain of Ire1
  111. 3f9n: Crystal Structure of Chk1 Kinase in Complex with Inhibitor 38
  112. 3f6q: Crystal Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain
  113. 3f69: Crystal Structure of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain in Complex with Kt5720
  114. 3f61: Crystal Structure of M. Tuberculosis Pknb LEU33ASP/VAL222ASP Double Mutant in Complex with Adp
  115. 3f5u: Crystal Structure of The Death Associated Protein Kinase in Complex with Amppnp and Mg2+
  116. 3f5g: Crystal Structure of Death Associated Protein Kinase in Complex with Adp and Mg2+
  117. 3f2n: Crystal Structure of Human Haspin with an Imidazo- Pyridazine Ligand
  118. 3f2a: Crystal Structure of Human Pim-1 in Complex with Dappa
  119. 3eha: Crystal Structure of Death Associated Protein Kinase Complexed with Amppnp
  120. 3eh9: Crystal Structure of Death Associated Protein Kinase Complexed with Adp
  121. 3efw: Structure of Auroraa with Pyridyl-pyrimidine Urea Inhibitor
  122. 3e8d: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
  123. 3e88: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
  124. 3e87: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
  125. 3e7v: Crystal Structure of Human Haspin with a Pyrazolo- Pyrimidine Ligand
  126. 3e5a: Crystal Structure of Aurora a in Complex with Vx-680 and Tpx2
  127. 3e3b: Crystal Structure of Catalytic Subunit of Human Protein Kinase CK2ALPHA Prime with a Potent Indazole-derivative Inhibitor
  128. 3dvl: Crystal Structure of Full Length Circadian Clock Protein Kaic with Correct Geometry at Phosphorylation Sites
  129. 3dlz: Crystal Structure of Human Haspin in Complex with Amp
  130. 3dls: Crystal Structure of Human Pas Kinase Bound to Adp
  131. 3dj7: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 130.
  132. 3dj6: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 823.
  133. 3dj5: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 290.
  134. 3dgk: Crystal Structure of a Glycine-rich Loop Mutant of The Death Associated Protein Kinase Catalytic Domain
  135. 3dfc: Crystal Structure of a Glycine-rich Loop Mutant of The Death Associated Protein Kinase Catalytic Domain with Amppnp
  136. 3dcv: Crystal Structure of Human Pim1 Kinase Complexed with 4-(4- Hydroxy-3-methyl-phenyl)-6-phenylpyrimidin-2(1h)-one
  137. 3dak: Crystal Structure of Domain-swapped Osr1 Kinase Domain
  138. 3dae: Crystal Structure of Phosphorylated Snf1 Kinase Domain
  139. 3d9v: Crystal Structure of Rock I Bound to H-1152p a Di- Methylated Variant of Fasudil
  140. 3d6t: Structure of The Roc Domain from The Parkinson's Disease- Associated Leucine-rich Repeat Kinase 2 Reveals a Dimeric Gtpase
  141. 3d4q: Pyrazole-based Inhibitors of B-raf Kinase
  142. 1ul7: Solution Structure of Kinase Associated Domain 1 of Mouse Map/microtubule Affinity-regulating Kinase 3
  143. 3d2k: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with [7-(2-{2-[3-(3-chloro- Phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3- D]pyrimidin-1-yl]-acetic Acid
  144. 3d2i: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-{5-[2-(1-methyl-1h- Pyrazolo[4,3-d]pyrimidin-7-ylamino)-ethyl]-thiazol-2-yl}-3- (3-trifluoromethyl-phenyl)-urea
  145. 1unr: Crystal Structure of The Ph Domain of Pkb Alpha in Complex with a Sulfate Molecule
  146. 3d15: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-(3-chloro-phenyl)-3- {5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)- Ethyl]-thiazol-2- Yl}-urea [sns-314]
  147. 3d14: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-{5-[2-(thieno[3,2- D]pyrimidin-4-ylamino)-ethyl]- Thiazol-2-yl}-3-(3- Trifluoromethyl-phenyl)-urea
  148. 3d0e: Crystal Structure of Human Akt2 in Complex with Gsk690693
  149. 3cy3: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and The Jnk Inhibitor V
  150. 3cy2: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Beta Carboline Ligand II
  151. 3cxw: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Beta Carboline Ligand I
  152. 3cu8: Impaired Binding of 14-3-3 to Raf1 Is Linked to Noonan and Leopard Syndrome
  153. 1uwh: The Complex of Wild Type B-raf and Bay439006
  154. 1uwj: The Complex of Mutant V599E B-raf and Bay439006
  155. 3cqw: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
  156. 3cqu: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
  157. 3com: Crystal Structure of Mst1 Kinase
  158. 3coh: Crystal Structure of Aurora-a in Complex with a Pentacyclic Inhibitor
  159. 3ckx: Crystal Structure of Sterile 20-like Kinase 3 (mst3, Stk24) in Complex with Staurosporine
  160. 3ckw: Crystal Structure of Sterile 20-like Kinase 3 (mst3, Stk24)
  161. 3c4e: Pim-1 Kinase Domain in Complex with 3-aminophenyl-7- Azaindole
  162. 3c4c: B-raf Kinase in Complex with Plx4720
  163. 3c13: Low Ph-value Crystal Structure of Emodin in Complex with The Catalytic Subunit of Protein Kinase Ck2
  164. 3c0i: Cask Cam-kinase Domain- 3'-amp Complex, P212121 Form
  165. 3c0h: Cask Cam-kinase Domain- Amppnp Complex, P1 Form
  166. 3c0g: Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
  167. 3bwf: Crystal Structure of The Human Pim1 in Complex with an Osmium Compound
  168. 3bqr: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with an Imidazo-pyridazine Ligand
  169. 3bqc: High Ph-value Crystal Structure of Emodin in Complex with The Catalytic Subunit of Protein Kinase Ck2
  170. 3bhy: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with a Beta-carboline Ligand
  171. 3bgz: Human Pim-1 Kinase in Complex with Diphenyl Indole Inhibitor Vx3
  172. 3bgq: Human Pim-1 Kinase in Complex with an Triazolo Pyridazine Inhibitor Vx2
  173. 3bgp: Human Pim-1 Complexed with a Benzoisoxazole Inhibitor Vx1
  174. 3beg: Crystal Structure of Sr Protein Kinase 1 Complexed to Its Substrate Asf/sf2
  175. 3be9: Structure-based Design and Synthesis of Novel Macrocyclic Pyrazolo[1,5-a] [1,3,5]triazine Compounds as Potent Inhibitors of Protein Kinase Ck2 and Their Anticancer Activities
  176. 1wak: X-ray Structure of Srpk1
  177. 3b43: I-band Fragment I65-i70 from Titin
  178. 3akl: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
  179. 3akk: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
  180. 3akj: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
  181. 3aad: Structure of The Histone Chaperone Cia/asf1-double Bromodomain Complex Linking Histone Modifications and Site-specific Histone Eviction
  182. 3a99: Structure of Pim-1 Kinase Crystallized in The Presence of P27KIP1 Carboxy-terminal Peptide
  183. 3a62: Crystal Structure of Phosphorylated P70S6K1
  184. 3a61: Crystal Structure of Unphosphorylated P70S6K1 (form Ii)
  185. 3a60: Crystal Structure of Unphosphorylated P70S6K1 (form I)
  186. 3a2c: Crystal Structure of a Pyrazolopyrimidine Inhibitor Complex Bound to Mapkap Kinase-2 (mk2)
  187. 2zjw: Crystal Structure of Human Ck2 Alpha Complexed with Ellagic Acid
  188. 2zej: Structure of The Roc Domain from The Parkinson's Disease- Associated Leucine-rich Repeat Kinase 2 Reveals a Dimeric Gtpase
  189. 2z7s: Crystal Structure of The N-terminal Kinase Domain of Human Rsk1 Bound to Purvalnol a
  190. 2z7r: Crystal Structure of The N-terminal Kinase Domain of Human Rsk1 Bound to Staurosporine
  191. 2z7q: Crystal Structure of The N-terminal Kinase Domain of Human Rsk-1 Bound to Amp-pcp
  192. 2z6d: Crystal Structure of Lov1 Domain of Phototropin2 from Arabidopsis Thaliana
  193. 2z6c: Crystal Structure of Lov1 Domain of Phototropin1 from Arabidopsis Thaliana
  194. 2yza: Crystal Structure of Kinase Domain of Human 5'-amp- Activated Protein Kinase Alpha-2 Subunit Mutant (T172D)
  195. 2yz0: Solution Structure of Rwd/gi Domain of Saccharomyces Cerevisiae Gcn2
  196. 2ywp: Crystal Structure of Chk1 with a Urea Inhibitor
  197. 2yub: Solution Structure of The Pdz Domain from Mouse Lim Domain Kinase
  198. 2xru: Aurora-a T288E Complexed with Pha-828300
  199. 2xng: Structure of Aurora-a Bound to a Selective Imidazopyrazine Inhibitor
  200. 2xne: Structure of Aurora-a Bound to an Imidazopyrazine Inhibitor
  201. 2xkf: Structure of Nek2 Bound to Aminopyrazine Compound 2
  202. 2xke: Structure of Nek2 Bound to Aminipyrazine Compound 5
  203. 2xkd: Structure of Nek2 Bound to Aminopyrazine Compound 12
  204. 2xkc: Structure of Nek2 Bound to Aminopyrazine Compound 14
  205. 2xk8: Structure of Nek2 Bound to Aminopyrazine Compound 15
  206. 2xk7: Structure of Nek2 Bound to Aminopyrazine Compound 23
  207. 2xk6: Structure of Nek2 Bound to Aminopyrazine Compound 36
  208. 2xk4: Structure of Nek2 Bound to Aminopyrazine Compound 17
  209. 2xk3: Structure of Nek2 Bound to Aminopyrazine Compound 35
  210. 2xik: Structure of Human Ysk1 (yeast Sps1-ste20-related Kinase 1)
  211. 2xh5: Structure of 4-(4-tert-butylbenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidin-4-amine Bound to Pkb
  212. 2xf0: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  213. 2xez: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  214. 2xey: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  215. 2xck: Crystal Structure of Pdk1 in Complex with a Pyrazoloquinazoline Inhibitor
  216. 2xch: Crystal Structure of Pdk1 in Complex with a Pyrazoloquinazoline Inhibitor
  217. 2x8i: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
  218. 2x8e: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
  219. 2x8d: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
  220. 2x81: Structure of Aurora a in Complex with Mln8054
  221. 2x7g: Structure of Human Serine-arginine-rich Protein-specific Kinase 2 (srpk2) Bound to Purvalanol B
  222. 2x7f: Crystal Structure of The Kinase Domain of Human Traf2- and Nck-interacting Kinase with WEE1CHK1 Inhibitor
  223. 2x6e: Aurora-a Bound to an Inhibitor
  224. 2x6d: Aurora-a Bound to an Inhibitor
  225. 2x4z: Crystal Structure of The Human P21-activated Kinase 4 in Complex with Pf-03758309
  226. 2x4f: The Crystal Structure of The Human Myosin Light Chain Kinase Loc340156.
  227. 2x39: Structure of 4-amino-n-(4-chlorobenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidine-4-carboxamide Bound to Pkb
  228. 2x18: The Crystal Structure of The Ph Domain of Human Akt3 Protein Kinase
  229. 2x0g: X-ray Structure of a Dap-kinase Calmodulin Complex
  230. 2wzj: Catalytic and Uba Domain of Kinase Mark2/(par-1) K82R, T208E Double Mutant
  231. 2wwm: Crystal Structure of The Titin M10-obscurin like 1 Ig Complex in Space Group P1
  232. 2wwk: Crystal Structure of The Titin M10-obscurin like 1 Ig F17R Mutant Complex
  233. 2wvi: Crystal Structure of The N-terminal Domain of Bubr1
  234. 2wtw: Aurora-a Inhibitor Structure (2nd Crystal Form)
  235. 2wtv: Aurora-a Inhibitor Structure
  236. 2wtk: Structure of The Heterotrimeric LKB1-STRADALPHA-MO25ALPHA Complex
  237. 2wtj: Crystal Structure of Chk2 in Complex with an Inhibitor
  238. 2wti: Crystal Structure of Chk2 in Complex with an Inhibitor
  239. 2wtd: Crystal Structure of Chk2 in Complex with an Inhibitor
  240. 2wtc: Crystal Structure of Chk2 in Complex with an Inhibitor
  241. 2wqo: Structure of Nek2 Bound to The Aminopyridine Cct241950
  242. 2wqn: Structure of Adp-bound Human Nek7
  243. 2wqm: Structure of Apo Human Nek7
  244. 2wqe: Structure of S155R Aurora-a Somatic Mutant
  245. 2wp3: Crystal Structure of The Titin M10-obscurin like 1 Ig Complex
  246. 2wnt: Crystal Structure of The Human Ribosomal Protein S6 Kinase
  247. 2wmx: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  248. 2wmw: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  249. 2wmv: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  250. 2wmu: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  251. 2wmt: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  252. 2wms: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  253. 2wmr: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  254. 2wmq: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  255. 2wiu: Mercury-modified Bacterial Persistence Regulator Hipba
  256. 2wb8: Crystal Structure of Haspin Kinase
  257. 2w7x: Cellular Inhibition of Checkpoint Kinase 2 and Potentiation of Cytotoxic Drugs by Novel Chk2 Inhibitor Pv1019
  258. 2w7r: Structure of The Pdz Domain of Human Microtubule Associated Serine-threonine Kinase 4
  259. 2w5h: Human Nek2 Kinase Apo
  260. 2w5b: Human Nek2 Kinase Atpgammas-bound
  261. 2w5a: Human Nek2 Kinase Adp-bound
  262. 2w4k: X-ray Structure of a Dap-kinase 2-302
  263. 2w4j: X-ray Structure of a Dap-kinase 2-277
  264. 2w1g: Structure Determination of Aurora Kinase in Complex with Inhibitor
  265. 2w1f: Structure Determination of Aurora Kinase in Complex with Inhibitor
  266. 2w1e: Structure Determination of Aurora Kinase in Complex with Inhibitor
  267. 2w1d: Structure Determination of Aurora Kinase in Complex with Inhibitor
  268. 2w1c: Structure Determination of Aurora Kinase in Complex with Inhibitor
  269. 2w0j: Crystal Structure of Chk2 in Complex with Nsc 109555, a Specific Inhibitor
  270. 2vwi: Structure of The Osr1 Kinase, a Hypertension Drug Target
  271. 2vuw: Structure of Human Haspin Kinase Domain
  272. 2vu3: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  273. 2vtt: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  274. 2vts: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  275. 2vtr: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  276. 2vtq: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  277. 2vtp: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  278. 2vto: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  279. 2vtn: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  280. 2vtm: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  281. 2vtl: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  282. 2vtj: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  283. 2vti: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  284. 2vth: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
  285. 2vrx: Structure of Aurora B Kinase in Complex with Zm447439
  286. 7atu: The Limk1 Kinase Domain Bound to Lijtf500025
  287. 7b6f: Gsk3-beta in Complex with Compound (s)-5c
  288. 7b36: Mst4 in Complex with Compound G-5555
  289. 7b35: Mst3 in Complex with Compound Mria13
  290. 7b34: Mst3 in Complex with Compound Mria12
  291. 7b33: Mst3 in Complex with Mria11
  292. 7b32: Mst3 in Complex with Mria7
  293. 7b31: Mst3 in Complex with Compound Mria9
  294. 7b30: Mst3 in Complex with Compound G-5555
  295. 6zxh: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State H2
  296. 6tlw: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4-bromobenzotriazole
  297. 6tlv: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 5-bromobenzotriazole
  298. 6tls: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,6-dibromobenzotriazole
  299. 6tlr: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,7-dibromobenzotriazole
  300. 6tlp: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 5,6-dibromobenzotriazole
  301. 6tlo: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,5,6-tribromobenzotriazole
  302. 6tll: Human Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,5,6,7-tetrabromobenzotriazole (tbbt)
  303. 2vki: Structure of The Pdk1 Ph Domain K465E Mutant
  304. 2a38: Crystal Structure of The N-terminus of Titin
  305. 7jv1: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Aps-9-95-1
  306. 7jv0: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Pd0325901
  307. 7juz: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Selumetinib
  308. 7juy: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Cobimetinib
  309. 7jux: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Trametinib
  310. 7juw: Crystal Structure of Ksr1:mek1 in Complex with Amp-pnp
  311. 7juv: Crystal Structure of Ksr2:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Aps-9-95-1
  312. 7juu: Crystal Structure of Ksr2:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Pd0325901
  313. 7jut: Crystal Structure of Ksr2:mek1 in Complex with Anp-pnp, and Allosteric Mek Inhibitor Selumetinib
  314. 7jus: Crystal Structure of Ksr2:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Cobimetinib
  315. 7jur: Crystal Structure of Ksr2:mek1 in Complex with Amp-pnp, and Allosteric Mek Inhibitor Trametinib
  316. 7juq: Crystal Structure of Ksr2:mek1 in Complex with Adp
  317. 7jov: Crystal Structure of Rho-associated Protein Kinase 2 (rock2) in Complex with a Phenylpyrazole Amide Inhibitor
  318. 7jou: Crystal Structure of Rho-associated Protein Kinase 1 (rock1) in Complex with a Phenylpyrazole Amide Inhibitor
  319. 7jnt: Crystal Structure of Rho-associated Protein Kinase 2 (rock2) in Complex with a Potent and Selective Dual Rock Inhibitor
  320. 2vgp: Crystal Structure of Aurora B Kinase in Complex with a Aminothiazole Inhibitor
  321. 2vgo: Crystal Structure of Aurora B Kinase in Complex with Reversine Inhibitor
  322. 7jhp: Crystal Structure of Hras in Complex with The Ras-binding and Cysteine-rich Domains of Craf-kinase
  323. 2vd5: Structure of Human Myotonic Dystrophy Protein Kinase in Complex with The Bisindoylmaleide Inhibitor Bim VIII
  324. 2v9j: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Mg.atp-amp
  325. 7c2w: Crystal Structure of Irak4 Kinase in Complex with a Small Molecule Inhibitor
  326. 7c2v: Crystal Structure of Irak4 Kinase in Complex with The Inhibitor Ca- 4948
  327. 2v92: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Atp-amp
  328. 2v8q: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Amp
  329. 7brc: Crystal Structure of The Tmk3 Lrr Domain
  330. 7avq: Crystal Structure of Haspin in Complex with Disubstituted Imidazo[1,2- B]pyridazine Inhibitor (compound 12)
  331. 7ats: The Limk1 Kinase Domain Bound to Lijtf500127
  332. 2v62: Structure of Vaccinia-related Kinase 2
  333. 2v55: Mechanism of Multi-site Phosphorylation from a Rock-i:rhoe Complex Structure
  334. 7akg: Crystal Structure of STK17B with Bound Dovitinib
  335. 2v3s: Structural Insights into The Recognition of Substrates and Activators by The Osr1 Kinase
  336. 7a4c: Crystal Structure of Human Protein Kinase CK2ALPHA (CSNK2A1 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6,7- Tribromo-1h-triazolo[4,5-b]pyridine
  337. 7a4b: Crystal Structure of Human Protein Kinase CK2ALPHA (CSNK2A1 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6-dibromo- 1h-triazolo[4,5-b]pyridine
  338. 7a49: Crystal Structure of Human Protein Kinase CK2ALPHA (CSNK2A1 Gene Product) in Complex with The Atp-competitive Inhibitor 6-bromo-5- Chloro-1h-triazolo[4,5-b]pyridine
  339. 7a2h: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6,7- Tribromo-1h-imidazo[4,5-b]pyridine
  340. 7a22: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6,7- Tribromo-1h-triazolo[4,5-b]pyridine
  341. 7a1z: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The Atp-competitive Inhibitor 6-bromo-5- Chloro-1h-triazolo[4,5-b]pyridine
  342. 7a1b: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The Atp-competitive Inhibitor 5,6-dibromo- 1h-triazolo[4,5-b]pyridine
  343. 6zxg: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State H1
  344. 6zxf: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State G
  345. 2uzs: A Transforming Mutation in The Pleckstrin Homology Domain of Akt1 in Cancer (AKT1-PH_E17K)
  346. 2uzr: A Transforming Mutation in The Pleckstrin Homology Domain of Akt1 in Cancer (AKT1-PH_E17K)
  347. 6zxe: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State F2
  348. 6zxd: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State F1
  349. 6zwo: Cryo-em Structure of Human Mtor Complex 2, Focused on One Half
  350. 6zwm: Cryo-em Structure of Human Mtor Complex 2, Overall Refinement
  351. 2uw9: Structure of Pkb-beta (akt2) Complexed with 4-(4-chloro- Phenyl)-4-(4-(1h-pyrazol-4-yl)-phenyl)-piperidine
  352. 2uvm: Structure of Pkbalpha Ph Domain in Complex with a Novel Inositol Headgroup Surrogate, Benzene 1,2,3,4- Tetrakisphosphate
  353. 2uv2: Crystal Structure of Human Ste20-like Kinase Bound to 4-(4-( 5-cyclopropyl-1h-pyrazol-3-ylamino)-quinazolin-2-ylamino)- Phenyl)-acetonitrile
  354. 2uue: Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors
  355. 6zjf: Crystal Structure of STK17B (drak2) in Complex with Ap-229
  356. 6ziw: The Irak3 Pseudokinase Domain Bound to Atpgammas
  357. 6zhe: Cryo-em Structure of Dna-pk Dimer
  358. 6zha: Cryo-em Structure of Dna-pk Monomer
  359. 6zh8: Cryo-em Structure of Dna-pkcs:dna
  360. 6zh6: Cryo-em Structure of DNA-PKCS:KU80CT194
  361. 6zh4: Cryo-em Structure of Dna-pkcs (state 3)
  362. 6zh2: Cryo-em Structure of Dna-pkcs (state 1)
  363. 6zfp: Cryo-em Structure of Dna-pkcs (state 2)
  364. 2rq8: Solution Nmr Structure of Titin I27 Domain Mutant
  365. 2row: The C1 Domain of Rock II
  366. 2rov: The Split Ph Domain of Rock II
  367. 2bfx: Mechanism of Aurora-b Activation by Incenp and Inhibition by Hesperidin.
  368. 2bfy: Complex of Aurora-b with Incenp and Hesperidin.
  369. 2rjm: 3ig Structure of Titin Domains I67-i69 E-to-a Mutated Variant
  370. 2rio: Structure of The Dual Enzyme Ire1 Reveals The Basis for Catalysis and Regulation of Non-conventional Splicing
  371. 2rik: I-band Fragment I67-i69 from Titin
  372. 2r7i: Crystal Structure of Catalytic Subunit of Protein Kinase Ck2
  373. 2r7b: Crystal Structure of The Phosphoinositide-dependent Kinase- 1 (pdk-1)catalytic Domain Bound to a Dibenzonaphthyridine Inhibitor
  374. 2r5t: Crystal Structure of Inactive Serum and Glucocorticoid- Regulated Kinase 1 in Complex with Amp-pnp
  375. 2r0u: Crystal Structure of Chek1 in Complex with Inhibitor 54
  376. 2r0i: Crystal Structure of a Kinase Mark2/par-1 Mutant
  377. 2qre: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with 5-aminoimidazole- 4-carboxamide 1-beta-d-ribofuranotide (zmp)
  378. 2qrd: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp and Atp
  379. 2qrc: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp and Amp
  380. 2qr8: 2.0a X-ray Structure of C-terminal Kinase Domain of P90 Ribosomal S6 Kinase 2 (rsk2)
  381. 2qr7: 2.0a X-ray Structure of C-terminal Kinase Domain of P90 Ribosomal S6 Kinase 2: Se-met Derivative
  382. 2qr1: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp
  383. 2qnj: Kinase and Ubiquitin-associated Domains of Mark3/par-1
  384. 2qme: Crystal Structure of Human Rac3 in Complex with Crib Domain of Human P21-activated Kinase 1 (pak1)
  385. 2qlv: Crystal Structure of The Heterotrimer Core of The S. Cerevisiae Ampk Homolog Snf1
  386. 2qkw: Structural Basis for Activation of Plant Immunity by Bacterial Effector Protein Avrpto
  387. 2qhn: Crystal Structure of Chek1 in Complex with Inhibitor 1a
  388. 2qhm: Crystal Structure of Chek1 in Complex with Inhibitor 2a
  389. 2cke: Human Death-associated Drp-1 Kinase in Complex with Inhibitor
  390. 2qc6: Protein Kinase Ck2 in Complex with Dbc
  391. 2cmw: Structure of Human Casein Kinase 1 Gamma-1 in Complex with 2-(2-hydroxyethylamino)-6-(3-chloroanilino)-9- Isopropylpurine (casp Target)
  392. 2cn5: Crystal Structure of Human Chk2 in Complex with Adp
  393. 2cn8: Crystal Structure of Human Chk2 in Complex with Debromohymenialdisine
  394. 2q0n: Structure of Human P21 Activating Kinase 4 (pak4) in Complex with a Consensus Peptide
  395. 2pzy: Structure of Mk2 Complexed with Compound 76
  396. 2pzi: Crystal Structure of Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Tetrahydrobenzothiophene Ax20017
  397. 2pvr: Crystal Structure of The Catalytic Subunit of Protein Kinase Ck2 (c-terminal Deletion Mutant 1-335) in Complex with Two Sulfate Ions
  398. 2pvn: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  399. 2pvm: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  400. 2pvl: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  401. 2pvk: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  402. 2pvj: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  403. 2pvh: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
  404. 2pe2: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) 3-{5-[2-oxo-5-ureido-1,2-dihydro- Indol-(3z)-ylidenemethyl]-1h-pyrrol-3-yl}-n-(2-piperidin-1- Yl-ethyl)-benzamide Complex
  405. 2pe1: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) {2-oxo-3-[1-(1h-pyrrol-2-yl)-eth- (z)-ylidene]-2,3-dihydro-1h-indol-5-yl}-urea {bx-517} Complex
  406. 2pe0: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) 5-hydroxy-3-[1-(1h-pyrrol-2-yl)- Eth-(z)-ylidene]-1,3-dihydro-indol-2-one Complex
  407. 2p3g: Crystal Structure of a Pyrrolopyridine Inhibitor Bound to Mapkap Kinase-2
  408. 2oza: Structure of P38ALPHA Complex
  409. 2oxy: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole Derivatives K17, K22 and K32
  410. 2oxx: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole Derivatives K17, K22 and K32
  411. 2oxd: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
  412. 2ov2: The Crystal Structure of The Human Rac3 in Complex with The Crib Domain of Human P21-activated Kinase 4 (pak4)
  413. 6z3a: Mec1-ddc2 (wild-type) in Complex with Amp-pnp
  414. 6z2x: Mec1-ddc2 (F2244L Mutant) in Complex with Mg Amp-pnp (state Ii)
  415. 6z2w: Mec1-ddc2 (F2244L Mutant) in Complex with Mg Amp-pnp
  416. 2ooy: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase Complexed with Atp
  417. 2oox: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase Complexed with Amp
  418. 2onl: Crystal Structure of The P38A-MAPKAP Kinase 2 Heterodimer
  419. 2okr: Crystal Structure of The P38A-MAPKAP Kinase 2 Heterodimer
  420. 6ypn: Crystal Structure of CK2ALPHA with 2 Molecules of Adp Bound
  421. 6ypk: Crystal Structure of CK2ALPHA with Gtp Bound
  422. 6ypj: Crystal Structure of CK2ALPHA with Compound 1 Bound
  423. 6yph: Crystal Structure of CK2ALPHA with Compound 2 Bound
  424. 6ypg: Crystal Structure of CK2ALPHA with Compound 2 Bound to Second Crystal Form
  425. 6ykd: Human Pim-1 Kinase in Complex with an Inhibitor Identified by Virtual Screening
  426. 2oid: Crystal Structure of Irak4 Kinase Domain Complexed with Amppnp
  427. 2oic: Crystal Structure of Irak4 Kinase Domain Complexed with Staurosporine
  428. 2oib: Crystal Structure of Irak4 Kinase Domain Apo Form
  429. 2oi4: Crystal Structure of Human Pim1 in Complex with Fluorinated Ruthenium Pyridocarbazole
  430. 6y9o: Crystal Structure of Whirlin Pdz3_c-ter in Complex with Cask Internal Pdz Binding Motif Peptide
  431. 6xwe: Crystal Structure of Lyk3 Ectodomain
  432. 2obj: Crystal Structure of Human Pim-1 Kinase in Complex with Inhibitor
  433. 6xrm: Crystal Structure of Human PI3K-GAMMA in Complex with Compound 4
  434. 6xrl: Crystal Structure of Human PI3K-GAMMA in Complex with Inhibitor Ipi- 549
  435. 6xr4: Integrative in Situ Structure of Parkinsons Disease-linked Human Lrrk2
  436. 2o8y: Apo Irak4 Kinase Domain
  437. 6xka: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 Dephosphorylated, and Coalated on C290
  438. 6c83: Structure of Aurora a (122-403) Bound to Inhibitory Monobody Mb2 and Amppcp
  439. 6c4d: Structure Based Design of Rip1 Kinase Inhibitors
  440. 6c3e: Crystal Structure of Rip1 Kinase Bound to Inhibitor
  441. 6c2t: Aurora a Ligand Complex
  442. 6c2r: Aurora a Ligand Complex
  443. 6c1s: Phosphoinositide 3-kinase Gamma Bound to an Pyrrolopyridinone Inhibitor
  444. 6bxi: X-ray Crystal Structure of Ndr1 Kinase Domain
  445. 6bx6: Amp-activated Protein Kinase (ampk) Inhibition by Sbi-0206965: Alpha 2 Kinase Domain Bound to Sbi-0206965
  446. 6buu: Crystal Structure of Akt1 (aa 144-480) with a Bisubstrate
  447. 6bu6: Crystal Structure of The Human Vaccinia-related Kinase Bound to a Bis- Difluorophenol-aminopyridine Inhibitor
  448. 6btw: Crystal Structure of The Human Vaccinia-related Kinase Bound to a Phenyl-pteridinone Inhibitor
  449. 6bsk: Human Pim1 Kinase in Complex with Compound 12b
  450. 6bru: Crystal Structure of The Human Vaccinia-related Kinase Bound to a (s)- 2-phenylaminopteridinone Inhibitor
  451. 6bqd: Taf1-bd2 Bromodomain in Complex with (e)-3-(6-(but-2-en-1-yl)-7-oxo-6, 7-dihydro-1h-pyrrolo[2,3-c]pyridin-4-yl)-n,n-dimethylbenzamide
  452. 6bp0: Crystal Structure of The Human Vaccinia-related Kinase 1 Bound to (r)- 2-phenylaminopteridinone Inhibitor
  453. 6boe: Tbk1 in Complex with Amide-coupled Tetrazole Analog of Amlexanox
  454. 6bod: Tbk1 in Complex with Ethyl Ester Analog of Amlexanox
  455. 6bny: Tbk1 in Complex with Tetrazole Analog of Amlexanox
  456. 6bn1: Salvador Hippo Sarah Domain Complex
  457. 6bfn: Crystal Structure of Human Irak1
  458. 2dwb: Aurora-a Kinase Complexed with Amppnp
  459. 2o65: Crystal Structure of Pim1 with Pentahydroxyflavone
  460. 2o64: Crystal Structure of Pim1 with Quercetagetin
  461. 2o63: Crystal Structure of Pim1 with Myricetin
  462. 6bdn: Crystal Structure of Human Tao3 Kinase Binding Adp
  463. 2o3p: Crystal Structure of Pim1 with Quercetin
  464. 6b8u: Crystals Structure of B-raf Kinase Domain in Complex with an Imidazopyridinyl Benzamide Inhibitor
  465. 6b8j: Co-structure of Human Glycogen Synthase Kinase Beta with a Selective (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino) Ethyl]amine Inhibitor
  466. 6b5j: TNNI3K Complexed with a 4,6-diaminopyrimidine
  467. 2nzi: Crystal Structure of Domains A168-a170 from Titin
  468. 6b2q: Dual Inhibition of The Essential Protein Kinases a and B in Mycobacterium Tuberculosis
  469. 6b2p: Dual Inhibition of The Essential Protein Kinases a and B in Mycobacterium Tuberculosis
  470. 6b2e: Structure of Full Length Human Ampk (A2B2G1) in Complex with a Small Molecule Activator Sc4.
  471. 6b1u: Structure of Full-length Human Ampk (A2B1G1) in Complex with a Small Molecule Activator Sc4
  472. 6b16: P21-activated Kinase 1 in Complex with a 4-azaindole Inhibitor
  473. 6ayd: Pim1 Complexed with N-(6-(4-hydroxyphenyl)-1h-indazol-3-yl) Cyclopropanecarboxamide
  474. 6aud: PI3K-GAMMA K802T in Complex with Cpd 8 10-((1-(tert-butyl)piperidin-4- Yl)sulfinyl)-2-(1-isopropyl-1h-1,2,4-triazol-5-yl)-5,6- Dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
  475. 2nry: Crystal Structure of Irak-4
  476. 2nru: Crystal Structure of Irak-4
  477. 2e9n: Structure of H-chk1 Complexed with A767085
  478. 2e9o: Structure of H-chk1 Complexed with Aa582939
  479. 2e9p: Structure of H-chk1 Complexed with A771129
  480. 2e9u: Structure of H-chk1 Complexed with A780125
  481. 2e9v: Structure of H-chk1 Complexed with A859017
  482. 6ao5: Crystal Structure of Human Mst2 in Complex with Sav1 Sarah Domain
  483. 2np8: Structural Basis for The Inhibition of Aurora a Kinase by a Novel Class of High Affinity Disubstituted Pyrimidine Inhibitors
  484. 6ae3: Crystal Structure of GSK3BETA Complexed with Morin
  485. 6ac9: Crystal Structure of Human Vaccinia-related Kinase 1 (vrk1) in Complex with Amp-pnp
  486. 6ac5: Crystal Structure of Ripk1 Death Domain Glcnacylated by Epec Effector Nleb
  487. 6aar: Crystal Structure of Dapk1 in Complex with Purpurin
  488. 6a5e: Crystal Structure of Plant Peptide Ralf23 in Complex with fer and Llg2
  489. 6a5c: Crystal Structure of Plant Receptor-like Kinase Anx2
  490. 6a5b: Crystal Structure of Plant Receptor-like Kinase fer
  491. 6a5a: Crystal Structure of Plant Receptor-like Kinase Anx1
  492. 6a1c: Crystal Structure of The CK2A1-GO289 Complex
  493. 5zxb: Crystal Structure of Ack1 with Compound 10d
  494. 5zx5: 3.3 Angstrom Structure of Mouse Trpm7 with Edta
  495. 2ehb: The Structure of The C-terminal Domain of The Protein Kinase Atsos2 Bound to The Calcium Sensor Atsos3
  496. 2l05: Solution Nmr Structure of The Ras-binding Domain of Serine/threonine- Protein Kinase B-raf from Homo Sapiens, Northeast Structural Genomics Consortium Target HR4694F
  497. 5zn5: X-ray Structure of Protein Kinase Ck2 Alpha Subunit H148A Mutant
  498. 5zn4: X-ray Structure of Protein Kinase Ck2 Alpha Subunit H148N Mutant
  499. 5zn3: X-ray Structure of Protein Kinase Ck2 Alpha Subunit H148S Mutant
  500. 5zn2: X-ray Structure of Protein Kinase Ck2 Alpha Subunit H148A Mutant
  501. 5zn1: X-ray Structure of Protein Kinase Ck2 Alpha Subunit in D2O
  502. 5zn0: Joint X-ray/neutron Structure of Protein Kinase Ck2 Alpha Subunit
  503. 5zjw: Crystal Structure of Pak4 in Complex with Inhibitor Czg353
  504. 5zcs: 4.9 Angstrom Cryo-em Structure of Human Mtor Complex 2
  505. 2kui: Nmr Structure of The Pasta Domain of Mycobacterium Tuberculosis of Pknb
  506. 2kuf: Nmr Structure of The Pasta Domain 3 and 4 of Mycobacterium Tuberculosis of Pknb
  507. 2kue: Nmr Structure of The Pasta Domain 2 and 3 of Mycobacterium Tuberculosis of Pknb
  508. 2kud: Nmr Structure of The Pasta Domain 1 and 2 of Mycobacterium Tuberculosis of Pknb
  509. 5zan: Crystal Structure of Aurora-a in Complex with a New Quinazoline Inhibitor
  510. 5yzv: Biophysical and Structural Characterization of The Thermostable Wd40 Domain of a Prokaryotic Protein, Thermomonospora Curvata Pkwa
  511. 5yz8: Crystal Structure of N-terminal C1 Domain of Kaic
  512. 5yz0: Cryo-em Structure of Human Atr-atrip Complex
  513. 5yyz: Crystal Structure of The Mek1 Fha Domain in Complex with The Hop1 Pthr318 Peptide.
  514. 5yyx: Crystal Structure of The Mek1 Fha Domain
  515. 6l24: Crystal Structure of CK2A1 H115Y/V116I with Hematein
  516. 5ywm: Crystal Structure of CK2A2 Form-1
  517. 2h34: Apoenzyme Crystal Structure of The Tuberculosis Serine/threonine Kinase, Pkne
  518. 5yrn: Structure of Rip2 Card Domain
  519. 2h6d: Protein Kinase Domain of The Human 5'-amp-activated Protein Kinase Catalytic Subunit Alpha-2 (ampk Alpha-2 Chain)
  520. 2h9v: Structural Basis for Induced-fit Binding of Rho-kinase to The Inhibitor Y27632
  521. 2hak: Catalytic and Ubiqutin-associated Domains of Mark1/par-1
  522. 6g78: Rsk4 N-terminal Kinase Domain S232E in Complex with Amp-pnp
  523. 6g77: Rsk4 N-terminal Kinase Domain in Complex with Amp-pnp
  524. 6g76: Phosphorylated Rsk4 N-terminal Kinase Domain in Complex with Amp-pnp
  525. 6pxo: Human Casein Kinase 1 Delta (anion-free Crystallization Conditions)
  526. 6pxp: Human Casein Kinase 1 Delta Site 2 Mutant (K171E)
  527. 6u5l: Structure of Human Ulk4 in Complex with an Inhibitor
  528. 6tsz: The Ulk4 Pseudokinase Domain Bound to Atpgammas
  529. 6t3c: Crystal Structure of PI3KGAMMA in Complex with Dna-pk Inhibitor Azd7648
  530. 6t3b: Crystal Structure of PI3KGAMMA with a Dihydropurinone Inhibitor (compound 4)
  531. 6syt: Structure of The Smg1-smg8-smg9 Complex
  532. 2hog: Crystal Structure of Chek1 in Complex with Inhibitor 20
  533. 2hw6: Crystal Structure of Mnk1 Catalytic Domain
  534. 2hw7: Crystal Structure of MNK2-D228G in Complex with Staurosporine
  535. 2hxl: Crystal Structure of Chek1 in Complex with Inhibitor 1
  536. 2hxq: Crystal Structure of Chek1 in Complex with Inhibitor 2
  537. 2hy0: Crystal Structure of Chek1 in Complex with Inhibitor 22
  538. 2hy8: Pak1 Complex with St2001
  539. 2i3s: Bub3 Complex with Bub1 Glebs Motif
  540. 2ill: Anomalous Substructure of Titin-a168169
  541. 2iwi: Crystal Structure of The Human Pim2 in Complex with a Ruthenium Organometallic Ligand Ru1
  542. 2izr: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  543. 2izs: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  544. 2izt: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  545. 2izu: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
  546. 2j0i: Crystal Structure of The Human P21-activated Kinase 4
  547. 2j2i: Crystal Structure of The Humab Pim1 in Complex with Ly333531
  548. 2j4z: Structure of Aurora-2 in Complex with Pha-680626
  549. 2j50: Structure of Aurora-2 in Complex with Pha-739358
  550. 2j51: Crystal Structure of Human Ste20-like Kinase Bound to 5- Amino-3-((4-(aminosulfonyl)phenyl)amino)-n-(2,6- Difluorophenyl)-1h-1,2,4-triazole-1-carbothioamide
  551. 2j7t: Crystal Structure of Human Serine Threonine Kinase-10 Bound to Su11274
  552. 2j8h: Structure of The Immunoglobulin Tandem Repeat A168-a169 of Titin
  553. 2j8o: Structure of The Immunoglobulin Tandem Repeat of Titin A168- A169
  554. 2j90: Crystal Structure of Human Zip Kinase in Complex with a Tetracyclic Pyridone Inhibitor (pyridone 6)
  555. 2jbo: Protein Kinase Mk2 in Complex with an Inhibitor (crystal Form-1, Soaking)
  556. 2jbp: Protein Kinase Mk2 in Complex with an Inhibitor (crystal Form-2, Co-crystallization)
  557. 2jd5: SKY1P Bound to NPL3P-DERIVED Substrate Peptide
  558. 2jdo: Structure of Pkb-beta (akt2) Complexed with Isoquinoline-5- Sulfonic Acid (2-(2-(4-chlorobenzyloxy) Ethylamino)ethyl) Amide
  559. 2jdr: Structure of Pkb-beta (akt2) Complexed with The Inhibitor A- 443654
  560. 2jfl: Crystal Structure of Human Ste20-like Kinase ( Diphosphorylated Form) Bound to 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-n-(2,6- Difluorophenyl)-1h-1,2, 4-triazole-1-carbothioamide
  561. 2jfm: Crystal Structure of Human Ste20-like Kinase (unliganded Form)
  562. 2jii: Structure of Vaccinia Related Kinase 3
  563. 6xag: Apo Braf Dimer Bound to 14-3-3
  564. 2jo8: Solution Structure of C-terminal Domain of Human Mammalian Sterile 20-like Kinase 1 (mst1)
  565. 2jqi: Nmr Structure of The Rad53 Fha1 Domain in Complex with a Phosphothreonien Peptide Derived from Rad53 Scd1
  566. 2jqj: Nmr Structure of Yeast Dun1 Fha Domain
  567. 2jql: Nmr Structure of The Yeast Dun1 Fha Domain in Complex with a Doubly Phosphorylated (pt) Peptide Derived from Rad53 Scd1
  568. 6w3k: Structure of Unphosphorylated Human Ire1 Bound to G-9807
  569. 6w3e: Structure of Phosphorylated Ire1 in Complex with G-0701
  570. 6w3c: Structure of Phosphorylated Apo Ire1
  571. 6w3b: Structure of Apo Unphosphorylated Ire1
  572. 6w3a: Structure of Unphosphorylated Ire1 in Complex with G-7658
  573. 6w39: Structure of Unphosphorylated Ire1 in Complex with G-1749
  574. 6vxr: Structure of Maternal Embryonic Leucine Zipper Kinase Bound to Ldsm276
  575. 6vrv: Discovery of Sarxxxx92, a Pan-pim Kinase Inhibitor, Efficacious in a Kg1 Tumor Model
  576. 6vru: Pim-inhibitor Complex 1
  577. 6vpm: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 with C290 Disulfide Bonded to Compound 8-34, and in Complex with Amp-pnp
  578. 6vpl: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 with C290 Disulfide Bonded to Compound 7-80, and in Complex with Amp-pnp
  579. 6vpj: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 C247V + C319V Double Mutant Dephosphorylated, and in Complex with Amp-pnp
  580. 6vpi: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 C247V + D256N + C319V Triple Mutant Disulfide Homodimer in Complex with Amp-pnp
  581. 6vph: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 Modified with Cacodylate and in Complex with Amp-pnp
  582. 6vpg: Tpx2 Residues 7-20 Fused to Aurora a Residues 116-389 in Complex with Amp-pnp
  583. 6vp8: Cryo-em Structure of The C-terminal Half of The Parkinson's Disease- Linked Protein Leucine Rich Repeat Kinase 2 (lrrk2)
  584. 6vp7: Cryo-em Structure of The C-terminal Half of The Parkinson's Disease- Linked Protein Leucine Rich Repeat Kinase 2 (lrrk2)
  585. 6vp6: Cryo-em Structure of The C-terminal Half of The Parkinson's Disease- Linked Protein Leucine Rich Repeat Kinase 2 (lrrk2)
  586. 6vno: Cryo-em Structure of The C-terminal Half of The Parkinson's Disease- Linked Protein Leucine Rich Repeat Kinase 2 (lrrk2)
  587. 6vjj: Crystal Structure of Wild-type KRAS4B (gmppnp-bound) in Complex with Ras-binding Domain (rbd) of Raf1/craf
  588. 6v32: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Selumetinib
  589. 6v31: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Ch5126766
  590. 6v30: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Pimasertib
  591. 6v2z: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Cobimetinib
  592. 6v2y: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Trametinib
  593. 6v2x: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Binimetinib
  594. 6v2w: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp
  595. 6v2v: Crystal Structure of The Braf:mek1 Kinases in Complex with Amppnp and Pd0325901
  596. 6v2u: Crystal Structure of The Insect Cell-expressed Wt-braf Kinase in Complex with Dabrafenib
  597. 6tia: Irak4 in Complex with Inhibitor
  598. 6ti8: Irak4 in Complex with Inhibitor
  599. 6thz: Irak4 in Complex with Inhibitor
  600. 6thx: Irak4 in Complex with Inhibitor
  601. 6thw: Irak4 in Complex with Inhibitor
  602. 6tgu: Crystal Structure of Human Protein Kinase CK2ALPHA'(CSNK2A2 Gene Product) in Complex with The 2-aminothiazole-type Inhibitor Cl-oh-3
  603. 2kbx: Solution Structure of Ilk-pinch Complex
  604. 6tew: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The 2-aminothiazole-type Inhibitor 27
  605. 6tei: Crystal Structure of Human Protein Kinase CK2ALPHA (CSNK2A1 Gene Product) in Complex with The 2-aminothiazole-type Inhibitor 17
  606. 6te2: Crystal Structure of Human Protein Kinase CK2ALPHA' (CSNK2A2 Gene Product) in Complex with The 2-aminothiazole-type Inhibitor 17
  607. 6tcu: Glycogen Synthase Kinase-3 Beta (GSK3B) in Complex with Ligand 1
  608. 6tca: Phosphorylated P38 and Mapkapk2 Complex with Inhibitor
  609. 6seq: Lemur Tyrosine Kinase 3 (lmtk3)
  610. 6s46: Room Temperature Structure of The Lov2 Domain of Phototropin-2 from Arabidopsis Thaliana 4158 Ms after Initiation of Illumination, Determined with a Serial Crystallography Approach
  611. 6s45: Room Temperature Structure of The Dark State of The Lov2 Domain of Phototropin-2 from Arabidopsis Thaliana Determined with a Serial Crystallography Approach
  612. 2kio: Nmr Structure of The Oxidized Yeast Tor1 Fatc Domain Bound to Dpc Micelles at 318k
  613. 2kit: The Solution Struture of The Reduced Yeast Tor1 Fatc Domain Bound to Dpc Micelles at 298k
  614. 6ruu: Pseudokinase Domain of Human Irak3
  615. 6p7g: The Co-crystal Structure of BRAF(V600E) with Phi1
  616. 6p3d: The Co-crystal Structure of BRAF(V600E) with Ponatinib
  617. 6ojf: Dimeric Structure of Lrrk2 Gtpase Domain
  618. 6oje: Dimeric Structure of Lrrk2 Gtpase Domain
  619. 6m4w: Crystal Structure of Mbp Fused Split Fkbp-frb T2098L Mutant in Complex with Rapamycin
  620. 6m4u: Crystal Structure of Fkbp-frb T2098L Mutant in Complex with Rapamycin
  621. 6m37: The Crystal Structure of B. Subtilis Rsbv/rsbw Complex in The Hexagonal Crystal Form
  622. 6m36: The Crystal Structure of B. Subtilis Rsbv/rsbw Complex in The Monoclinic Crystal Form
  623. 6lxy: Irak4 in Complex with Inhibitor
  624. 6l17: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  625. 6kyr: Crystal Structure of Dclk1 Mutant (P675L) Autoinhibited Kinase Domain
  626. 6kyq: Crystal Structure of Dclk1 Autoinhibited Kinase Domain
  627. 6kmh: The Crystal Structure of Cask/mint1 Complex
  628. 3ncz: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Potent 2h-isoquinolin-1-one Inhibitor
  629. 6jpd: Mouse Receptor-interacting Protein Kinase 3 (rip3) Amyloid Structure by Solid-state Nmr
  630. 3pa3: X-ray Crystal Structure of Compound 70 Bound to Human Chk1 Kinase Domain
  631. 3pa4: X-ray Crystal Structure of Compound 2a Bound to Human Chk1 Kinase Domain
  632. 3pa5: X-ray Crystal Structure of Compound 1 Bound to Human Chk1 Kinase Domain
  633. 3pm8: Cad Domain of PFF0520W, Calcium Dependent Protein Kinase
  634. 2kr9: Kalirin Dh1 Nmr Structure
  635. 2kty: Solution Structure of Human Vaccinia Related Kinase-1
  636. 2kul: Solution Structure of Human Vaccinia Related Kinase 1(vrk1)
  637. 6z3r: Structure of Smg1-8-9 Kinase Complex Bound to Upf1-lsq
  638. 6wly: Pak4 Kinase Domain in Complex with Limk1 Thr508 Substrate Peptide
  639. 6wlx: Pak4 Kinase Domain in Complex with Beta-catenin Ser675 Substrate Peptide
  640. 6vql: Crystal Structure of Interleukin-1 Receptor-associated Kinase 4 (irak4-wt) Complex with a Nicotinamide Inhibitor
  641. 2xbj: Crystal Structure of Chk2 in Complex with an Inhibitor
  642. 2xix: Protein Kinase Pim-1 in Complex with Fragment-1 from Crystallographic Fragment Screen
  643. 2xiy: Protein Kinase Pim-1 in Complex with Fragment-2 from Crystallographic Fragment Screen
  644. 2xiz: Protein Kinase Pim-1 in Complex with Fragment-3 from Crystallographic Fragment Screen
  645. 2xj0: Protein Kinase Pim-1 in Complex with Fragment-4 from Crystallographic Fragment Screen
  646. 2xj1: Protein Kinase Pim-1 in Complex with Small Molecule Inibitor
  647. 2xj2: Protein Kinase Pim-1 in Complex with Small Molecule Inhibitor
  648. 2xm8: Co-crystal Structure of a Small Molecule Inhibitor Bound to The Kinase Domain of Chk2
  649. 2xm9: Structure of a Small Molecule Inhibitor with The Kinase Domain of Chk2
  650. 6yid: Crystal Structure of Ulk2 in Complex with Sbi-0206965
  651. 2y9r: Crystal Structure of The M10 Domain of Titin
  652. 6sk9: Nek2 Bound to Purine Compound 51
  653. 6sgk: Nek2 Kinase Bound to Inhibitor 102
  654. 6sgi: Nek2 Kinase Bound to Inhibitor 96
  655. 6sgh: Nek2 Kinase Covalently Bound to 2-arylamino-6-ethynylpurine Inhibitor 66
  656. 6sgd: Nek2 Kinase Covalently Bound to 2-arylamino-6-ethynylpurine Inhibitor 24
  657. 6s76: Crystal Structure of Human Nek7
  658. 3nga: Human Ck2 Catalytic Domain in Complex with Cx-4945
  659. 6s75: Crystal Structure of Nek7 Bound to Compound 51
  660. 6s73: Crystal Structure of Nek7 Srs Mutant Bound to Compound 51
  661. 3nsz: Human Ck2 Catalytic Domain in Complex with Amppn
  662. 6z5e: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2004093
  663. 6z5d: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2004082
  664. 6z5c: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2004070
  665. 6z5b: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2003128
  666. 6z5a: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2002941
  667. 6z59: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2003816
  668. 6z58: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2003791
  669. 6z57: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2004078
  670. 6z56: Crystal Structure of Haspin (gsg2) in Complex with Macrocycle Ods2003208
  671. 6z4y: Crystal Structure of Aurora a (stk6) in Complex with Macrocycle Ods2003208
  672. 3ofm: Structure of a Human CK2ALPHA Prime, The Paralog Isoform of The Catalytic Subunit of Protein Kinase Ck2 from Homo Sapiens
  673. 3ose: Structure of The Kinase Associated Domain 1 (ka1) from Mark1 Kinase
  674. 3osm: Structure of The Kinase Associated Domain-1 (ka1) from KCC4P
  675. 3ost: Structure of The Kinase Associated-1 (ka1) from KCC4P
  676. 6vrf: Adp Bound Ttbk2 Kinase Domain
  677. 6uuo: Crystal Structure of Braf Kinase Domain Bound to The Protac P4B
  678. 3p23: Crystal Structure of The Human Kinase and Rnase Domains in Complex with Adp
  679. 3pcs: Structure of Espg-pak2 Autoinhibitory Ialpha3 Helix Complex
  680. 3ppj: Human B-raf Kinase in Complex with a Furopyridine Inhibitor
  681. 3ppk: Human B-raf Kinase in Complex with a Non-oxime Furopyridine Inhibitor
  682. 3prf: Crystal Structure of Human B-raf Kinase Domain in Complex with a Non- Oxime Furopyridine Inhibitor
  683. 3pri: Crystal Structure of Human B-raf Kinase in Complex with a Non-oxime Furopyridine Inhibitor
  684. 3ps4: Pdz Domain from Human Microtubule-associated Serine/threonine-protein Kinase 1
  685. 3psb: Furo[2,3-c]pyridine-based Indanone Oximes as Potent and Selective B- Raf Inhibitors
  686. 6ya8: Cdc7-dbf4 Bound to Adp-bef3
  687. 6ya7: Cdc7-dbf4 Bound to an Mcm2-s40 Derived Bivalent Substrate
  688. 6ya6: Minimal Construct of Cdc7-dbf4 Bound to Xl413
  689. 3pvg: Crystal Structure of Z. Mays Ck2 Alpha Subunit in Complex with The Inhibitor 4,5,6,7-tetrabromo-1-carboxymethylbenzimidazole (k68)
  690. 3q4c: Crystal Structure of Wild Type Braf Kinase Domain in Complex with Organometallic Inhibitor Cns292
  691. 3q5z: Crystal Structure of Virulent Allele ROP5B Pseudokinase Domain
  692. 3q60: Crystal Structure of Virulent Allele ROP5B Pseudokinase Domain Bound to Atp
  693. 6p3a: Crystal Structure Analysis of Taf1 Bromodomain
  694. 6p39: Crystal Structure Analysis of Taf1 Bromodomain
  695. 6p38: Crystal Structure Analysis of Taf1 Bromodomain
  696. 6l16: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  697. 6l15: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  698. 6l14: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  699. 6l13: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  700. 6l12: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  701. 6l11: Crystal Structure of Ser/thr Kinase Pim1 in Complex with 10-debc Derivatives
  702. 3qf9: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Furan- Thiazolidinedione Ligand
  703. 6y9s: Crystal Structure of Gsk-3b in Complex with The Imidazo[1,5- A]pyridine-3-carboxamide Inhibitor 16
  704. 6y9r: Crystal Structure of Gsk-3b in Complex with The 1h-indazole-3- Carboxamide Inhibitor 2
  705. 2xnm: Structure of Nek2 Bound to Cct
  706. 2xnn: Structure of Nek2 Bound to Cct242430
  707. 2xno: Structure of Nek2 Bound to Cct243779
  708. 2xnp: Structure of Nek2 Bound to Cct244858
  709. 6jlr: Crystal Structure of Wild Type Mnk2 in Complex with Inhibitor
  710. 2y8l: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with Two Adp
  711. 2y8q: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with One Adp
  712. 2ya3: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with Coumarin Adp
  713. 2ya9: Crystal Structure of The Autoinhibited Form of Mouse Dapk2
  714. 2yaa: Crystal Structure of The Autoinhibited Form of Mouse Dapk2 in Complex with Atp
  715. 2yab: Crystal Structure of The Autoinhibited Form of Mouse Dapk2 in Complex with Amp
  716. 2yak: Structure of Death-associated Protein Kinase 1 (dapk1) in Complex with a Ruthenium Octasporine Ligand (osv)
  717. 3aqv: Human Amp-activated Protein Kinase Alpha 2 Subunit Kinase Domain (T172D) Complexed with Compound C
  718. 3m11: Crystal Structure of Aurora a Kinase Complexed with Inhibitor
  719. 3m42: Crystal Structure of Mapkap Kinase 2 (mk2) Complexed with a Tetracyclic Atp Site Inhibitor
  720. 3o0z: Crystal Structure of a Coiled-coil Domain from Human Rock I
  721. 6ru8: Crystal Structure of Casein Kinase I Delta (CK1D) in Complex with Triple Phosphorylated P63 PAD3P Peptide
  722. 6ru7: Crystal Structure of Casein Kinase I Delta (CK1D) in Complex with Double Phosphorylated P63 PAD2P Peptide
  723. 6ru6: Crystal Structure of Casein Kinase I Delta (CK1D) in Complex with Monophosphorylated P63 PAD1P Peptide
  724. 3orx: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Inhibitor 1f8
  725. 3orz: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Activator 2a2
  726. 3otu: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Activator Js30
  727. 3p9j: Aurora a Kinase Domain with Phthalazinone Pyrazole Inhibitor
  728. 3pwy: Crystal Structure of an Extender (spd28345)-modified Human Pdk1 Complex 2
  729. 3q96: B-raf Kinase Domain in Complex with a Tetrahydronaphthalene Inhibitor
  730. 3qc4: Pdk1 in Complex with Dfg-out Inhibitor XXX
  731. 3qcq: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-(3- Amino-1h-indazol-6-yl)-n4-ethyl-2,4-pyrimidinediamine
  732. 3qcs: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-[2- Amino-6-(4-morpholinyl)-4-pyrimidinyl]-1h-indazol-3-amine
  733. 3qcx: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-{2- Amino-6-[(3r)-3-methyl-4-morpholinyl]-4-pyrimidinyl}-1h-indazol-3- Amine
  734. 3qcy: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 4-[2- Amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-n-phenyl-2- Morpholinecarboxamide
  735. 3qd0: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with (2r,5s)- 1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-6-methyl-n- Phenyl-3-piperidinecarboxamide
  736. 3qd2: Crsytal Structure of Mouse Perk Kinase Domain
  737. 3qd3: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 1,1- Dimethylethyl {(3r,6s)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4- Pyrimidinyl]-6-methyl-3-piperidinyl}carbamate
  738. 3qd4: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 1,1- Dimethylethyl{(3r,5r)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4- Pyrimidinyl]-5-methyl-3-piperidinyl}carbamate
  739. 3qkk: Spirochromane Akt Inhibitors
  740. 3qkl: Spirochromane Akt Inhibitors
  741. 3qkm: Spirocyclic Sulfonamides as Akt Inhibitors
  742. 6ra5: Human Tnik in Complex with Compound 9
  743. 6yat: Crystal Structure of Stk4 (mst1) in Complex with Compound 6
  744. 2lav: Nmr Solution Structure of Human Vaccinia-related Kinase 1
  745. 2lah: Solution Nmr Structure of Mitotic Checkpoint Serine/threonine-protein Kinase Bub1 N-terminal Domain from Homo Sapiens, Northeast Structural Genomics Consortium Target HR5460A (methods Development)
  746. 3r00: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  747. 3r01: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  748. 3r02: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  749. 3r04: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
  750. 3lcy: Titin Ig Tandem Domains A164-a165
  751. 3nlb: Novel Kinase Profile Highlights The Temporal Basis of Context Dependent Checkpoint Pathways to Cell Death
  752. 3psd: Non-oxime Pyrazole Based Inhibitors of B-raf Kinase
  753. 6xx9: Arabidopsis Thaliana Casein Kinase 2 (ck2) Alpha-1 Crystal Form III
  754. 6xx8: Arabidopsis Thaliana Casein Kinase 2 (ck2) Alpha-1 Crystal Form II
  755. 3r1n: Mk3 Kinase Bound to Compound 5b
  756. 6xx7: Arabidopsis Thaliana Casein Kinase 2 (ck2) Alpha-1 Crystal in Complex with Anp
  757. 6xx6: Arabidopsis Thaliana Casein Kinase 2 (ck2) Alpha-1 Crystal Form I
  758. 3r2b: Mk2 Kinase Bound to Compound 5b
  759. 3r2y: Mk2 Kinase Bound to Compound 1
  760. 3r30: Mk2 Kinase Bound to Compound 2
  761. 2kyl: Solution Structure of Mast2-pdz Complexed with The C-terminus of Pten
  762. 6ol2: Crystallography of Novel Wnk1 and Wnk3 Inhibitors Discovered from High-throughput-screening
  763. 6l54: Structure of Smg189
  764. 6l53: Structure of Smg1
  765. 6rff: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 7
  766. 6rfe: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 4
  767. 6rcm: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 3
  768. 6rcb: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 14
  769. 6rb1: Human Protein Kinase Ck2 Alpha in Complex with 2-cyano-2-propenamide Compound 1
  770. 6lnm: Crystal Structure of Cask-camk in Complex with Mint1-cid
  771. 6rsu: Tbk1 in Complex with Inhibitor Compound 35
  772. 6rch: Crystal Structure of Casein Kinase I Isoform Delta (ck1 Delta) Complexed with Sr4133 Inhibitor
  773. 6rcg: Crystal Structure of Casein Kinase 1 Delta (ck1 Delta) Complexed with Sr3029 Inhibitor
  774. 6qy8: Human CSNK2A2 Bound to Erb-041
  775. 6qy7: Human CSNK2A1 Bound to Erb-041
  776. 6y7c: Early Cytoplasmic Yeast Pre-40s Particle (purified with Tsr1 as Bait)
  777. 6l1z: Crystal Structure of CK2A1 with Hematein
  778. 6p5p: Discovery of a Novel, Highly Potent, and Selective Thieno[3,2- D]pyrimidinone-based Cdc7 Inhibitor with a Quinuclidine Moiety (tak- 931) as an Orally Active Investigational Anti-tumor Agent
  779. 6y6h: Crystal Structure of STK17B (drak2) in Complex with Unc-ap-194 Probe
  780. 6y6f: Crystal Structure of STK17B (drak2) in Complex with Pkis43
  781. 6vzh: Structure of Human Vaccinia-related Kinase 1 (vrk1) Bound to Ldsm311
  782. 3rcj: Rapid Preparation of Triazolyl Substituted Nh-heterocyclic Kinase Inhibitors via One-pot Sonogashira Coupling Tms-deprotection Cuaac Sequence
  783. 3rgx: Structural Insight into Brassinosteroid Perception by Bri1
  784. 3rgz: Structural Insight into Brassinosteroid Perception by Bri1
  785. 3riz: Crystal Structure of The Plant Steroid Receptor Bri1 Ectodomain
  786. 3rj0: Plant Steroid Receptor Bri1 Ectodomain in Complex with Brassinolide
  787. 3rps: Structure of Human CK2ALPHA in Complex with The Atp-competitive Inhibitor 3-(4,5,6,7-tetrabromo-1h-benzotriazol-1-yl)propan-1-ol
  788. 6u0k: Ttbk2 Kinase Domain in Complex with Compound 1
  789. 6ntd: Crystal Structure of G12V Hras-gppnhp Bound in Complex with The Engineered Rbd Variant 12 of Craf Kinase Protein
  790. 3s95: Crystal Structure of The Human Limk1 Kinase Domain in Complex with Staurosporine
  791. 3sdj: Structure of Rnase-inactive Point Mutant of Oligomeric Kinase/rnase Ire1
  792. 3sdm: Structure of Oligomeric Kinase/rnase Ire1 in Complex with an Oligonucleotide
  793. 6shc: Crystal Structure of Human Ire1 Luminal Domain Q105C
  794. 3r21: Design, Synthesis, and Biological Evaluation of Pyrazolopyridine- Sulfonamides as Potent Multiple-mitotic Kinase (mmk) Inhibitors (part I)
  795. 3r22: Design, Synthesis, and Biological Evaluation of Pyrazolopyridine- Sulfonamides as Potent Multiple-mitotic Kinase (mmk) Inhibitors (part I)
  796. 6rst: Tbk1 in Complex with Inhibitor Compound 24
  797. 6rsr: Tbk1 in Complex with Compound 2
  798. 3skc: Human B-raf Kinase in Complex with an Amide Linked Pyrazolopyridine Inhibitor
  799. 6nid: Crystal Structure of a Human Calcium/calmodulin Dependent Serine Protein Kinase (cask) Pdz Domain in Complex with Neurexin-1 Peptide
  800. 6nh9: Crystal Structure of a Human Calcium/calmodulin Dependent Serine Protein Kinase (cask) Pdz Domain
  801. 2yiq: Structural Analysis of Checkpoint Kinase 2 in Complex with Inhibitor Pv1322
  802. 2yir: Structural Analysis of Checkpoint Kinase 2 in Complex with Inhibitor Pv1352
  803. 2yit: Structural Analysis of Checkpoint Kinase 2 in Complex with Pv1162, a Novel Inhibitor
  804. 6k9l: 4.27 Angstrom Resolution Cryo-em Structure of Human Dimeric Atm Kinase
  805. 6k9k: Monomeric Human Atm (ataxia Telangiectasia Mutated) Kinase
  806. 3pe1: Crystal Structure of Human Protein Kinase Ck2 Alpha Subunit in Complex with The Inhibitor Cx-4945
  807. 3pe2: Crystal Structure of Human Protein Kinase Ck2 in Complex with The Inhibitor Cx-5011
  808. 5qqn: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-010-382-606
  809. 5qqm: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-565-325
  810. 5qql: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-565-301
  811. 5qqk: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-359-835
  812. 5qqj: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-587-558
  813. 5qqi: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-178-994
  814. 5qqh: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-020-096-465
  815. 5qqg: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-541-216
  816. 5qqf: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-004-412-710
  817. 5qqe: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Molport-009-531-494
  818. 5qqd: Pandda Analysis Group Deposition -- Crystal Structure of Kalirin/rac1 in Complex with Z56880342
  819. 6uya: Crystal Structure of Compound 19 Bound to Irak4
  820. 6urc: Crystal Structure of IRE1A in Complex with Compound 18
  821. 6ul8: Rip2 Kinase Catalytic Domain Complex with (5s,6s,8r)-2- (benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8- Methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide
  822. 3s1a: Crystal Structure of The Phosphorylation-site Double Mutant S431E/T432E of The Kaic Circadian Clock Protein
  823. 6uan: B-raf:14-3-3 Complex
  824. 6u2h: Braf Dimer Bound to 14-3-3
  825. 6u2g: Braf-mek Complex with Amp-pcp Bound to Braf
  826. 3amy: Crystal Structure of Human Ck2 Alpha Complexed with Apigenin
  827. 6szj: Rip2 Kinase Catalytic Domain Complex with 5AMINO1TERTBUTYL3(3METHOXYPHENYL)1H PYRAZOLE4CARBOXAMIDE.
  828. 6sze: Rip2 Kinase Catalytic Domain Complex with 5-amino-1-phenylpyrazole-4- Carboxamide.
  829. 3t9i: Pim1 Complexed with a Novel 3,6-disubstituted Indole at 2.6 Ang Resolution
  830. 3tac: Crystal Structure of The Liprin-alpha/cask Complex
  831. 3tku: Mrck Beta in Complex with Fasudil
  832. 3tv4: Human B-raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor
  833. 3tv6: Human B-raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor
  834. 6sl1: Structure of The Open Conformation of Cttel1
  835. 6sl0: Complete Cttel1 Dimer with C2 Symmetry
  836. 6skz: Structure of The Closed Conformation of Cttel1
  837. 6sky: Fat and Kinase Domain of Cttel1
  838. 3zut: The Structure of Ost1 (D160A) Kinase
  839. 3zuu: The Structure of Ost1 (D160A, S175D) Kinase in Complex with Gold
  840. 6sdb: Chimeric Titin Z1Z2 Functionalized with a Kler Exogenous Peptide from Decorin
  841. 6sb2: Cryo-em Structure of Mtorc1 Bound to Active Raga/c Gtpases
  842. 6sb0: Cryo-em Structure of Mtorc1 Bound to Pras40-fused Active Raga/c Gtpases
  843. 6s9x: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 15c
  844. 6s9w: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 16a
  845. 6s8f: Structure of Nucleotide-bound Tel1/atm
  846. 3p86: Crystal Structure of Ctr1 Kinase Domain Mutant D676N in Complex with Staurosporine
  847. 3sc1: Novel Isoquinolone Pdk1 Inhibitors Discovered through Fragment-based Lead Discovery
  848. 3si5: Kinetochore-bubr1 Kinase Complex
  849. 6s1f: Structure of The Kinase Domain of Human Ripk2 in Complex with The Inhibitor Cslp3
  850. 2xuu: Crystal Structure of a Dap-kinase 1 Mutant
  851. 3at2: Crystal Structure of CK2ALPHA
  852. 3at3: Crystal Structure of CK2ALPHA with Pyradine Derivative
  853. 3at4: Crystal Structure of CK2ALPHA with Pyradine Derivertive
  854. 3pwd: Crystal Structure of Maize Ck2 in Complex with Nbc (z1)
  855. 3t4n: Structure of The Regulatory Fragment of Saccharomyces Cerevisiae Ampk in Complex with Adp
  856. 3tdh: Structure of The Regulatory Fragment of Sccharomyces Cerevisiae Ampk in Complex with Amp
  857. 3te5: Structure of The Regulatory Fragment of Sacchromyces Cerevisiae Ampk in Complex with Nadh
  858. 6rna: Rip2 Kinase Catalytic Domain Complex with 2({4[(1,3BENZOTHIAZOL5YL) AMINO]6(2METHYLPROPANE2SULFONYL)QUINAZOLIN7YL}OXY)ETHAN1OL
  859. 6rn8: Rip2 Kinase Catalytic Domain Complex with 2(4[(1,3BENZOTHIAZOL5YL) AMINO]6(2METHYLPROPANE2SULFONYL)QUINAZOLIN7YL)OXY)ETHYL Phosphate
  860. 6rln: Crystal Structure of Rip1 Kinase in Complex with Gsk3145095
  861. 2ycf: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv1531
  862. 2ycq: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv1115
  863. 2ycr: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv976
  864. 2ycs: Crystal Structure of Checkpoint Kinase 2 in Complex with Pv788
  865. 3rwp: Discovery of a Novel, Potent and Selective Inhibitor of 3- Phosphoinositide Dependent Kinase (pdk1)
  866. 3rwq: Discovery of a Novel, Potent and Selective Inhibitor of 3- Phosphoinositide Dependent Kinase (pdk1)
  867. 3tax: A Neutral Diphosphate Mimic Crosslinks The Active Site of Human O- Glcnac Transferase
  868. 3udb: Crystal Structure of Snrk2.6
  869. 6rfj: Irak4 in Complex with Inhibitor
  870. 6rfi: Irak4 in Complex with Inhibitor
  871. 6rbd: State 1 of Yeast Tsr1-tap Rps20-deltaloop Pre-40s Particles
  872. 2xzs: Death Associated Protein Kinase 1 Residues 1-312
  873. 6ra7: Human Tnik in Complex with Compound 9
  874. 2y0a: Structure of Dapk1 Construct Residues 1-304
  875. 3ppz: Crystal Structure of Ctr1 Kinase Domain in Complex with Staurosporine
  876. 3puc: Atomic Resolution Structure of Titin Domain M7
  877. 3pzh: Crystal Structure of Maize Ck2 Alpha in Complex with Emodin at 1.92 a Resolution
  878. 3q04: Crystal Structure of The Apo-form of Human Ck2 Alpha at Ph 8.5
  879. 3q4z: Structure of Unphosphorylated Pak1 Kinase Domain
  880. 3q52: Structure of Phosphorylated Pak1 Kinase Domain
  881. 3q53: Structure of Phosphorylated Pak1 Kinase Domain in Complex with Atp
  882. 3r0t: Crystal Structure of Human Protein Kinase Ck2 Alpha Subunit in Complex with The Inhibitor Cx-5279
  883. 6r5f: Crystal Structure of Rip1 Kinase in Complex with Dhp77
  884. 6r4d: Aurora-a in Complex with Shape-diverse Fragment 58
  885. 6r4c: Aurora-a in Complex with Shape-diverse Fragment 57
  886. 3she: Novel Atp-competitive Mk2 Inhibitors with Potent Biochemical and Cell- Based Activity throughout The Series
  887. 6r4b: Aurora-a in Complex with Shape-diverse Fragment 56
  888. 6r4a: Aurora-a in Complex with Shape-diverse Fragment 55
  889. 6r49: Aurora-a in Complex with Shape-diverse Fragment 39
  890. 6r1h: Crystal Structure of The Lrr Ectodomain of The Receptor Kinase Sobir1 from Arabidopsis Thaliana.
  891. 6qy9: Human CSNK2A2 Bound to a Pyrrolo[2,3-d]pyrimidinyl Inhibitor
  892. 3uc3: The Crystal Structure of Snf1-related Kinase 2.3
  893. 3uc4: The Crystal Structure of Snf1-related Kinase 2.6
  894. 6qxk: Human Pim1 Bound to Ox0999
  895. 4a06: Human Pdk1 Kinase Domain in Complex with Allosteric Activator Ps114 Bound to The Pif-pocket
  896. 4a07: Human Pdk1 Kinase Domain in Complex with Allosteric Activator Ps171 Bound to The Pif-pocket
  897. 6qsa: Cryogenic Temperature Structure of Blue Light-irradiated ATPHOT2LOV2 Recorded after an Accumulated Dose of 48 Kgy
  898. 6qs5: Crystal Structure of Maize Ck2 in Complex with Tyrphostin Ag99
  899. 6qqk: Room Temperature Structure of Blue Light-irradiated ATPHOT2LOV2 Recorded after an Accumulated Dose of 34 Kgy
  900. 6qqj: Room Temperature Structure of The Ground State of ATPHOT2LOV2 Recorded after an Accumulated Dose of 354 Kgy
  901. 6qqi: Cryogenic Temperature Structure of Blue Light-irradiated ATPHOT2LOV2 Recorded after an Accumulated Dose of 24 Kgy
  902. 6qqh: Cryogenic Temperature Structure of The Ground State of ATPHOT2LOV2 Recorded after an Accumulated Dose of 2.68 Mgy
  903. 2y4v: Crystal Structure of Human Calmodulin in Complex with a Dap Kinase-1 Mutant (W305Y) Peptide
  904. 6qn4: Death-associated Protein Kinase 1 (dapk1) Catalytic and Auto- Regulatory Domains with S289E and S308E Mutations
  905. 6qmo: Death-associated Protein Kinase 1 (dapk1) Catalytic and Auto- Regulatory Domains with S289E and S308A Mutations
  906. 4a55: Crystal Structure of P110ALPHA in Complex with Ish2 of P85ALPHA and The Inhibitor Pik-108
  907. 2ym3: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  908. 2ym4: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  909. 2ym5: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  910. 2ym6: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  911. 2ym7: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  912. 2ym8: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
  913. 3q9w: Crystal Structure of Human Ck2 Alpha in Complex with Emodin at Ph 8.5
  914. 3q9x: Crystal Structure of Human Ck2 Alpha in Complex with Emodin at Ph 6.5
  915. 3q9y: Crystal Structure of Human Ck2 Alpha in Complex with Quinalizarin at Ph 8.5
  916. 3q9z: Crystal Structure of Human Ck2 Alpha in Complex with Quinalizarin at Ph 6.5
  917. 3qa0: Crystal Structure of The Apo-form of Human Ck2 Alpha at Ph 6.5
  918. 6qf4: X-ray Structure of Human Serine/threonine Kinase 17b (STK17B) Aka Drak2 in Complex with Adp Obtained by On-chip Soaking
  919. 3tl8: The Avrptob-bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains in a Single Type III Effector
  920. 3uys: Crystal Structure of Apo Human CK1D
  921. 3uyt: Crystal Structure of CK1D with Pf670462 from P1 Crystal Form
  922. 3uzp: Crystal Structure of CK1D with Pf670462 from P21 Crystal Form
  923. 2y4p: Dimeric Structure of Dapk-1 Catalytic Domain
  924. 6qav: Crystal Structure of Ulk2 in Complexed with Mrt68921
  925. 6qau: Crystal Structure of Ulk2 in Complexed with Mrt67307
  926. 6qat: Crystal Structure of Ulk2 in Complexed with Hesperadin
  927. 6qas: Crystal Structure of Ulk1 in Complexed with Pf-03814735
  928. 3qbn: Structure of Human Aurora a in Complex with a Diaminopyrimidine
  929. 3uv5: Crystal Structure of The Tandem Bromodomains of Human Transcription Initiation Factor Tfiid Subunit 1 (taf1)
  930. 2ydj: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
  931. 6q4q: The Crystal Structure of CK2A Bound to P2-c4
  932. 6q38: The Crystal Structure of CK2A Bound to P1-c4
  933. 6q0t: Structure of a Mapk Pathway Complex
  934. 6q0k: Structure of a Mapk Pathway Complex
  935. 6q0j: Structure of a Mapk Pathway Complex
  936. 3u9n: X-ray Crystal Structure of Compound 1 Bound to Human Chk1 Kinase Domain
  937. 3unz: Aurora a in Complex with Rpm1679
  938. 3uo4: Aurora a in Complex with Rpm1680
  939. 3uo5: Aurora a in Complex with Yl1-038-31
  940. 3uo6: Aurora a in Complex with Yl5-083
  941. 3uod: Aurora a in Complex with Rpm1693
  942. 3uoh: Aurora a in Complex with Rpm1722
  943. 3uoj: Aurora a in Complex with Rpm1715
  944. 3uok: Aurora a in Complex with Yl5-81-1
  945. 3uol: Aurora a in Complex with So2-162
  946. 3up2: Aurora a in Complex with Rpm1686
  947. 3up7: Aurora a in Complex with Yl1-038-09
  948. 6pys: Human PI3KALPHA in Complex with Compound 2-10 ((3s)-3-benzyl-3-methyl- 5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3- Dihydro-2h-indol-2-one)
  949. 2lcs: Yeast NBP2P Sh3 Domain in Complex with a Peptide from STE20P
  950. 3q5o: Crystal Structure of Human Titin Domain M10
  951. 3ztx: Aurora Kinase Selective Inhibitors Identified Using a Taxol- Induced Checkpoint Sensitivity Screen.
  952. 6pp9: Crystal Structure of Braf:mek1 Complex
  953. 3v8s: Human Rho-associated Protein Kinase 1 (rock 1) in Complex with Indazole Derivative (compound 18)
  954. 2ygv: Conserved N-terminal Domain of The Yeast Histone Chaperone Asf1 in Complex with The C-terminal Fragment of Rad53
  955. 3qp3: Crystal Structure of Titin Domain M4, Tetragonal Form
  956. 3tv7: Human Rho-associated Protein Kinase 1 (rock 1) in Complex with Rki1342
  957. 3ujg: Crystal Structure of Snrk2.6 in Complex with Hab1
  958. 4a7c: Crystal Structure of Pim1 Kinase with Etp46546
  959. 6pk6: Human PRPF4B Bound to Benzothiophene Inhibitor 329
  960. 6pjj: Human PRPF4B Bound to Benzothiophene Inhibitor 224
  961. 4dit: Crystal Structure of GSK3BETA in Complex with a Imidazolopyridine Inhibitor
  962. 6pdp: Human Pim1 Bound to Benzothiophene Inhibitor 379
  963. 6pdo: Human Pim1 Bound to Benzothiophene Inhibitor 354
  964. 6pdn: Human Pim1 Bound to Benzothiophene Inhibitor 292
  965. 6pdi: Human Pim1 Bound to Benzothiophene Inhibitor 224
  966. 6pcw: Human Pim1 Bound to Benzothiophene Inhibitor 213
  967. 2y9q: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
  968. 6p5s: Hipk2 Kinase Domain Bound to Cx-4945
  969. 4a1g: The Crystal Structure of The Human Bub1 Tpr Domain in Complex with The Ki Motif of Knl1
  970. 4afj: 5-aryl-4-carboxamide-1,3-oxazoles: Potent and Selective Gsk-3 Inhibitors
  971. 2yer: Synthesis and Evaluation of Triazolones as Checkpoint Kinase 1 Inhibitors
  972. 2yex: Synthesis and Evaluation of Triazolones as Checkpoint Kinase 1 Inhibitors
  973. 3uv4: Crystal Structure of The Second Bromodomain of Human Transcription Initiation Factor Tfiid Subunit 1 (taf1)
  974. 6oko: Crystal Structure of Mripk3 Complexed with N-(3-fluoro-4-{1h- Pyrrolo[2,3-b]pyridin-4-yloxy}phenyl)-1-(4-fluorophenyl)-2-oxo-1,2- Dihydropyridine-3-carboxamide
  975. 4daw: Crystal Structure of Pak1 Kinase Domain with The Ruthenium Phthalimide Complex
  976. 4dug: Crystal Structure of Circadian Clock Protein Kaic E318A Mutant
  977. 6ocq: Crystal Structure of Rip1 Kinase in Complex with a Pyrrolidine
  978. 3vbq: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  979. 3vbt: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  980. 3vbv: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  981. 3vbw: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  982. 3vbx: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  983. 3vby: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  984. 3vc4: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
  985. 6oac: Pqr530 [(s)-4-(difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino- 1,3,5-triazin-2-yl)pyridin-2-amine] Bound to The PI3KA Catalytic Subunit P110ALPHA
  986. 6o9d: Structure of The Irak4 Kinase Domain with Compound 5
  987. 6o95: Structure of The Irak4 Kinase Domain with Compound 41
  988. 6o94: Structure of The Irak4 Kinase Domain with Compound 17
  989. 6o8u: Crystal Structure of Irak4 in Complex with Compound 23
  990. 6o8c: Crystal Structure of Sting Ctt in Complex with Tbk1
  991. 6o8b: Crystal Structure of Sting Ctd in Complex with Tbk1
  992. 2ydi: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
  993. 2ydk: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
  994. 3axw: Crystal Structure of Human CK2ALPHA Complexed with a Potent Inhibitor
  995. 3tkh: Crystal Structure of Chk1 in Complex with Inhibitor S01
  996. 3tki: Crystal Structure of Chk1 in Complex with Inhibitor S25
  997. 3uix: Crystal Structure of Pim1 Kinase in Complex with Small Molecule Inhibitor
  998. 4af3: Human Aurora B Kinase in Complex with Incenp and Vx-680
  999. 4aot: Crystal Structure of Human Serine Threonine Kinase-10 (lok) Bound to GW830263A
  1000. 4d9u: Rsk2 C-terminal Kinase Domain, (e)-tert-butyl 3-(4-amino-7-(3- Hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2- Cyanoacrylate
  1001. 4dbn: Crystal Structure of The Kinase Domain of Human B-raf with a [1, 3]thiazolo[5,4-b]pyridine Derivative
  1002. 6nyh: Structure of Human Ripk1 Kinase Domain in Complex with Gne684
  1003. 6nyb: Structure of a Mapk Pathway Complex
  1004. 6nw2: Structure of Human Ripk1 Kinase Domain in Complex with Compound 11
  1005. 6nt9: Cryo-em Structure of The Complex between Human Tbk1 and Chicken Sting
  1006. 3rny: Crystal Structure of Human Rsk1 C-terminal Kinase Domain
  1007. 6nsq: Crystal Structure of Braf Kinase Domain Bound to The Inhibitor 2l
  1008. 4a4x: Nek2-ede Bound to Cct248662
  1009. 4afe: Nek2 Bound to Hybrid Compound 21
  1010. 4apc: Crystal Structure of Human Nima-related Kinase 1 (nek1)
  1011. 4d9t: Rsk2 C-terminal Kinase Domain with Inhibitor (e)-methyl 3-(4-amino-7- (3-hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2- Cyanoacrylate
  1012. 6npz: Crystal Structure of Akt1 (aa 123-480) Kinase with a Bisubstrate
  1013. 6npy: Cryo-em Structure of Nlrp3 Bound to Nek7
  1014. 3re4: Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase Bound to Toyocamycin.
  1015. 6npn: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N,n- Dipropynyl-dihydropteridine-3-hydroxyindazole Inhibitor
  1016. 6no9: Pim1 in Complex with Cpd16 (5-amino-n-(5-((4r,5r)-4-amino-5- Fluoroazepan-1-yl)-1-methyl-1h-pyrazol-4-yl)-2-(2,6-difluorophenyl) Thiazole-4-carboxamide)
  1017. 6no8: Pim1 in Complex with Cpd9 ((r)-5-amino-n-(3-(4-aminoazepan-1-yl)-1h- Pyrazol-4-yl)-2-(2,6-difluorophenyl)thiazole-4-carboxamide)
  1018. 3vap: Synthesis and Sar Studies of Imidazo-[1,2-a]-pyrazine Aurora Kinase Inhibitors with Improved off Target Kinase Selectivity
  1019. 4anu: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  1020. 4anv: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  1021. 4anw: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  1022. 4anx: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
  1023. 4aof: Selective Small Molecule Inhibitor Discovered by Chemoproteomic Assay Platform Reveals Regulation of Th17 Cell Differentiation by PI3KGAMMA
  1024. 4dgl: Crystal Structure of The Ck2 Tetrameric Holoenzyme
  1025. 4e26: Braf in Complex with an Organic Inhibitor 7898734
  1026. 4e4x: Crystal Structure of B-raf Kinase Domain in Complex with a Dihydropyrido[2,3-d]pyrimidinone-based Inhibitor
  1027. 6ng0: Crystal Structure of Hpk1 Kinase Domain T165E,S171E Phosphomimetic Mutant in Complex with Sunitinib in The Inactive State.
  1028. 6nfz: Crystal Structure of Diphosphorylated Hpk1 Kinase Domain in Complex with Sunitinib in The Active State.
  1029. 6nfy: Crystal Structure of Nonphosphorylated, Hpk1 Kinase Domain in Complex with Sunitinib in The Inactive State.
  1030. 4acc: GSK3B in Complex with Inhibitor
  1031. 4acd: GSK3B in Complex with Inhibitor
  1032. 4acg: GSK3B in Complex with Inhibitor
  1033. 4ach: GSK3B in Complex with Inhibitor
  1034. 4dk5: Crystal Structure of Human PI3K-GAMMA in Complex with a Pyridyl- Triazine Inhibitor
  1035. 4e7w: Structure of Gsk3 from Ustilago Maydis
  1036. 4eep: Crystal Structure of Lov2 Domain of Arabidopsis Thaliana Phototropin 2
  1037. 4eer: Crystal Structure of Lov2 Domain of Arabidopsis Thaliana Phototropin 2 C426A Mutant
  1038. 4ees: Crystal Structure of Ilov
  1039. 4eet: Crystal Structure of Ilov
  1040. 4eeu: Crystal Structure of Philov2.1
  1041. 6nct: Structure of P110ALPHA/NISH2 - Vector Data Collection
  1042. 6ncg: Crystal Structure of Human Vaccinia-related Kinase 2 (vrk-2) Bound to Pyridin-benzenesulfonamide Inhibitor
  1043. 2lru: Solution Structure of The Wnk1 Autoinhibitory Domain
  1044. 3uim: Structural Basis for The Impact of Phosphorylation on Plant Receptor- like Kinase Bak1 Activation
  1045. 5qu9: Pandda Analysis Group Deposition of Ground-state Model of Kalirin/rac1 Screened against a Customized Urea Fragment Library by X-ray Crystallography at The Xchem Facility of Diamond Light Source Beamline I04-1
  1046. 4anm: Complex of Ck2 with a Cdc7 Inhibitor
  1047. 4ejn: Crystal Structure of Autoinhibited Form of Akt1 in Complex with N-(4- (5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3h-imidazo[4,5- B]pyridin-3-yl)benzyl)-3-fluorobenzamide
  1048. 4ekk: Akt1 with Amp-pnp
  1049. 4ekl: Akt1 with Gdc0068
  1050. 4eut: Structure of Bx-795 Complexed with Unphosphorylated Human Tbk1 Kinase- Uld Domain
  1051. 4euu: Structure of Bx-795 Complexed with Human Tbk1 Kinase Domain Phosphorylated on Ser172
  1052. 6n8g: Irak4 Bound to Benzoxazole Compound
  1053. 2rse: Nmr Structure of Fkbp12-mtor Frb Domain-rapamycin Complex Structure Determined Based on Pcs
  1054. 3u87: Structure of a Chimeric Construct of Human CK2ALPHA and Human CK2ALPHA' in Complex with a Non-hydrolysable Atp-analogue
  1055. 3u9c: Structure of a C-terminal Deletion Mutant of Human Protein Kinase Ck2 Catalytic Subunit with The Atp-competitive Inhibitor Resorufin
  1056. 6l20: Crystal Structure of CK2A2 with Hematein
  1057. 6n45: Crystal Structure of The Cryptic Polo Box Domain of Human Activated Plk4 Variant 1
  1058. 6n3o: Identification of Novel, Potent and Selective Gcn2 Inhibitors as First-in-class Anti-tumor Agents
  1059. 6n3n: Identification of Novel, Potent and Selective Gcn2 Inhibitors as First-in-class Anti-tumor Agents
  1060. 6n3l: Identification of Novel, Potent and Selective Gcn2 Inhibitors as First-in-class Anti-tumor Agents
  1061. 6n0q: Braf in Complex with N-(4-methyl-3-(1-methyl-2-oxo-2,3-dihydro-1h- Benzo[d]imidazol-5-yl)phenyl)-3-(trifluoromethyl)benzamide.
  1062. 6n0p: Braf in Complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4- Yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (lxh254)
  1063. 6mzl: Human Tfiid Canonical State
  1064. 6mzd: Human Tfiid Lobe a Canonical
  1065. 4eai: Co-crystal Structure of an Ampk Core with Amp
  1066. 4eaj: Co-crystal of Ampk Core with Amp Soaked with Atp
  1067. 4eak: Co-crystal Structure of an Ampk Core with Atp
  1068. 4eal: Co-crystal of Ampk Core with Atp Soaked with Amp
  1069. 4aw2: Crystal Structure of Cdc42 Binding Protein Kinase Alpha (mrck Alpha)
  1070. 6mt0: Crystal Structure of Human Pim-1 Kinase in Complex with a Quinazolinone-pyrrolodihydropyrrolone Inhibitor
  1071. 6mom: Crystal Structure of Human Interleukin-1 Receptor Associated Kinase 4 (irak 4, Cid 100300) in Complex with Compound Ncc00371481 (bsi 107591)
  1072. 6mnh: Ulk1 Unc-51 like Autophagy Activating Kinase in Complex with Inhibitor Btc
  1073. 4efo: Crystal Structure of The Ubiquitin-like Domain of Human Tbk1
  1074. 4f0f: Crystal Structure of The Roco4 Kinase Domain Bound to Appcp from D. Discoideum
  1075. 4f0g: Crystal Structure of The Roco4 Kinase Domain from D. Discoideum
  1076. 4f1m: Crystal Structure of The G1179S Roco4 Kinase Domain Bound to Appcp from D. Discoideum.
  1077. 4f1t: Crystal Structure of The Roco4 Kinase Domain from D. Discoideum Bound to The Rock Inhibitor H1152
  1078. 6mib: Crystal Structure of The Ilk Atp-binding Deficient Mutant (L207W) /alpha-parvin Core Complex
  1079. 6mg9: Human Obscurin Ig57 Domain
  1080. 4dhf: Structure of Aurora a Mutant Bound to Biogenidec Cpd 15
  1081. 4dtk: Novel and Selective Pan-pim Kinase Inhibitor
  1082. 4fhj: Crystal Structure of PI3K-GAMMA in Complex with Imidazopyridine 2
  1083. 4fr4: Crystal Structure of Human Serine/threonine-protein Kinase 32a (yank1)
  1084. 6mcq: L. Pneumophila Effector Kinase Legk7 in Complex with Human MOB1A
  1085. 6mcp: L. Pneumophila Effector Kinase Legk7 (amp-pnp Bound) in Complex with Human MOB1A
  1086. 3zxt: Dimeric Structure of Dapk-1 Catalytic Domain in Complex with Amppcp-mg
  1087. 6qdr: Crystal Structure of 14-3-3sigma in Complex with a Pak6 Pt99 Phosphopeptide
  1088. 6qds: Crystal Structure of 14-3-3sigma in Complex with a Pak6 Pt99 Phosphopeptide Stabilized by Semi-synthetic Fusicoccane Fc-ncpc
  1089. 4dgm: Crystal Structure of Maize Ck2 in Complex with The Inhibitor Apigenin
  1090. 4dgn: Crystal Structure of Maize Ck2 in Complex with The Inhibitor Luteolin
  1091. 3umx: Crystal Structure of Pim1 Kinase in Complex with Inhibitor (z)-2-[(1h- Indol-3-yl)methylene]-7-(azepan-1-ylmethyl)-6-hydroxybenzofuran- 3(2h)-one
  1092. 3uto: Twitchin Kinase Region from C.elegans (fn31-nl-kin-crd-ig26)
  1093. 4enx: Crystal Structure of Pim-1 Kinase in Complex with Inhibitor (2e,5z)-2- (2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4- One
  1094. 4eny: Crystal Structure of Pim-1 Kinase in Complex with (2e,5z)-2-(2- Chlorophenylimino)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidin-4- One
  1095. 4f1s: Crystal Structure of Human PI3K-GAMMA in Complex with a Pyridyl- Triazine-sulfonamide Inhibitor
  1096. 4fk3: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx3203
  1097. 4g31: Crystal Structure of Gsk6414 Bound to Perk (r587-r1092, Delete A660- T867) at 2.28 a Resolution
  1098. 4g34: Crystal Structure of Gsk6924 Bound to Perk (r587-r1092, Delete A660- T867) at 2.70 a Resolution
  1099. 3tei: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
  1100. 3twj: Rho-associated Protein Kinase 1 (rock 1) in Complex with Rki1447
  1101. 3u4u: Casein Kinase 2 in Complex with Az-inhibitor
  1102. 4dea: Aurora a in Complex with Yl1-038-18
  1103. 4deb: Aurora a in Complex with Rk2-17-01
  1104. 4ded: Aurora a in Complex with Yl1-038-21
  1105. 4dee: Aurora a in Complex with Adp
  1106. 6jxc: Tel1 Kinase Butterfly Symmetric Dimer
  1107. 6jxa: Tel1 Kinase Compact Monomer
  1108. 6jwa: Crystal Structure of CK2A1 with 5-iodotubercidin
  1109. 4fsm: Crystal Structure of The Chk1
  1110. 4fsn: Crystal Structure of The Chk1
  1111. 4fsq: Crystal Structure of The Chk1
  1112. 4fsr: Crystal Structure of The Chk1
  1113. 4fst: Crystal Structure of The Chk1
  1114. 4fsu: Crystal Structure of The Chk1
  1115. 4fsw: Crystal Structure of The Chk1
  1116. 4fsy: Crystal Structure of The Chk1
  1117. 4fsz: Crystal Structure of The Chk1
  1118. 4ft0: Crystal Structure of The Chk1
  1119. 4ft3: Crystal Structure of The Chk1
  1120. 4ft5: Crystal Structure of The Chk1
  1121. 4ft7: Crystal Structure of The Chk1
  1122. 4ft9: Crystal Structure of The Chk1
  1123. 4fta: Crystal Structure of The Chk1
  1124. 4ftc: Crystal Structure of The Chk1
  1125. 4fti: Crystal Structure of The Chk1
  1126. 4ftj: Crystal Structure of The Chk1
  1127. 4ftk: Crystal Structure of The Chk1
  1128. 4ftl: Crystal Structure of The Chk1
  1129. 4ftm: Crystal Structure of The Chk1
  1130. 4ftn: Crystal Structure of The Chk1
  1131. 4fto: Crystal Structure of The Chk1
  1132. 4ftq: Crystal Structure of The Chk1
  1133. 4ftr: Crystal Structure of The Chk1
  1134. 4ftt: Crystal Structure of The Chk1
  1135. 4ftu: Crystal Structure of The Chk1
  1136. 4gb9: Potent and Highly Selective Benzimidazole Inhibitors of PI3K-DELTA
  1137. 6jle: Crystal Structure of MORN4/MYO3A Complex
  1138. 3ubd: Structure of N-terminal Domain of Rsk2 Kinase in Complex with Flavonoid Glycoside Sl0101
  1139. 3uib: Map Kinase Lmampk10 from Leishmania Major in Complex with Sb203580
  1140. 4aze: Human DYRK1A in Complex with Leucettine L41
  1141. 4azf: Human Dyrk2 in Complex with Leucettine L41
  1142. 4b9d: Crystal Structure of Human Nima-related Kinase 1 (nek1) with Inhibitor.
  1143. 4el9: Structure of N-terminal Kinase Domain of Rsk2 with Afzelin
  1144. 6j6i: Reconstitution and Structure of a Plant Nlr Resistosome Conferring Immunity
  1145. 4ewh: Co-crystal Structure of Ack1 with Inhibitor
  1146. 6j68: Structure of Kibra and Lats1 Complex
  1147. 6j5v: Ligand-triggered Allosteric Adp Release Primes a Plant Nlr Complex
  1148. 6j5u: Ligand-triggered Allosteric Adp Release Primes a Plant Nlr Complex
  1149. 6j5t: Reconstitution and Structure of a Plant Nlr Resistosome Conferring Immunity
  1150. 4fie: Full-length Human Pak4
  1151. 4fif: Catalytic Domain of Human Pak4 with Rpkplvdp Peptide
  1152. 4fig: Catalytic Domain of Human Pak4
  1153. 4fih: Catalytic Domain of Human Pak4 with Qkftglprqw Peptide
  1154. 4fii: Catalytic Domain of Human Pak4 with Rpkplvdp Peptide
  1155. 4fij: Catalytic Domain of Human Pak4
  1156. 4fj3: 14-3-3 Isoform Zeta in Complex with a Diphoyphorylated C-raf Peptide
  1157. 4flh: Crystal Structure of Human PI3K-GAMMA in Complex with Amg511
  1158. 3tpb: Structure of HIPA(S150A)
  1159. 3tpd: Structure of Phipa, Monoclinic Form
  1160. 3tpe: The Phipa P3121 Structure
  1161. 3tpt: Structure of HIPA(D309Q) Bound to Adp
  1162. 3tpv: Structure of Phipa Bound to Adp
  1163. 3umw: Crystal Structure of Pim1 Kinase in Complex with Inhibitor (z)-2-[(1h- Indazol-3-yl)methylene]-6-methoxy-7-(piperazin-1-ylmethyl)benzofuran- 3(2h)-one
  1164. 4a9r: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  1165. 4a9s: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  1166. 4a9t: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  1167. 4a9u: Crystal Structure of Human Chk2 in Complex with Benzimidazole Carboxamide Inhibitor
  1168. 4as0: Cyclometalated Phthalimides as Protein Kinase Inhibitors
  1169. 4aw0: Human Pdk1 Kinase Domain in Complex with Allosteric Compound Ps182 Bound to The Pif-pocket
  1170. 4aw1: Human Pdk1 Kinase Domain in Complex with Allosteric Compound Ps210 Bound to The Pif-pocket
  1171. 4bc6: Crystal Structure of Human Serine Threonine Kinase-10 Bound to Novel Bosutinib Isoform 1, Previously Thought to Be Bosutinib
  1172. 6in4: Crystal Structure of Apo Dapk1 in The Presence of 18-crown-6
  1173. 4fbx: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit Crystallized in The Presence of a Bisubstrate Inhibitor
  1174. 4ful: Pi3 Kinase Gamma Bound to a Pyrmidine Inhibitor
  1175. 4gh2: Crystal Structure of The Chk1
  1176. 4gw8: Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and Leucettine L41
  1177. 4f99: Human Cdc7 Kinase in Complex with Dbf4 and Nucleotide
  1178. 4f9a: Human Cdc7 Kinase in Complex with Dbf4 and Nucleotide
  1179. 4f9b: Human Cdc7 Kinase in Complex with Dbf4 and Pha767491
  1180. 4f9c: Human Cdc7 Kinase in Complex with Dbf4 and Xl413
  1181. 4fjy: Crystal Structure of PI3K-GAMMA in Complex with Quinoline-indoline Inhibitor 24f
  1182. 4fjz: Crystal Structure of PI3K-GAMMA in Complex with Pyrrolo-pyridine Inhibitor 63
  1183. 4gyw: Crystal Structure of Human O-glcnac Transferase in Complex with Udp and a Glycopeptide
  1184. 4gyy: Crystal Structure of Human O-glcnac Transferase with Udp-5sglcnac and a Peptide Substrate
  1185. 4gz3: Crystal Structure of Human O-glcnac Transferase with Udp and a Thioglycopeptide
  1186. 6i2y: Human Stk10 Bound to Foretinib
  1187. 6i2u: Aurora-a Kinase Domain in Complex with Coenzyme a
  1188. 6i2p: Crystal Structure of The Mycobacterium Tuberculosis Pknb Kinase Domain (L33E Mutant) in Complex with Its Substrate Gara
  1189. 6i0y: Tnac-stalled Ribosome Complex with The Titin I27 Domain Folding close to The Ribosomal Exit Tunnel
  1190. 6hyo: Structure of Ulk1 Lir Motif Bound to Gabarap
  1191. 3uiu: Crystal Structure of Apo-pkr Kinase Domain
  1192. 3ulz: Crystal Structure of Apo Bak1
  1193. 6hxf: Human Stk10 Bound to a Maleimide Inhibitor
  1194. 6hx1: Ire1 Alpha in Complex with Imidazo[1,2-b]pyridazin-8-amine Compound 2
  1195. 4equ: Human Stk-10 (lok) Kinase Domain in Dfg-out Conformation with Inhibitor Dsa-7
  1196. 4g11: X-ray Structure of PI3K-GAMMA Bound to a 4-(morpholin-4-yl)- (6-oxo-1, 6-dihydropyrimidin-2-yl)amide Inhibitor
  1197. 4g9c: Human B-raf Kinase Domain Bound to a Type II Pyrazolopyridine Inhibitor
  1198. 4g9r: B-raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor
  1199. 4ggd: Structural Analysis of Human Cdc20 Supports Multisite Degron Recognition by Apc/c.
  1200. 4hgl: Crystal Structure of CK1G3 with Compound 1
  1201. 4hgs: Crystal Structure of CK1GS with Compound 13
  1202. 4hgt: Crystal Structure of CK1D with Compound 13
  1203. 4hnf: Crystal Structure of CK1D in Complex with Pf4800567
  1204. 4hni: Crystal Structure of CK1E in Complex with Pf4800567
  1205. 4hok: Crystal Structure of Apo CK1E
  1206. 3zdi: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide and Inhibitor 7d
  1207. 3zhp: Human Mst3 (stk24) in Complex with MO25BETA
  1208. 3zim: Discovery of a Potent and Isoform-selective Targeted Covalent Inhibitor of The Lipid Kinase PI3KALPHA
  1209. 4alu: Benzofuropyrimidinone Inhibitors of Pim-1
  1210. 4alv: Benzofuropyrimidinone Inhibitors of Pim-1
  1211. 4b7t: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide and Leucettine L4
  1212. 4drh: Co-crystal Structure of The Ppiase Domain of Fkbp51, Rapamycin and The Frb Fragment of Mtor at Low Ph
  1213. 4dri: Co-crystal Structure of The Ppiase Domain of Fkbp51, Rapamycin and The Frb Fragment of Mtor
  1214. 4drj: O-crystal Structure of The Ppiase Domain of Fkbp52, Rapamycin and The Frb Fragment of Mtor
  1215. 4gue: Structure of N-terminal Kinase Domain of Rsk2 with Flavonoid Glycoside Quercitrin
  1216. 4gv1: Pkb Alpha in Complex with Azd5363
  1217. 4h3p: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
  1218. 4h58: Braf in Complex with Compound 3
  1219. 4hle: Compound 21 (1-alkyl-substituted 1,2,4-triazoles)
  1220. 6hvd: Human Slk Bound to a Maleimide Inhibitor
  1221. 6hv0: Ire1 Kinase/rnase in Complex with Imidazo[1,2-b]pyridazin-8-amine Compound 33
  1222. 6hou: Human Protein Kinase Ck2 Alpha in Complex with Vanillin
  1223. 6hot: Human Protein Kinase Ck2 Alpha in Complex with Ferulic Aldehyde
  1224. 6hor: Human Protein Kinase Ck2 Alpha in Complex with Feruloylmethane
  1225. 6hoq: Human Protein Kinase Ck2 Alpha in Complex with Ferulic Acid
  1226. 6hop: Human Protein Kinase Ck2 Alpha in Complex with Curcumin Degradation Products
  1227. 6hny: Human Protein Kinase Ck2 Alpha in Complex with Boldine
  1228. 6hnw: Human Protein Kinase Ck2 Alpha in Complex with Coumestrol
  1229. 6hmx: Rip2 Kinase Catalytic Domain Complex with N(4,5DIMETHYL1HPYRAZOL3YL) 7METHOXY6(2METHYLPROPANE2SULFONYL)QUINOLIN4AMINE
  1230. 6hmr: Crystal Structure of Human Casein Kinase I Delta in Complex with a Photoswitchable 2-azothiazole-based Inhibitor (compound 2)
  1231. 6hmp: Crystal Structure of Human Casein Kinase I Delta in Complex with a Photoswitchable 2-azoimidazole-based Inhibitor (compound 3)
  1232. 4hzr: Crystal Structure of Ack1 Kinase Domain
  1233. 6hme: Low-salt Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA; CSNK2A1 Gene Product) in Complex with The Indenoindole-type Inhibitor Thn27
  1234. 4hzs: Crystal Structure of Ack1 Kinase Domain with C-terminal Sh3 Domain
  1235. 6hmd: Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA'; CSNK2A2 Gene Product) in Complex with The Indenoindole-type Inhibitor Ar18
  1236. 6hmc: Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA'; CSNK2A2 Gene Product) in Complex with The Indenoindole-type Inhibitor Thn27
  1237. 6hmb: Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA'; CSNK2A2 Gene Product) in Complex with The Inhibitor Cx-4945 (silmitasertib)
  1238. 6hka: The Solution Structure of The Micelle-associated Fatc Domain of The Human Protein Kinase Ataxia Telangiectasia Mutated (atm)
  1239. 6hk7: Crystal Structure of Gsk-3b in Complex with Pyrazine Inhibitor C50
  1240. 6hk6: Human Riok2 Bound to Inhibitor
  1241. 4id7: Ack1 Kinase in Complex with The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
  1242. 6hk4: Crystal Structure of Gsk-3b in Complex with Pyrazine Inhibitor C22
  1243. 6hk3: Crystal Structure of Gsk-3b in Complex with Pyrazine Inhibitor C44
  1244. 6pxn: Human Casein Kinase 1 Delta Tau Mutant (R178C)
  1245. 6hjk: Crystal Structure of Aurora-a L210C Catalytic Domain in Complex with Asdo2
  1246. 6hjj: Crystal Structure of Aurora-a L210C Catalytic Domain in Complex with Asdo6 Ligand
  1247. 4ijm: Crystal Structure of Circadian Clock Protein Kaic A422V Mutant
  1248. 6hho: Crystal Structure of Rip1 Kinase in Complex with Gsk547
  1249. 6hhj: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 24b
  1250. 6hhg: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor 27
  1251. 6hhf: Crystal Structure of Akt1 in Complex with Covalent-allosteric Akt Inhibitor Borussertib
  1252. 6hci: Crystal Structure of Titin M3 Domain
  1253. 6hbn: High-salt Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA/CSKN2A1 Gene Product) in Complex with The Indenoindole-type Inhibitor Thn27
  1254. 3zon: Human Tyk2 Pseudokinase Domain Bound to a Kinase Inhibitor
  1255. 6h4l: Structure of Titin M4 Trigonal Form
  1256. 4b0g: Complex of Aurora-a Bound to an Imidazopyridine-based Inhibitor
  1257. 6h0u: Glycogen Synthase Kinase-3 Beta (gsk3) Complex with a Covalent [1,2, 4]triazolo[1,5-a][1,3,5]triazine Inhibitor
  1258. 6paw: Crystal Structure of Dapk2 S308A Calcium/calmodulin Complex
  1259. 6gzm: Crystal Structure of Human Ckidelta with A86
  1260. 6gzd: Crystal Structure of Human CSNK1A1 with A86
  1261. 4ezj: Potent and Selective Inhibitors of PI3K-DELTA: Obtaining Isoform Selectivity from The Affinity Pocket and Tryptophan Shelf
  1262. 4ezk: Potent and Selective Inhibitors of PI3K-DELTA: Obtaining Isoform Selectivity from The Affinity Pocket and Tryptophan Shelf
  1263. 4ezl: Potent and Selective Inhibitors of PI3K-DELTA: Obtaining Isoform Selectivity from The Affinity Pocket and Tryptophan Shelf
  1264. 4fa6: Design and Synthesis of a Novel Pyrrolidinyl Pyrido Pyrimidinone Derivative as a Potent Inhibitor of PI3KA and Mtor
  1265. 4fad: Design and Synthesis of a Novel Pyrrolidinyl Pyrido Pyrimidinone Derivative as a Potent Inhibitor of PI3KA and Mtor
  1266. 4fhk: Crystal Structure of PI3K-GAMMA in Complex with Imidazopyridazine 19e
  1267. 4fza: Crystal Structure of Mst4-mo25 Complex
  1268. 4fzd: Crystal Structure of Mst4-mo25 Complex with Wsf Motif
  1269. 4fzf: Crystal Structure of Mst4-mo25 Complex with Dki
  1270. 4geh: Crystal Structure of Mst4 Dimerization Domain Complex with Pdcd10
  1271. 6gwm: Solution Structure of Rat Rip2 Caspase Recruitment Domain
  1272. 6gvx: Crystal Structure of Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with Dorsomorphin (compound C)
  1273. 6gvi: Crystal Structure of PI3K Alpha in Complex with 3-(2-amino- Benzooxazol-5-yl)-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidine-4,6- Diamine
  1274. 6gvh: Crystal Structure of PI3K Alpha in Complex with 3-(2-amino- Benzooxazol-5-yl)-4-chloro-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidin-6- Ylamine
  1275. 6gvg: Crystal Structure of PI3K Alpha in Complex with 3-(2-amino- Benzooxazol-5-yl)-1-isopropyl-4-methyl-1h-pyrazolo[3,4-d]pyrimidin-6- Ylamine
  1276. 6gvf: Crystal Structure of PI3K Alpha in Complex with 3-(2-amino- Benzooxazol-5-yl)-1-isopropyl-1h-pyrazolo[3,4-d]pyrimidin-4-ylamine
  1277. 4hyh: X-ray Crystal Structure of Compound 39 Bound to Human Chk1 Kinase Domain
  1278. 4hyi: X-ray Crystal Structure of Compound 40 Bound to Human Chk1 Kinase Domain
  1279. 6gtt: Human Stk10 Bound to Birb-796
  1280. 4ib5: Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with a CK2BETA-COMPETITIVE Cyclic Peptide
  1281. 4im0: Structure of Tank-binding Kinase 1
  1282. 4im2: Structure of Tank-binding Kinase 1
  1283. 4im3: Structure of Tank-binding Kinase 1
  1284. 6gro: Human CSNK1G3 Bound to Sb-223133
  1285. 6gra: Human Aurka Bound to Brd-7880
  1286. 6gr9: Human Aurkc Incenp Complex Bound to Vx-680
  1287. 6gr8: Human Aurkc Incenp Complex Bound to Brd-7880
  1288. 6gq7: PI3KG in Complex with Inh
  1289. 4ith: Crystal Structure of Rip1 Kinase in Complex with Necrostatin-1 Analog
  1290. 4iti: Crystal Structure of Rip1 Kinase in Complex with Necrostatin-3 Analog
  1291. 4itj: Crystal Structure of Rip1 Kinase in Complex with Necrostatin-4
  1292. 4iw0: Crystal Structure and Mechanism of Activation of Tbk1
  1293. 4iwo: Crystal Structure and Mechanism of Activation of Tbk1
  1294. 4iwp: Crystal Structure and Mechanism of Activation of Tbk1
  1295. 4iwq: Crystal Structure and Mechanism of Activation of Tbk1
  1296. 6gpv: Crystal Structure of Blue-light Irradiated Minisog
  1297. 6gpu: Crystal Structure of Minisog at 1.17a Resolution
  1298. 4j1r: Crystal Structure of GSK3B in Complex with Inhibitor 15r
  1299. 4j71: Crystal Structure of GSK3B in Complex with Inhibitor 1r
  1300. 6gn1: Crystal Structure of Glycogen Synthase Kinase-3 Beta (GSK3B) in Complex with Pik-75
  1301. 4jg6: Rsk2 Ctd Bound to 2-cyano-3-(1h-indazol-5-yl)acrylamide
  1302. 4jg7: Structure of Rsk2 Ctd Bound to 3-(3-(1h-pyrrolo[2,3-b]pyridine-3- Carbonyl)phenyl)-2-cyanoacrylamide
  1303. 4jg8: Structure of Rsk2 T493M Ctd Mutant Bound to 2-cyano-n-(1-hydroxy-2- Methylpropan-2-yl)-3-(3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl) Acrylamide
  1304. 4jik: X-ray Crystal Structure of Compound 22a (r)-2-(4-chlorophenyl)-8- (piperidin-3-ylamino)imidazo[1,2-c]pyrimidine-5-carboxamide Bound to Human Chk1 Kinase Domain
  1305. 6gmd: The Crystal Structure of CK2ALPHA in Complex with Compound 3
  1306. 6gjo: Crystal Structure of Glycogen Synthase Kinase-3 Beta in Complex with Bi-91bs
  1307. 4ehe: B-raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor
  1308. 4ehg: B-raf Kinase Domain in Complex with an Aminopyridimine-based Inhibitor
  1309. 4iq6: Gsk-3beta with Inhibitor 6-chloro-n-cyclohexyl-4-(1h-pyrrolo[2,3- B]pyridin-3-yl)pyridin-2-amine
  1310. 4jin: X-ray Crystal Structure of Archaeoglobus Fulgidus Rio1 Bound to (2e)- N-benzyl-2-cyano-3-(pyridine-4-yl)acrylamide (wp1086)
  1311. 4bl1: Crystal Structure of Unphosphorylated Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with Amp-pnp
  1312. 6gih: Crystal Structure of CK2ALPHA with Cam187 Bound
  1313. 6ggs: Structure of Rip2 Card Filament
  1314. 6gfj: Structure of Rip2 Card Domain Fused to Crystallisable Mbp Tag
  1315. 4jsn: Structure of Mtordeltan-mlst8 Complex
  1316. 4jsp: Structure of Mtordeltan-mlst8-atpgammas-mg Complex
  1317. 4jsv: Structure of Mtordeltan-mlst8-adp-mgf3-mg2 Complex
  1318. 4jsx: Structure of Mtordeltan-mlst8-torin2 Complex
  1319. 4jt5: Mtordeltan-mlst8-pp242 Complex
  1320. 6spw: Structure of Protein Kinase Ck2 Catalytic Subunit with The CK2BETA- Competitive Bisubstrate Inhibitor Arc3140
  1321. 6spx: Structure of Protein Kinase Ck2 Catalytic Subunit in Complex with The CK2BETA-COMPETITIVE Bisubstrate Inhibitor Arc1502
  1322. 6g5i: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State R
  1323. 6g51: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State D
  1324. 6g4j: Structure of The Protein Kinase Yabt from Bacillus Subtilis in Complex with an Alpharep Crystallization Helper
  1325. 6g3w: Crystal Structure of The Bir3 - Serk2 Complex from Arabidopsis Thaliana.
  1326. 6g3a: Crystal Structure of Haspin F605T Mutant in Complex with 5- Iodotubercidin
  1327. 6g39: Crystal Structure of Haspin F605Y Mutant in Complex with 5- Iodotubercidin
  1328. 6g38: Crystal Structure of Haspin in Complex with Tubercidin
  1329. 6g37: Crystal Structure of Haspin in Complex with 5-fluorotubercidin
  1330. 6g36: Crystal Structure of Haspin in Complex with 5-chlorotubercidin
  1331. 6g35: Crystal Structure of Haspin in Complex with 5-bromotubercidin
  1332. 6g34: Crystal Structure of Haspin in Complex with 5-iodotubercidin
  1333. 6g18: Cryo-em Structure of a Late Human Pre-40s Ribosomal Subunit - State C
  1334. 6fwx: Chimeric Titin Z1Z2-Z1Z2 Tandem (z1212) Functionalized with a Grgds Exogenous Peptide from Fibronectin
  1335. 4g16: Crystal Structure of CK1G3 with 2-[(4-{[3-(trifluoromethyl)pyridin2- Yl]oxy}phenyl)amino]-1h-benzimidazole-6-carbonitrile
  1336. 4g17: Crystal Structure of CK1G3 with 2-[(4-tert-butylphenyl)amino]-1h- Benzimidazole-6-carbonitrile
  1337. 6fvg: The Structure of CK2ALPHA with Cch507 Bound
  1338. 6fvf: The Structure of CK2ALPHA with Cch503 Bound
  1339. 6fu5: Structure of The Kinase Domain of Human Ripk2 in Complex with The Inhibitor Cslp18
  1340. 4hq1: Crystal Structure of an Lrr Protein with Two Solenoids
  1341. 4jai: Crystal Structure of Aurora Kinase a in Complex with N-{4-[(6-oxo-5,6- Dihydrobenzo[c][1,8]naphthyridin-1-yl)amino]phenyl}benzamide
  1342. 4jaj: Crystal Structure of Aurora Kinase a in Complex with Benzo[c][1, 8]naphthyridin-6(5h)-one
  1343. 4jbo: Novel Aurora Kinase Inhibitors Reveal Mechanisms of Hurp in Nucleation of Centrosomal and Kinetochore Microtubules
  1344. 4jbp: Novel Aurora Kinase Inhibitors Reveal Mechanisms of Hurp in Nucleation of Centrosomal and Kinetochore Microtubules
  1345. 4jbq: Novel Aurora Kinase Inhibitors Reveal Mechanisms of Hurp in Nucleation of Centrosomal and Kinetochore Microtubules
  1346. 4jjr: A P21 Crystal Form of Mammalian Casein Kinase 1d with a Novel Dimer Interface.
  1347. 4jvg: B-raf Kinase in Complex with Birb796
  1348. 4k0y: Structure of Pim-1 Kinase Bound to N-(4-fluorophenyl)-7-hydroxy-5- (piperidin-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
  1349. 4k18: Structure of Pim-1 Kinase Bound to 5-(4-cyanobenzyl)-n-(4- Fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide
  1350. 4k1b: Structure of Pim-1 Kinase Bound to N-(5-(2-fluorophenyl)-1h-pyrrolo[2, 3-b]pyridin-3-yl)-5-((((3r,4r)-3-fluoropiperidin-4-yl)methyl)amino) Pyrazolo[1,5-a]pyrimidine-3-carboxamide
  1351. 6fih: Crystal Structure of The Anx2 Ectodomain from Arabidopsis Thaliana
  1352. 6fig: Crystal Structure of The Anx1 Ectodomain from Arabidopsis Thaliana
  1353. 6fif: Crystal Structure of The Bri1 Gly644-asp (bri1-6) Mutant from Arabidopsis Thaliana.
  1354. 6fic: Bivalent Inhibitor Unc4512 Bound to The Taf1 Bromodomain Tandem
  1355. 6fhb: Death-associated Protein Kinase 1 (dapk1) Catalytic and Auto- Regulatory Domains with S289A and S308E Mutations
  1356. 6fha: Death-associated Protein Kinase 1 (dapk1) Catalytic and Auto- Regulatory Domains with S289A and S308A Mutations
  1357. 6fh5: PI3KG in Complex with Compound 7
  1358. 6fg8: Crystal Structure of The Bir3 - Serk1 Complex from Arabidopsis Thaliana.
  1359. 4fi1: Crystal Structure of Scck2 Alpha in Complex with Atp
  1360. 6fdz: Unc-51-like Kinase 3 (ulk3) in Complex with Momelotinib
  1361. 6fdy: Unc-51-like Kinase 3 (ulk3) in Complex with Bosutinib
  1362. 6fdo: Rio2 Structure
  1363. 6fdn: Rio2 Structure
  1364. 6fdm: Human Rio2 Kinase Structure
  1365. 4jl9: Crystal Structure of Mouse Tbk1 Bound to Bx795
  1366. 4jlc: Crystal Structure of Mouse Tbk1 Bound to Su6668
  1367. 6fd3: Thiophosphorylated Pak3 Kinase Domain
  1368. 6fck: Chk1 Kinase in Complex with Compound 13
  1369. 6fcf: Chk1 Kinase in Complex with Compound 44
  1370. 6fc8: Chk1 Kinase in Complex with Compound 13
  1371. 4l0n: Crystal Structure of Stk3 (mst2) Sarah Domain
  1372. 6fbk: Crystal Structure of The Human Wnk2 Cct-like 1 Domain in Complex with a Wnk1 Rfxv Peptide
  1373. 6fai: Structure of a Eukaryotic Cytoplasmic Pre-40s Ribosomal Subunit
  1374. 4bda: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1375. 4bdb: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1376. 4bdc: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1377. 4bdd: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1378. 4bde: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1379. 4bdf: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1380. 6fad: Sr Protein Kinase 1 (srpk1) in Complex with The Rgg-box of Hsv1 Icp27
  1381. 4bdg: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1382. 4bdh: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1383. 4bdi: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1384. 4bdj: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1385. 4bdk: Fragment-based Screening Identifies a New Area for Inhibitor Binding to Checkpoint Kinase 2 (chk2)
  1386. 4f2l: Structure of a Regulatory Domain of Ampk
  1387. 6f7b: Crystal Structure of The Human Bub1 Kinase Domain in Complex with Bay 1816032
  1388. 2m9x: Solution Nmr Structure of Microtubule-associated Serine/threonine- Protein Kinase 1 from Homo Sapiens, Northeast Structural Genomics Consortium (nesg) Target HR9151A
  1389. 3w8h: Crystal Structure of Ccm3 in Complex with The C-terminal Regulatory Domain of Stk25
  1390. 3w8i: Crystal Structure of Ccm3 in Complex with The C-terminal Regulatory Domain of Mst4
  1391. 4b8l: Aurora B Kinase P353G Mutant
  1392. 4b8m: Aurora B Kinase in Complex with Vx-680
  1393. 6f3i: Irak4 in Complex with Inhibitor
  1394. 6f3g: Irak4 in Complex with Inhibitor
  1395. 6f3e: Irak4 in Complex with Inhibitor
  1396. 6f3d: Irak4 in Complex with Inhibitor
  1397. 6f26: Crystal Structure of Human Casein Kinase I Delta in Complex with Compound 31b
  1398. 6f1w: Crystal Structure of Human Casein Kinase I Delta in Complex with Compound 31a
  1399. 4g0n: Crystal Structure of Wt H-ras-gppnhp Bound to The Rbd of Raf Kinase
  1400. 4g3x: Crystal Structure of Q61L H-ras-gppnhp Bound to The Rbd of Raf Kinase
  1401. 6tlj: Cryo-em Structure of The Anaphase-promoting Complex/cyclosome, in Complex with The Mitotic Checkpoint Complex (apc/c-mcc) at 3.8 Angstrom Resolution
  1402. 6tm5: Cryo-em Structure of The Anaphase-promoting Complex/cyclosome, in Complex with The NEK2A Substrate at 3.9 Angstrom Resolution
  1403. 6s6q: Crystal Structure of The Lrr Ectodomain of The Plant Membrane Receptor Kinase Gassho1/schengen3 from Arabidopsis Thaliana in Complex with Casparian Strip Integrity Factor 2.
  1404. 4kz0: Structure of PI3K Gamma with Imidazopyridine Inhibitors
  1405. 4kzc: Structure of PI3K Gamma with Imidazopyridine Inhibitors
  1406. 6es0: Crystal Structure of The Kinase Domain of Human Ripk2 in Complex with The Activation Loop Targeting Inhibitor Cs-r35
  1407. 6eqi: Structure of Pink1 Bound to Ubiquitin
  1408. 6eml: Cryo-em Structure of a Late Pre-40s Ribosomal Subunit from Saccharomyces Cerevisiae
  1409. 6emk: Cryo-em Structure of Saccharomyces Cerevisiae Target of Rapamycin Complex 2
  1410. 4j0m: Crystal Structure of Brl1 (lrr) in Complex with Brassinolide
  1411. 6elm: Crystal Structure of The Human Wnk2 Cct1 Domain
  1412. 4ksp: Crystal Structure of Human B-raf Bound to a Dfg-out Inhibitor Tak-632
  1413. 4ksq: Crystal Structure of Human B-raf Bound to a Dfg-out Inhibitor 5b
  1414. 6eim: Human Stk10 Bound to GW683134A
  1415. 6eii: The Crystal Structure of CK2ALPHA in Complex with Compound 18
  1416. 6ehu: The Crystal Structure of CK2ALPHA in Complex with Compound 32
  1417. 6ehk: The Crystal Structure of CK2ALPHA in Complex with Cam4712 and Compound 37
  1418. 6egf: Crystal Structure of The Inactive Unphosphorylated Irak4 Kinase Domain Bound to Amp-pnp
  1419. 6ege: Crystal Structure of The Unphosphorylated Irak4 Kinase Domain Bound to a Type I Inhibitor
  1420. 6egd: Crystal Structure of The Unphosphorylated Irak4 Kinase Domain Bound to a Type I Inhibitor
  1421. 6ega: Irak4 in Complex with a Type II Inhibitor
  1422. 6eg9: Irak4 in Complex with Ponatinib
  1423. 6edx: Crystal Structure of Sgk3 Px Domain
  1424. 6ed6: Crystal Structure of Rock2 with a Pyridinylbenzamide Based Inhibitor
  1425. 6e9w: Crystal Structure of Rock1 with a Pyridinylbenzamide Based Inhibitor
  1426. 6e4w: Structure of Ampk Bound to Activator
  1427. 6e4u: Structure of Ampk Bound to Activator
  1428. 6e4t: Structure of Ampk Bound to Activator
  1429. 6dlp: Crystal Structure of Lrrk2 Wd40 Domain Dimer
  1430. 6dlo: Crystal Structure of Lrrk2 Wd40 Domain Dimer
  1431. 6dl4: Human Titin Zig10
  1432. 6dd4: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N,n- Dipropyl-dihydropteridine Inhibitor
  1433. 6d8z: Crystal Structure of The C-terminal Guanine Exchange Factor Module of Human Trio
  1434. 2rsv: Solution Structure of Human Full-length Vaccinia Related Kinase 1 (vrk1)
  1435. 6p5m: Discovery of a Novel, Highly Potent, and Selective Thieno[3,2- D]pyrimidinone-based Cdc7 Inhibitor with a Quinuclidine Moiety (tak- 931) as an Orally Active Investigational Anti-tumor Agent
  1436. 6d3l: Crystal Structure of Unphosphorylated Human Pkr
  1437. 6d3k: Crystal Structure of Unphosphorylated Human Pkr Kinase Domain in Complex with Adp
  1438. 3w10: Aurora Kinase a Complexed to Pyrazole Aminoquinoline I
  1439. 3w16: Structure of Aurora Kinase a Complexed to Pyrazole-aminoquinoline Inhibitor III
  1440. 3w18: Structure of Aurora Kinase a Complexed to Benzoimidazole-indazole Inhibitor XIII
  1441. 3w2c: Structure of Aurora Kinase a Complexed to Benzoimidazole-indazole Inhibitor Xv
  1442. 3w8l: Crystal Structure of Human Ck2 in Complex with Inositol Hexakisphosphate
  1443. 3war: Crystal Structure of Human CK2A
  1444. 6csw: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N- Methyl-n-propyl-dihydropteridine Inhibitor
  1445. 3we4: Crystal Structure of S6K1 Kinase Domain in Complex with a Pyrimidine Derivative Pf-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1- Yl]methyl}-5-(trifluoromethyl)-1h-benzimidazole
  1446. 3we8: Pim-1 Kinase in Complex with Ruthenium-based Inhibitor
  1447. 3wf5: Crystal Structure of S6K1 Kinase Domain in Complex with a Pyrazolopyrimidine Derivative 4-[4-(1h-benzimidazol-2-yl)piperidin-1- Yl]-1h-pyrazolo[3,4-d]pyrimidine
  1448. 3wf6: Crystal Structure of S6K1 Kinase Domain in Complex with a Pyrazolopyrimidine Derivative 4-[4-(1h-indol-3-yl)-3,6- Dihydropyridin-1(2h)-yl]-1h-pyrazolo[3,4-d]pyrimidine
  1449. 3wf7: Crystal Structure of S6K1 Kinase Domain in Complex with a Purine Derivative 1-(9h-purin-6-yl)-n-[3-(trifluoromethyl)phenyl]piperidine- 4-carboxamide
  1450. 3wf8: Crystal Structure of S6K1 Kinase Domain in Complex with a Quinoline Derivative 2-oxo-2-[(4-sulfamoylphenyl)amino]ethyl 7,8,9,10- Tetrahydro-6h-cyclohepta[b]quinoline-11-carboxylate
  1451. 3wf9: Crystal Structure of S6K1 Kinase Domain in Complex with a Quinoline Derivative 1-oxo-1-[(4-sulfamoylphenyl)amino]propan-2-yl-2-methyl-1, 2,3,4-tetrahydroacridine-9-carboxylate
  1452. 6cqh: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N- Propynyl-n-ethyl-dihydropteridine Inhibitor
  1453. 6cqf: Crystal Structure of Hpk1 in Complex an Inhibitor G1858
  1454. 6cqe: Crystal Structure of Hpk1 Kinase Domain S171A Mutant
  1455. 6cqd: Crystal Structure of Hpk1 in Complex with Atp Analogue (amppnp)
  1456. 6cq5: Tbk1 in Complex with Sulfone Analog of Amlexanox
  1457. 6cq4: Tbk1 in Complex with Cyclohexyl Analog of Amlexanox
  1458. 6cq0: Tbk1 in Complex with Dimethyl Amino Analog of Amlexanox
  1459. 6cpg: Structure of Dephosphorylated Aurora a (122-403) in Complex with Inhibiting Monobody and At9283 in an Inactive Conformation
  1460. 6cpf: Structure of Dephosphorylated Aurora a (122-403) Bound to Amppcp in an Active Conformation
  1461. 6cpe: Structure of Apo, Dephosphorylated Aurora a (122-403) in an Active Conformation
  1462. 3wi6: Crystal Structure of Mapkap Kinase-2 (mk2) in Complex with Non- Selective Inhibitor
  1463. 3wik: Crystal Structure of The CK2ALPHA/COMPOUND10 Complex
  1464. 3wil: Crystal Structure of The CK2ALPHA/COMPOUND3 Complex
  1465. 6cnx: Crystal Structure of The Human Vaccinia-related Kinase 1 (vrk1) Bound to an N-propynyl-n-isopentyl-dihydropteridin Inhibitor
  1466. 6cnh: Human PRPF4B in Complex with Rebastinib
  1467. 6cn9: Crystal Structure of The Kinase Domain of Wnk1
  1468. 6cmm: Crystal Structure of The Human Vaccinia-related Kinase Bound to a N,n- Dipropynyl-dihydropteridine Inhibitor
  1469. 6cki: Co-crystal Structure of Mnk2 in Complex with Inhibitor
  1470. 6ck6: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1471. 6ck3: Co-crytsal Structure of Mnk2 in Complex with an Inhibitor
  1472. 6cjy: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1473. 6cjw: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1474. 6cjh: Co-crystal Structure of Mnk2 in Complex with an Inhibitor
  1475. 6cje: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1476. 6cj5: Crystal Structure of MNK2-D228G in Complex with Inhibitor
  1477. 6cfm: Crystal Structure of The Human Vaccinia-related Kinase Bound to a Propynyl-pteridinone Inhibitor
  1478. 4b4l: Crystal Structure of an Ard Dap-kinase 1 Mutant
  1479. 4bfm: The Crystal Structure of Mouse Pk38
  1480. 4bky: Crystal Structure of Unphosphorylated Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with Pyrrolopyrazole Inhibitor
  1481. 4bkz: Crystal Structure of Unphosphorylated Maternal Embryonic Leucine Zipper Kinase (melk) in Complex with a Benzodipyrazole Inhibitor
  1482. 4bl0: Crystal Structure of Yeast Bub3-bub1 Bound to Phospho-spc105
  1483. 6ccy: Crystal Structure of Akt1 in Complex with a Selective Inhibitor
  1484. 4bn1: Crystal Structure of V174M Mutant of Aurora-a Kinase
  1485. 4btj: Ttbk1 in Complex with Atp
  1486. 4btk: Ttbk1 in Complex with Inhibitor
  1487. 4btm: Ttbk1 in Complex with Inhibitor
  1488. 6cad: Crystal Structure of Raf Kinase Domain Bound to The Inhibitor 2a
  1489. 6c9j: Amp-activated Protein Kinase Bound to Pharmacological Activator R734
  1490. 6c9h: Non-phosphorylated Amp-activated Protein Kinase Bound to Pharmacological Activator R734
  1491. 6c9g: Amp-activated Protein Kinase Bound to Pharmacological Activator R739
  1492. 6c9f: Amp-activated Protein Kinase Bound to Pharmacological Activator R734
  1493. 6c9d: Crystal Structure of Ka1-autoinhibited Mark1 Kinase
  1494. 4byi: Aurora a Kinase Bound to a Highly Selective Imidazopyridine Inhibitor
  1495. 4byj: Aurora a Kinase Bound to a Highly Selective Imidazopyridine Inhibitor
  1496. 4bzn: Crystal Structure of Pim1 in Complex with a Pyrrolo(1,2-a) Pyrazinone Inhibitor
  1497. 4bzo: Crystal Structure of Pim1 in Complex with a Pyrrolo- Pyrazinone Inhibitor
  1498. 4c0t: Candida Albicans Pkh Kinase Domain
  1499. 4c2v: Aurora B Kinase in Complex with The Specific Inhibitor Barasertib
  1500. 4c2w: Crystal Structure of Aurora B in Complex with Amp-pnp
  1501. 4c3p: Structure of Dephosphorylated Aurora a (122-403) Bound to Tpx2 and Amppcp
  1502. 4c3r: Structure of Dephosphorylated Aurora a (122-403) Bound to Amppcp
  1503. 4c4k: Crystal Structure of The Titin M10-obscurin Ig Domain 1 Complex
  1504. 4c57: Structure of Gak Kinase in Complex with a Nanobody
  1505. 4c58: Structure of Gak Kinase in Complex with Nanobody (nbgak_4)
  1506. 4c59: Structure of Gak Kinase in Complex with Nanobody (nbgak_4)
  1507. 4c8b: Structure of The Kinase Domain of Human Ripk2 in Complex with Ponatinib
  1508. 4cfe: Structure of Full Length Human Ampk in Complex with a Small Molecule Activator, a Benzimidazole Derivative (991)
  1509. 4cff: Structure of Full Length Human Ampk in Complex with a Small Molecule Activator, a Thienopyridone Derivative (a-769662)
  1510. 4cfh: Structure of an Active Form of Mammalian Ampk
  1511. 4ch9: Crystal Structure of The Human Klhl3 Kelch Domain in Complex with a Wnk4 Peptide
  1512. 4chb: Crystal Structure of The Human Klhl2 Kelch Domain in Complex with a Wnk4 Peptide
  1513. 4cqg: The Crystal Structure of Mpk38 in Complex with Otssp167, an Orally-administrative Melk Selective Inhibitor
  1514. 4ct1: Human Pdk1-pkczeta Kinase Chimera in Complex with Allosteric Compound Ps315 Bound to The Pif-pocket
  1515. 4ct2: Human Pdk1-pkczeta Kinase Chimera
  1516. 4czt: Crystal Structure of The Kinase Domain of Snrk3.23 AT1G30270
  1517. 4czu: Crystal Structure of The Kinase Domain of Snrk3.23 AT1G30270 T190D Mutant
  1518. 4d28: Crystal Structure of The Kinase Domain of Snrk3.11 AT5G35410
  1519. 4d2p: Structure of Melk in Complex with Inhibitors
  1520. 4d2t: Structure of Melk in Complex with Inhibitors
  1521. 4d2v: Structure of Melk in Complex with Inhibitors
  1522. 4d2w: Structure of Melk in Complex with Inhibitors
  1523. 4eqc: Crystal Structure of Pak1 Kinase Domain in Complex with Frax597 Inhibitor
  1524. 4fc0: Crystal Structure of Human Kinase Domain of B-raf with a Dfg-out Inhibitor
  1525. 4grb: Casein Kinase 2 (ck2) Bound to Inhibitor
  1526. 4gub: Casein Kinase II Bound to Inhibitor
  1527. 4hhd: 2.75 Angstrom Resolution Crystal Structure of The A. Thaliana Lov2 Domain with an Extended N-terminal A' Helix (cryo Dark Structure)
  1528. 4hi8: Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain Collected at High Energy, Wavelength 0.32800
  1529. 4hi9: 1.2 Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain Collected at Wavelength 0.91974
  1530. 4hkd: Crystal Structure of Human Mst2 Sarah Domain
  1531. 4hvb: Catalytic Unit of PI3KG in Complex with PI3K/MTOR Dual Inhibitor Pf- 04979064
  1532. 4i41: Crystal Structure of Human Ser/thr Kinase Pim1 in Complex with Mitoxantrone
  1533. 4i92: Structure of The Bsk8 Kinase Domain
  1534. 4i93: Structure of The Bsk8 Kinase Domain (semet Labeled)
  1535. 4i94: Structure of Bsk8 in Complex with Amp-pnp
  1536. 4iaa: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Thioridazine
  1537. 4ian: Crystal Structure of Apo Human PRPF4B Kinase Domain
  1538. 4iea: 14-3-3 Isoform Sigma in Complex with a Phosphorylated C-raf Peptide
  1539. 4ifc: Crystal Structure of Adp-bound Human PRPF4B Kinase Domain
  1540. 4ihl: Human 14-3-3 Isoform Zeta in Complex with a Diphoyphorylated C-raf Peptide and Cotylenin a
  1541. 4iir: Crystal Structure of Amppnp-bound Human PRPF4B Kinase Domain
  1542. 4ijp: Crystal Structure of Human PRPF4B Kinase Domain in Complex with 4-{5- [(2-chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}- Benzo[b]thiophene-2-carboxylic Acid Amine
  1543. 4ixp: Crystal Structure of Maternal Embryonic Leucine Zipper Kinase (melk)
  1544. 4j6i: Discovery of Thiazolobenzoxepin Pi3-kinase Inhibitors That Spare The Pi3-kinase Beta Isoform
  1545. 4j8m: Aurora a in Complex with Cd532
  1546. 4j8n: Aurora a Kinase Apo
  1547. 4jdh: Crystal Structure of Serine/threonine-protein Kinase Pak 4 in Complex with Paktide T Peptide Substrate
  1548. 4jdi: Crystal Structure of Serine/threonine-protein Kinase Pak 4 in Complex with Paktide S Peptide Substrate
  1549. 4jdj: Crystal Structure of Serine/threonine-protein Kinase Pak 4 F461V Mutant in Complex with Paktide T Peptide Substrate
  1550. 4jdk: Crystal Structure of Serine/threonine-protein Kinase Pak 4 F461V Mutant in Complex with Paktide S Peptide Substrate
  1551. 4jnw: Bacterially Expressed Titin Kinase
  1552. 4jps: Co-crystal Structures of The Lipid Kinase PI3K Alpha with Pan and Isoform Selective Inhibitors
  1553. 4jqe: Crystal Structure of Scck2 Alpha in Complex with Amppn
  1554. 4jr7: Crystal Structure of Scck2 Alpha in Complex with Gmppnp
  1555. 4jx3: Crystal Structure of Pim1 Kinase
  1556. 4jx7: Crystal Structure of Pim1 Kinase in Complex with Inhibitor 2-[(trans- 4-aminocyclohexyl)amino]-4-{[3-(trifluoromethyl) Phenyl]amino}pyrido[4,3-d]pyrimidin-5(6h)-one
  1557. 6l21: Crystal Structure of CK2A1 H160A with Hematein
  1558. 6l22: Crystal Structure of CK2A1 H115Y with Hematein
  1559. 4kb8: CK1D in Complex with 1-{4-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4- Yl]pyridin-2-yl}-n-methylmethanamine Ligand
  1560. 4kba: CK1D in Complex with 9-[3-(4-fluorophenyl)-1-methyl-1h-pyrazol-4-yl]- 2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine Inhibitor
  1561. 4kbc: CK1D in Complex with {4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]pyridin-2- Yl}methanol Inhibitor
  1562. 4kbk: CK1D in Complex with (3s)-3-{4-[3-(4-fluorophenyl)-1-methyl-1h- Pyrazol-4-yl]pyridin-2-yl}morpholine Inhibitor
  1563. 4ks7: Pak6 Kinase Domain in Complex with Pf-3758309
  1564. 4ks8: Pak6 Kinase Domain in Complex with Sunitinib
  1565. 4kwp: Crystal Structure of Human Ck2-alpha in Complex with a Benzimidazole Inhibitor (k164) at 1.25 a Resolution
  1566. 4l1b: Crystal Structure of P110ALPHA Complexed with Nish2 of P85ALPHA
  1567. 4l23: Crystal Structure of P110ALPHA Complexed with Nish2 of P85ALPHA and Pi-103
  1568. 4l2y: Crystal Structure of P110ALPHA Complexed with Nish2 of P85ALPHA and Compound 9d
  1569. 4l67: Crystal Structure of Catalytic Domain of Pak4
  1570. 4l6q: Rock2 in Complex with Benzoxaborole
  1571. 4lb5: Crystal Structure of Pkz Zalpha in Complex with Ds(cg)6 (hexagonal Form)
  1572. 4lb6: Crystal Structure of Pkz Zalpha in Complex with Ds(cg)6 (tetragonal Form)
  1573. 4lfi: Crystal Structure of Scck2 Alpha in Complex with Gmppnp
  1574. 4lg4: Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by Rassf5
  1575. 4lgd: Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by Rassf5
  1576. 6v6l: Co-structure of Human Glycogen Synthase Kinase Beta with 1-(6-((2-((6- Amino-5-nitropyridin-2-yl)amino)ethyl)amino)-2-(2,4-dichlorophenyl) Pyridin-3-yl)-4-methylpiperazin-2-one
  1577. 4ll5: Crystal Structure of Pim-1 in Complex with The Fluorescent Compound Skf86002
  1578. 4lm5: Crystal Structure of Pim1 in Complex with 2-{4-[(3-aminopropyl) Amino]quinazolin-2-yl}phenol (resulting from Displacement of Skf86002)
  1579. 4lmu: Crystal Structure of Pim1 in Complex with The Inhibitor Quercetin (resulting from Displacement of Skf86002)
  1580. 4lqp: Crystal Structure of The CBK1(T743E)-MOB2 Kinase-coactivator Complex, in Crystal Form a
  1581. 4lqq: Crystal Structure of The CBK1(T743E)-MOB2 Kinase-coactivator Complex in Crystal Form B
  1582. 4lqs: Crystal Structure of The Cbk1-mob2 Kinase-coactivator Complex
  1583. 4lrj: Bacterial Effector Nleh1 Kinase Domain with Amppnp and Mg2+
  1584. 4lrk: Bacterial Effector Nleh2 Kinase Domain
  1585. 4m66: Crystal Structure of The Mouse Rip3 Kinase Domain
  1586. 4m69: Crystal Structure of The Mouse Rip3-mlkl Complex
  1587. 4m7e: Structural Insight into Bl-induced Activation of The Bri1-bak1 Complex
  1588. 4m7i: Crystal Structure of Gsk6157 Bound to Perk (r587-r1092, Delete A660- T867) at 2.34a Resolution
  1589. 4m8t: Rsk2 T493M C-terminal Kinase Domain in Complex with 3-(3-(1h-pyrazol- 4-yl)phenyl)-2-cyanoacrylamide
  1590. 4mao: Rsk2 T493M C-terminal Kinase Domain in Complex with Rmm58
  1591. 4mbi: Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitors
  1592. 4mbj: Human B-raf Kinase Domain in Complex with an Imidazopyridine-based Inhibitor
  1593. 4mbl: Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitors
  1594. 4md7: Crystal Structure of Full-length Symmetric Ck2 Holoenzyme
  1595. 4md8: Crystal Structure of Full-length Symmetric Ck2 Holoenzyme with Mutated Alpha Subunit (F121E)
  1596. 4md9: Crystal Structure of Symmetric Ck2 Holoenzyme with Mutated Alpha Subunit (F121E Truncated at Aa 336)
  1597. 4med: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Thioridazine Derivatives
  1598. 4mn8: Crystal Structure of Flg22 in Complex with The Fls2 and Bak1 Ectodomains
  1599. 4mna: Crystal Structure of The Free Fls2 Ectodomains
  1600. 4mne: Crystal Structure of The Braf:mek1 Complex
  1601. 4mnf: Crystal Structure of BRAF-V600E Bound to Gdc0879
  1602. 4mvf: Crystal Structure of Plasmodium Falciparum Cdpk2 Complexed with Inhibitor Staurosporine
  1603. 4mwh: Crystal Structure of Scck2 Alpha in Complex with Atp
  1604. 4n6y: Pim1 Complexed with a Phenylcarboxamide
  1605. 4n6z: Pim1 Complexed with a Pyridylcarboxamide
  1606. 4n70: Pim1 Complexed with a Pyridylcarboxamide
  1607. 4neu: X-ray Structure of Receptor Interacting Protein 1 (rip1)kinase Domain with a 1-aminoisoquinoline Inhibitor
  1608. 4nfm: Human Tau Tubulin Kinase 1 (ttbk1)
  1609. 4nfn: Human Tau Tubulin Kinase 1 (ttbk1) Complexed with 3-({5-[(4-amino-4- Methylpiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)- 5-bromophenol
  1610. 4nh1: Crystal Structure of a Heterotetrameric Ck2 Holoenzyme Complex Carrying The Andante-mutation in CK2BETA and Consistent with Proposed Models of Autoinhibition and Trans-autophosphorylation
  1611. 4nif: Heterodimeric Structure of Erk2 and Rsk1
  1612. 4njd: Structure of P21-activated Kinase 4 with a Novel Inhibitor Ky-04031
  1613. 4nkb: Crystal Structure of The Cryptic Polo Box (cpb)of Zyg-1
  1614. 4nm0: Crystal Structure of Peptide Inhibitor-free Gsk-3/axin Complex
  1615. 4nm3: Crystal Structure of Gsk-3/axin Complex Bound to Phosphorylated N- Terminal Auto-inhibitory Ps9 Peptide
  1616. 4nr2: Crystal Structure of Stk4 (mst1) Sarah Domain
  1617. 4nu1: Crystal Structure of a Transition State Mimic of The Gsk-3/axin Complex Bound to Phosphorylated N-terminal Auto-inhibitory Ps9 Peptide
  1618. 4nus: Rsk2 N-terminal Kinase in Complex with Ljh685
  1619. 4nw5: Rsk2 N-terminal Kinase in Complex with 2-amino-7-substituted Benzoxazole Compound 8
  1620. 4nw6: Rsk2 N-terminal Kinase in Complex with 2-amino-7-substituted Benzoxazole Compound 27
  1621. 4nxb: Crystal Structure of Ilov-i486(2lt) at Ph 7.0
  1622. 4nxe: Crystal Structure of Ilov-i486(2lt) at Ph 6.5
  1623. 4nxf: Crystal Structure of Ilov-i486(2lt) at Ph 8.0
  1624. 4nxg: Crystal Structure of ILOV-I486Z(2LT) at Ph 9.0
  1625. 4o0m: Crystal Structure of T. Elongatus Bp-1 Clock Protein Kaic
  1626. 4o0r: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1627. 4o0t: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1628. 4o0v: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1629. 4o0x: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1630. 4o0y: Back Pocket Flexibility Provides Group-ii Pak Selectivity for Type 1 Kinase Inhibitors
  1631. 4o38: Crystal Structure of The Human Cyclin G Associated Kinase (gak)
  1632. 4obo: MAP4K4 in Complex with Inhibitor (compound 22), 6-(3-chlorophenyl) Quinazolin-4-amine
  1633. 4obp: MAP4K4 in Complex with Inhibitor (compound 29), 6-(2-fluoropyridin-4- Yl)pyrido[3,2-d]pyrimidin-4-amine
  1634. 4obq: MAP4K4 in Complex with Inhibitor (compound 31), N-[3-(4- Aminoquinazolin-6-yl)-5-fluorophenyl]-2-(pyrrolidin-1-yl)acetamide
  1635. 4oh4: Crystal Structure of Bri1 in Complex with Bki1
  1636. 4oh8: Crystal Structure of The Human Mst1-rassf5 Sarah Heterodimer
  1637. 4oh9: Crystal Structure of The Human Mst2 Sarah Homodimer
  1638. 4otm: Crystal Structure of The C-terminal Domain from Yeast Gcn2
  1639. 4otn: Crystal Structure of The C-terminal Regulatory Domain of Murine Gcn2
  1640. 4otp: Crystal Structure of The Catalytic Domain of The Human Riok1 Atypical Protein Kinase in Complex with Adp/mg2+
  1641. 4ouc: Structure of Human Haspin in Complex with Histone H3 Substrate
  1642. 5yks: Crystal Structure of Sucrose Nonfermenting-related Kinase (snrk)
  1643. 5yh3: The Structure of HFAM20C and HFAM20A Complex
  1644. 5yf9: Crystal Structure of CK2A2 Form-2
  1645. 5yf4: A Kinase Complex Mst4-mob4
  1646. 5y9m: Crystal Structure of CK2A2 Form 3
  1647. 5y96: Crystal Structure of Anxur1 Extracellular Domain from Arabidopsis Thaliana
  1648. 5y92: Crystal Structure of Anxur2 Extracellular Domain from Arabidopsis Thaliana
  1649. 4p7i: Crystal Structure of The Merlin Ferm/dcaf1 Complex
  1650. 4p90: Crystal Structure of The Kinase Domain of Human Pak1 in Complex with Compound 15
  1651. 5y80: Complex Structure of Cyclin G-associated Kinase with Gefitinib
  1652. 5y7z: Complex Structure of Cyclin G-associated Kinase with Gefitinib
  1653. 4pf4: 1.1a X-ray Structure of The Apo Catalytic Domain of Death-associated Protein Kinase 1, Aa 1-277
  1654. 5y3r: Cryo-em Structure of Human Dna-pk Holoenzyme
  1655. 4pl3: Crystal Structure of Murine Ire1 in Complex with Mkc9989 Inhibitor
  1656. 4pl4: Crystal Structure of Murine Ire1 in Complex with Oicr464 Inhibitor
  1657. 4pl5: Crystal Structure of Murine Ire1 in Complex with Oicr573 Inhibitor
  1658. 5xy9: Structure of The Mst4 and 14-3-3 Complex
  1659. 4pp7: Highly Potent and Selective 3-n-methylquinazoline-4(3h)-one Based Inhibitors of B-RAFV600E Kinase
  1660. 4prj: Aurora a Kinase Domain with Compound 2 (n-[1-(3-cyanobenzyl)-1h- Pyrazol-4-yl]-6-(1h-pyrazol-4-yl)-1h-indazole-3-carboxamide)
  1661. 4ps3: Structure of PI3K Gamma in Complex with 1-[6-(5-methoxypyridin-3-yl)- 1,3-benzothiazol-2-yl]-3-[2-(1-propyl-1h-imidazol-4-yl)ethyl]urea
  1662. 4ps7: Structure of PI3K Gamma in Complex with N-[6-(pyridin-3-yl)-1,3- Benzothiazol-2-yl]acetamide
  1663. 5xvu: Crystal Structure of The Protein Kinase Ck2 Catalytic Domain from Plasmodium Falciparum Bound to Atp
  1664. 4ps8: Structure of PI3K Gamma in Complex with N-[6-(5,6-dimethoxypyridin-3- Yl)-1,3-benzothiazol-2-yl]acetamide
  1665. 5xvg: Crystal Structure of Pak4 in Complex with Inhibitor Czh226
  1666. 5xvf: Crystal Structure of Pak4 in Complex with Inhibitor Czh062
  1667. 5xva: Crystal Structure of Pak4 in Complex with Inhibitor Czh216
  1668. 5xqz: Structure of The Mob1-ndr2 Complex
  1669. 4pwn: Crystal Structure of Active Wnk1 Kinase
  1670. 4pxw: Crystal Structure of Human Dcaf1 Wd40 Repeats (Q1250L)
  1671. 4q2a: Wnk1: a Chloride Sensor via Autophosphorylation
  1672. 5xlm: Monomer Form of M.tuberculosis Pkni Sensor Domain
  1673. 5xll: Dimer Form of M. Tuberculosis Pkni Sensor Domain
  1674. 4q5j: Crystal Structure of Semet Derivative Bri1 in Complex with Bki1
  1675. 5xkn: Crystal Structure of Plant Receptor Erl2 in Complexe with Epfl4
  1676. 5xkj: Crystal Structure of Plant Receptor Erl1-tmm in Complexe with Epf2
  1677. 5xka: Crystal Structure of M.tuberculosis Pkni Kinase Domain
  1678. 5xjx: Pre-formed Plant Receptor Erl1-tmm Complex
  1679. 5xjo: Plant Receptor Erl1-tmm in Complex with Peptide Epf1
  1680. 5xgj: Crystal Structure of PI3K Complex with an Inhibitor
  1681. 5xgi: Crystal Structure of PI3K Complex with an Inhibitor
  1682. 5xgh: Crystal Structure of PI3K Complex with an Inhibitor
  1683. 4qfg: Structure of Ampk in Complex with Staurosporine Inhibitor and in The Absence of a Synthetic Activator
  1684. 4qfr: Structure of Ampk in Complex with Cl-a769662 Activator and Staurosporine Inhibitor
  1685. 4qfs: Structure of Ampk in Complex with BR2-A769662CORE Activator and Staurosporine Inhibitor
  1686. 5x6o: Intact Atr/mec1-atrip/ddc2 Complex
  1687. 5x18: Crystal Structure of Casein Kinase I Homolog 1
  1688. 5x17: Crystal Structure of Murine CK1D in Complex with Adp
  1689. 5wnm: Crystal Structure of Murine Receptor-interacting Protein 4 (ripk4) D143N Bound to Tozasertib (vx-680)
  1690. 5wnl: Crystal Structure of Murine Receptor-interacting Protein 4 (ripk4) D143N Bound to Staurosporine
  1691. 5wnk: Crystal Structure of Murine Receptor-interacting Protein 4 (ripk4) D143N Bound to Tg100-115
  1692. 5wnj: Crystal Structure of Murine Receptor-interacting Protein Kinase 4 (ripk4) D143N in Complex with Lestaurtinib
  1693. 5wni: Crystal Structure of Murine Receptor-interacting Protein Kinase 4 (ripk4) D143N in Complex with Atp
  1694. 5wnh: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Highly Selective Inhibitor
  1695. 5wng: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Highly Selective Inhibitor
  1696. 5wnf: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Highly Selective Inhibitor
  1697. 5wne: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Highly Selective Inhibitor
  1698. 5wls: Crystal Structure of a Pollen Receptor Kinase 3
  1699. 5we8: Crystal Structure of Wnk1 in Complex with N-{(3r)-1-[(4-chlorophenyl) Methyl]pyrrolidin-3-yl}-2-(3-methoxyphenyl)-n-methylquinoline-4- Carboxamide (compound 8)
  1700. 5wdy: Crystal Structure of Wnk1 in Complex with 1-cyclohexyl-n-({6-fluoro-1- [2-(3-methoxyphenyl)pyridin-4-yl]-1h-indol-3-yl}methyl)methanamine (compound 6)
  1701. 5wby: Crystal Structure of Mtor(deltan)-mlst8-pras40(beta-strand) Complex
  1702. 5wbu: Crystal Structure of Mtor(deltan)-mlst8-pras40(alpha-helix & Beta- Strand) Complex
  1703. 5wbk: Crystal Structure of The Arabidopsis Thaliana Raptor in Complex with The Tos Peptide of Human S6K1
  1704. 5wbh: Structure of The Frb Domain of Mtor Bound to a Substrate Recruitment Peptide of S6K1
  1705. 5w85: Crystal Structure of Irak-4 with a 4,6-diaminonicotinamide Inhibitor (compound Number 9)
  1706. 5w84: Crystal Structure of Irak-4 with a 4,6-diaminonicotinamide Inhibitor (compound Number 4)
  1707. 5w7t: Structure of Phosphorylated Wnk1
  1708. 5w5v: Tbk1 Co-crystal Structure with Amlexanox
  1709. 5w5q: MAP4K4 in Complex with Inhibitor Compound 12 (n3-methyl-10-(3-methyl- 3-(5-methyloxazol-2-yl)but-1-yn-1-yl)-6,7-dihydro-5h-5,7- Methanobenzo[c]imidazo[1,2-a]azepine-2,3-dicarboxamide)
  1710. 5w5o: Identification of Potent and Selective Ripk2 Inhibitors for The Treatment of Inflammatory Diseases.
  1711. 5w4w: Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (ck1) Inhibitors
  1712. 5w1r: Cryo-em Structure of Dnapkcs
  1713. 4qox: Crystal Structure of Cdpk4 from Plasmodium Falciparum, PF3D7_0717500
  1714. 4qpm: Structure of Bub1 Kinase Domain
  1715. 5vyk: Crystal Structure of The Brs Domain of Braf in Complex with The Cc-sam Domain of Ksr1
  1716. 4qtc: Structure of Human Haspin (gsg2) in Complex with Sch772984 Revealing The First Type-i Binding Mode
  1717. 4r8q: Structure and Substrate Recruitment of The Human Spindle Checkpoint Kinase Bub1
  1718. 5vuc: Pim1 Kinase in Complex with a Benzofuranone Inhibitor
  1719. 5vub: Pim1 Kinase in Complex with a Benzofuranone Inhibitor
  1720. 5vua: Pim1 Kinase in Complex with a Benzofuranone Inhibitor
  1721. 6kzi: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Thioridazine Derivatives
  1722. 4rgj: Apo Crystal Structure of Cdpk4 from Plasmodium Falciparum, PF3D7_0717500
  1723. 5vr3: Crystal Structure of The Brs Domain of Braf
  1724. 4tpt: Crystal Structure of The Human Limk2 Kinase Domain in Complex with a Non-atp Competitive Inhibitor
  1725. 4tuu: Isolated P110A Subunit of PI3KA Provides a Platform for Structure- Based Drug Design
  1726. 4tv3: Isolated P110A Subunit of PI3KA Provides a Platform for Structure- Based Drug Design
  1727. 4tw9: Difluoro-dioxolo-benzoimidazol-benzamides as Potent Inhibitors of CK1DELTA and Epsilon with Nanomolar Inhibitory Activity on Cancer Cell Proliferation
  1728. 4twc: 2-benzamido-n-(1h-benzo[d]imidazol-2-yl)thiazole-4- Carboxamide Derivatives as Potent Inhibitors of CK1D/E
  1729. 4txc: Crystal Structure of Dapk1 Kinase Domain in Complex with a Small Molecule Inhibitor
  1730. 5vja: Crystal Structure of Human Zipper-interacting Protein Kinase (zipk, Alias Dapk3) in Complex with a Pyrazolo[3,4-d]pyrimidinone Ligand (hs38)
  1731. 4u43: MAP4K4 in Complex with Inhibitor (compound 6)
  1732. 4u44: MAP4K4 in Complex with Inhibitor (compound 16)
  1733. 4u45: MAP4K4 in Complex with Inhibitor (compound 25)
  1734. 4u6r: Crystal Structure of Human Ire1 Cytoplasmic Domains in Complex with a Sulfonamide Inhibitor.
  1735. 4u97: Crystal Structure of Asymmetric Irak4 Dimer
  1736. 4u9a: Sulphur Anomalous Crystal Structure of Asymmetric Irak4 Dimer
  1737. 4uak: Mrck Beta in Complex with Adp
  1738. 4ual: Mrck Beta in Complex with Bdp00005290
  1739. 5vef: Pak4 Kinase Domain in Complex with Fasudil
  1740. 5vee: Pak4 Kinase Domain in Complex with Frax486
  1741. 5ved: Pak4 Kinase Domain in Complex with Staurosporine
  1742. 4ump: Structure of Melk in Complex with Inhibitors
  1743. 4umq: Structure of Melk in Complex with Inhibitors
  1744. 4umr: Structure of Melk in Complex with Inhibitors
  1745. 4umt: Structure of Melk in Complex with Inhibitors
  1746. 4umu: Structure of Melk in Complex with Inhibitors
  1747. 5vd3: Crystal Structure of Human Myt1 Kinase Domain (de-phosphorylated) in Complex with Saracatinib
  1748. 5vd1: Crystal Structure of Human Myt1 Kinase Domain in Complex with Pha- 848125
  1749. 5vd0: Crystal Structure of Human Myt1 Kinase Domain in Complex with Mk1775
  1750. 5vcz: Crystal Structure of Human Myt1 Kinase Domain in Complex with Bosutinib Isomer
  1751. 5vcy: Crystal Structure of Human Myt1 Kinase Domain in Complex with Bosutinib
  1752. 5vcx: Crystal Structure of Human Myt1 Kinase Domain (untreated) in Complex with Saracatinib
  1753. 5vcw: Crystal Structure of Human Myt1 Kinase Domain in Complex with Pelitinib
  1754. 5vcv: Crystal Structure of Human Myt1 Kinase Domain in Complex with Dasatinib
  1755. 5vam: Braf in Complex with Raf709
  1756. 5val: Braf in Complex with N-(3-(tert-butyl)phenyl)-4-methyl-3-(6- Morpholinopyrimidin-4-yl)benzamide
  1757. 4urk: PI3KG in Complex with Azd6482
  1758. 5v82: Pim1 Kinase in Complex with Cpd17 (1-(6-(4,4-difluoropiperidin-3-yl) Pyridin-2-yl)-6-(6-methylpyrazin-2-yl)-1h-pyrazolo[4,3-c]pyridine)
  1759. 5v80: Pim1 Kinase in Complex with Cpd1 (1-methyl-4-(3-(6-(piperazin-1-yl) Pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridin-5-yl)piperazin-2-one)
  1760. 4uyn: Sar156497 an Exquisitely Selective Inhibitor of Aurora Kinases
  1761. 4uzd: Sar156497 an Exquisitely Selective Inhibitor of Aurora Kinases
  1762. 4uzh: Sar156497 an Exquisitely Selective Inhibitor of Aurora Kinases
  1763. 5v62: Phospho-erk2 Bound to Bivalent Inhibitor Sbp3
  1764. 5v61: Phospho-erk2 Bound to Bivalent Inhibitor Sbp2
  1765. 4w7p: Crystal Structure of Rock 1 Bound to Yb-15-qd37
  1766. 4w9w: Crystal Structure of Bmp-2-inducible Kinase in Complex with Small Molecule Azd-7762
  1767. 4w9x: Crystal Structure of Bmp-2-inducible Kinase in Complex with Baricitinib
  1768. 5uzj: Crystal Structure of Rock1 Bound to an Aminopyridine Inhibitor
  1769. 4wsq: Crystal Structure of Adaptor Protein 2 Associated Kinase (aak1) in Complex with Small Molecule Inhibitor
  1770. 5uvf: Crystal Structure of The Human Vaccinia-related Kinase Bound to Bi- D1870
  1771. 5uu1: Crystal Structure of Human Vaccinia-related Kinase 2 (vrk-2) Bound to Bi-d1870
  1772. 4nzw: Crystal Structure of Stk25-mo25 Complex
  1773. 4o27: Crystal Structure of Mst3-mo25 Complex with wif Motif
  1774. 4rgw: Crystal Structure of a Taf1-taf7 Complex in Human Transcription Factor Iid
  1775. 5upl: Cdc42 Binds Pak4 via an Extended Gtpase-effector Inteface - 2 Peptide: PAK4FL, Cdc42 - Unrefined
  1776. 5upk: Cdc42 Binds Pak4 via an Extended Gtpase-effector Interface - 3 Peptide: PAK4CAT, Pak4-n45, Cdc42
  1777. 4wo5: Crystal Structure of a Braf Kinase Domain Monomer
  1778. 5ul1: The Co-structure of 3-amino-6-(4-((1-(dimethylamino)propan-2-yl) Sulfonyl)phenyl)-n-phenylpyrazine-2-carboxamide and a Rationally Designed PI3K-ALPHA Mutant That Mimics Atr
  1779. 5ukj: The Co-structure of N,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3- B]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5- A]pyrazin-3- Yl]benzenesulfonamide and a Rationally Designed PI3K-ALPHA Mutant That Mimics Atr
  1780. 5ukf: Crystal Structure of The Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor
  1781. 5uke: Nmr Structure of Monomeric Human Irak-m Death Domain R56D, Y61E Mutant
  1782. 4o0s: Crystal Structures of Human Kinase Aurora a
  1783. 4o0u: Crystal Structures of Human Kinase Aurora a
  1784. 4o0w: Crystal Structures of Human Kinase Aurora a
  1785. 5uk8: The Co-structure of (r)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2- (1h-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine and a Rationally Designed PI3K-ALPHA Mutant That Mimics Atr
  1786. 4qye: Chk1 Kinase Domain in Complex with Diarylpyrazine Compound 1
  1787. 4qyf: Chk1 Kinase Domain in Complex with Aminopyrazine Compound 13
  1788. 4qyg: Chk1 Kinase Domain in Complex with Diazacarbazole Compound 14
  1789. 4qyh: Chk1 Kinase Domain in Complex with Diazacarbazole Gne-783
  1790. 5uiu: Crystal Structure of Irak4 in Complex with Compound 30
  1791. 5uit: Crystal Structure of Irak4 in Complex with Compound 14
  1792. 5uis: Crystal Structure of Irak4 in Complex with Compound 12
  1793. 5uir: Crystal Structure of Irak4 in Complex with Compound 11
  1794. 5uiq: Crystal Structure of Irak4 in Complex with Compound 9
  1795. 5ufu: Structure of Ampk Bound to Activator
  1796. 5u94: Crystal Structure of The Mycobacterium Tuberculosis Pasta Kinase Pknb in Complex with The Potential Theraputic Kinase Inhibitor Gsk690693.
  1797. 5u7r: Identification of a New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1h)-ones
  1798. 5u7q: Identification of a New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1h)-ones
  1799. 5tzm: 59th Ig Domain of Human Obscurin (obscn Ig59)
  1800. 5tx5: Rip1 Kinase ( Flag 1-294, C34A, C127A, C233A, C240A) with Gsk772
  1801. 5tx3: Structure of Maternal Embryonic Leucine Zipper Kinase
  1802. 5twz: Structure of Maternal Embryonic Leucine Zipper Kinase
  1803. 5twy: Structure of Maternal Embryonic Leucine Zipper Kinase
  1804. 5twu: Structure of Maternal Embryonic Leucine Zipper Kinase
  1805. 5twl: Structure of Maternal Embryonic Leucine Zipper Kinase
  1806. 5tvt: Structure of Maternal Embryonic Leucine Zipper Kinase
  1807. 5tur: Pim-1 Kinase in Complex with a 7-azaindole
  1808. 5tos: Botrytis-induced Kinase 1 (bik1) from Arabidopsis Thaliana
  1809. 5toe: Pim-1 Kinase in Complex with a 7-azaindole
  1810. 5tf9: Crystal Structure of Wnk1 in Complex with Mn2+amppnp and Wnk476
  1811. 5tex: Pim-1 Kinase in Complex with a 7-azaindole
  1812. 5tel: Pim-1 Kinase in Complex with a 7-azaindole
  1813. 5te0: Crystal Structure of Adaptor Protein 2 Associated Kinase (aak1) in Complex with Bibf 1120
  1814. 5t5t: Ampk Bound to Allosteric Activator
  1815. 5t31: Exploiting an Asp-glu Switch in Glycogen Synthase Kinase 3 to Design Paralog Selective Inhibitors for Use in Acute Myeloid Leukemia
  1816. 5t23: PI3KG in Complex with 5d
  1817. 5t1t: Irak4 Kinase - Compound 1 Co-structure
  1818. 5t1s: Irak4 Kinase - Compound 1 Co-structure
  1819. 5t1h: Crystal Structure of Ck2
  1820. 5sxk: Crystal Structure of PI3KALPHA in Complex with Fragment 18
  1821. 5sxj: Crystal Structure of PI3KALPHA in Complex with Fragment 29
  1822. 5sxi: Crystal Structure of PI3KALPHA in Complex with Fragment 13
  1823. 5sxf: Crystal Structure of PI3KALPHA in Complex with Fragment 9
  1824. 5sxe: Crystal Structure of PI3KALPHA in Complex with Fragments 19 and 28
  1825. 5sxd: Crystal Structure of PI3KALPHA in Complex with Fragment 22
  1826. 5sxc: Crystal Structure of PI3KALPHA in Complex with Fragment 8
  1827. 5sxb: Crystal Structure of PI3KALPHA in Complex with Fragment 23
  1828. 5sxa: Crystal Structure of PI3KALPHA in Complex with Fragment 10
  1829. 5sx9: Crystal Structure of PI3KALPHA in Complex with Fragment 14
  1830. 5sx8: Crystal Structure of PI3KALPHA in Complex with Fragments 12 and 15
  1831. 5swt: Crystal Structure of PI3KALPHA in Complex with Fragments 17 and 27
  1832. 5swr: Crystal Structure of PI3KALPHA in Complex with Fragments 20 and 26
  1833. 5swp: Crystal Structure of PI3KALPHA in Complex with Fragments 6 and 24
  1834. 5swo: Crystal Structure of PI3KALPHA in Complex with Fragments 4 and 19
  1835. 5swg: Crystal Structure of PI3KALPHA in Complex with Fragments 5 and 21
  1836. 5sw8: Crystal Structure of PI3KALPHA in Complex with Fragments 7 and 11
  1837. 5sv7: The Crystal Structure of a Chaperone
  1838. 5oyf: The Crystal Structure of CK2ALPHA in Complex with Compound 31
  1839. 5oy4: GSK3BETA Complex with N-(6-(3,4-dihydroxyphenyl)-1h-pyrazolo[3,4- B]pyridin-3-yl)acetamide
  1840. 5owr: Human Stk10 Bound to Dasatinib
  1841. 5owq: Human Stk10 Bound to Dovitinib
  1842. 5owl: Low Salt Structure of Human Protein Kinase CK2ALPHA in Complex with 3- Aminopropyl-4,5,6,7-tetrabromobenzimidazol
  1843. 5owh: High Salt Structure of Human Protein Kinase CK2ALPHA in Complex with 3-aminopropyl-4,5,6,7-tetrabromobenzimidazol
  1844. 5ouu: The Crystal Structure of CK2ALPHA in Complex with Compound 22
  1845. 5oum: The Crystal Structure of CK2ALPHA in Complex with Compound 21
  1846. 5oul: The Crystal Structure of CK2ALPHA in Complex with Compound 9
  1847. 5oue: The Crystal Structure of CK2ALPHA in Complex with Compound 20
  1848. 5otz: The Crystal Structure of CK2ALPHA in Complex with Compound 1
  1849. 5oty: The Crystal Structure of CK2ALPHA in Complex with Cam4712
  1850. 5ots: The Crystal Structure of CK2ALPHA in Complex with an Analogue of Compound 22
  1851. 5otr: The Crystal Structure of CK2ALPHA in Complex with Compound 14
  1852. 5otq: The Crystal Structure of CK2ALPHA in Complex with Compound 33
  1853. 5otp: The Crystal Structure of CK2ALPHA in Complex with an Analogue of Compound 22
  1854. 5oto: The Crystal Structure of CK2ALPHA in Complex with Compound 30
  1855. 5otl: The Crystal Structure of CK2ALPHA in Complex with Compound 29
  1856. 5oti: The Crystal Structure of CK2ALPHA in Complex with Compound 27
  1857. 5oth: The Crystal Structure of CK2ALPHA in Complex with Compound 26
  1858. 5otf: Mrck Beta in Complex with Bdp-00009066
  1859. 5ote: Mrck Beta in Complex with Bdp-00008900
  1860. 5otd: The Crystal Structure of CK2ALPHA in Complex with Compound 25
  1861. 5ot6: The Crystal Structure of CK2ALPHA in Complex with Compound 19
  1862. 5ot5: The Crystal Structure of CK2ALPHA in Complex with Compound 24
  1863. 5osz: The Crystal Structure of CK2ALPHA in Complex with Compound 23
  1864. 5osu: The Crystal Structure of CK2ALPHA in Complex with Analogues of Compound 1
  1865. 5osr: The Crystal Structure of CK2ALPHA in Complex with an Analogue of Compound 1
  1866. 5osp: The Crystal Structure of CK2ALPHA in Complex with an Analogue of Compound 1
  1867. 5osl: The Crystal Structure of CK2ALPHA in Complex with Compound 7
  1868. 5osf: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1869. 5ose: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1870. 5osd: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1871. 5os8: The Crystal Structure of CK2ALPHA in Complex with Compound 11
  1872. 5os7: The Crystal Structure of CK2ALPHA in Complex with Compound 4
  1873. 5os6: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1874. 5os5: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1875. 5os4: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1876. 5os3: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1877. 5os2: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1878. 5os1: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1879. 5os0: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1880. 5orz: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1881. 5ory: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1882. 5orx: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1883. 5orw: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1884. 5orv: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1885. 5ort: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1886. 5ors: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1887. 5orr: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1888. 5orp: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1889. 5oro: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1890. 5orn: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1891. 5orl: Crystal Structure of Aurora-a Kinase in Complex with an Allosterically Binding Fragment
  1892. 5ork: The Crystal Structure of CK2ALPHA in Complex with Compound 6
  1893. 5orj: The Crystal Structure of CK2ALPHA in Complex with Compound 3
  1894. 5orh: The Crystal Structure of CK2ALPHA in Complex with Compound 2
  1895. 5oqu: The Crystal Structure of CK2ALPHA in Complex with Compound 5
  1896. 5oq8: Structure of Chk1 12-pt. Mutant Complex with Arylbenzamide Lrrk2 Inhibitor
  1897. 5oq7: Structure of Chk1 8-pt. Mutant Complex with Arylbenzamide Lrrk2 Inhibitor
  1898. 5oq6: Structure of Chk1 12-pt. Mutant Complex with Aminopyrimido- Benzodiazepinone Lrrk2 Inhibitor
  1899. 5oq5: Structure of Chk1 8-pt. Mutant Complex with Aminopyrimido- Benzodiazepinone Lrrk2 Inhibitor
  1900. 5oq4: Pqr309 - a Potent, Brain-penetrant, Orally Bioavailable, Pan-class I PI3K/MTOR Inhibitor as Clinical Candidate in Oncology
  1901. 5opv: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyridine Lrrk2 Inhibitor
  1902. 5opu: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyridine Lrrk2 Inhibitor
  1903. 5ops: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyridine Lrrk2 Inhibitor
  1904. 5opr: Structure of Chk1 10-pt. Mutant Complex with Aminopyridine Lrrk2 Inhibitor
  1905. 5opb: Structure of Chk1 10-pt. Mutant Complex with Indazole Lrrk2 Inhibitor
  1906. 5op7: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyrimidine Lrrk2 Inhibitor
  1907. 5op5: Structure of Chk1 10-pt. Mutant Complex with Pyrrolopyrimidine Lrrk2 Inhibitor
  1908. 5op4: Structure of Chk1 10-pt. Mutant Complex with Aminopyrimidine Lrrk2 Inhibitor
  1909. 5op2: Structure of Chk1 10-pt. Mutant Complex with Arylbenzamide Lrrk2 Inhibitor
  1910. 5oot: Structure of Chk1 10-pt. Mutant Complex with Aminopyrimido- Benzodiazepinone Lrrk2 Inhibitor
  1911. 5oor: Structure of Chk1 10-pt. Mutant Complex with Staurosporine
  1912. 5oop: Structure of Chk1 10-pt. Mutant Complex with Amp-pnp
  1913. 5ooi: Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA') in Complex with The Indenoindole-type Inhibitor 4p
  1914. 5oni: Low-salt Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA) in Complex with The Indenoindole-type Inhibitor 4p
  1915. 5one: Crystal Structure of Aurora-a in Complex with Fmf-03-145-1 (compound 2)
  1916. 5omy: High-salt Structure of Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA) in Complex with The Indenoindole-type Inhibitor 4p
  1917. 5okt: Crystal Structure of Human Casein Kinase I Delta in Complex with Iwp-2
  1918. 5odt: Aurora-a in Complex with Tacc3
  1919. 5oc7: Crystal Structure of The Pleckstrin-homology Domain of Bcr-abl in Complex with Monobody Mb(bcr-ph_4).
  1920. 5obr: Aurora a Kinase in Complex with 2-(3-chloro-5-fluorophenyl)quinoline- 4-carboxylic Acid and Jnj-7706621
  1921. 5obj: Aurora a Kinase in Complex with 2-(3-fluorophenyl)quinoline-4- Carboxylic Acid and Atp
  1922. 5o33: A Structure of The Gef Kalirin Dh1 Domain in Complex with The Small Gtpase Rac1
  1923. 5o2c: Crystal Structure of Wnk3 Kinase and Cct1 Didomain in a Unphosphorylated State
  1924. 5o2b: Crystal Structure of Wnk3 Kinase Domain in a Diphosphorylated State and in a Complex with The Inhibitor Pp-121
  1925. 5o26: Crystal Structure of Wnk3 Kinase Domain in a Diphosphorylated State and in Complex with Amp-pnp/mg2+
  1926. 5o23: Crystal Structure of Wnk3 Kinase Domain in a Monophosphorylated Apo State
  1927. 5o21: Crystal Structure of Wnk3 Kinase Domain in a Monophosphorylated State with Chloride Bound in The Active Site
  1928. 5o1v: Crystal Structure of Wnk3 Kinase Domain in a Monophosphorylated Apo State (a-loop Swapped)
  1929. 5o1s: Dimethyl Fumarate Is an Allosteric Covalent Inhibitor of The P90 Ribosomal S6 Kinases
  1930. 5o13: Crystal Structure of Pim1 Kinase in Complex with Small-molecule Inhibitor
  1931. 5o12: Crystal Structure of Pim1 Kinase in Complex with Small-molecule Inhibitor
  1932. 5o11: Crystal Structure of Pim1 Kinase in Complex with Small-molecule Inhibitor
  1933. 5o0y: Tlk2 Kinase Domain from Human
  1934. 5nyy: Formylglycine Generating Enzyme from T. Curvata in Complex with Cd(ii)
  1935. 5nxl: Formylglycine Generating Enzyme from T. Curvata in Complex with Ag(i)
  1936. 5nxd: Lim Domain Kinase 2 (limk2) in Complex with Th-300
  1937. 5nxc: Lim Domain Kinase 1 (limk1) in Complex with Pf-00477736
  1938. 5nqc: CK2ALPHA in Complex with Nmr154
  1939. 5np1: Open Protomer of Human Atm (ataxia Telangiectasia Mutated)
  1940. 5np0: Closed Dimer of Human Atm (ataxia Telangiectasia Mutated)
  1941. 5nod: Pasta Subunit 4 of Streptococcus Pneumoniae Stkp Crystallized with Peg and Succinate
  1942. 5nkp: Crystal Structure of The Human Klhl3 Kelch Domain in Complex with a Wnk3 Peptide
  1943. 5ng3: Structure of Inactive Kinase RIP2K(K47R)
  1944. 5ng2: Structure of RIP2K(D146N) with Bound Staurosporine
  1945. 5ng0: Structure of RIP2K(L294F) with Bound Amppcp
  1946. 5ndt: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule (e)-3-(2-(thiophen-2-yl)vinyl)-3, 4-dihydroquinoxalin-2(1h)-one
  1947. 5ncn: Crystal Structure Dbf2(ntr)-mob1 Complex
  1948. 5ncm: Crystal Structure Cbk1(ntr)-mob2 Complex
  1949. 5ncl: Crystal Structure of The Cbk1-mob2 Kinase-coactivator Complex with an Ssd1 Peptide
  1950. 5n9n: Crystal Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with The Atp-competitive, Tight-binding Dibenzofuran Inhibitor Tf85 (4a)
  1951. 5n9l: Crystal Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with The Atp-competitive Dibenzofuran Inhibitor Tf (4b)
  1952. 5n9k: Crystal Structure of Human Protein Kinase Ck2 Catalytic Subunit in Complex with The Atp-competitive, Tight-binding Dibenzofuran Inhibitor Tf107 (5)
  1953. 5n8y: Kaicba Circadian Clock Backbone Model Based on a Cryo-em Density
  1954. 5n7g: Magi-1 Complexed with a Synthetic Prsk1 Peptide
  1955. 5n7f: Magi-1 Complexed with a Prsk1 Peptide
  1956. 5n7e: Crystal Structure of The Dbl-homology Domain of Bcr-abl in Complex with Monobody Mb(bcr-dh_4).
  1957. 5n7d: Magi-1 Complexed with a Rsk1 Peptide
  1958. 5n6r: Solution Structure of The Dbl-homology Domain of Bcr-abl
  1959. 5n5m: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and (r)-3-(2-((isoquinolin-5-ylmethyl)(methyl) Carbamoyl)phenyl)pyrrolidin-1-ium
  1960. 5n5l: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and [2-oxo-2-(1h-pyrrol-2-yl)ethyl] 5-bromo-1h- Indole-3-carboxylate
  1961. 5n52: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule (e)-3-(2,3-dimethoxyphenyl)acrylic Acid
  1962. 5n51: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 3,4-dibromothiophene-2-carboxylic Acid
  1963. 5n50: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 2-(4-chlorophenyl) Sulfanylacetohydrazide
  1964. 5n4z: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule (e)-4-(4-hydroxyphenyl)but-3-en-2- One
  1965. 5n4y: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 2,5-dihydro-1h-isothiochromeno[3, 4-d]pyrazol-3-one
  1966. 5n4x: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule 4,5-dibromothiophene-2- Carbohydrazide
  1967. 5n4v: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule 2-cyclopropyl-4,5- Dimethylthieno[5,4-d]pyrimidine-6-carboxylic Acid
  1968. 5n4u: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule 5-(2-amino-1,3-thiazol-4- Yl)-1,3-dihydrobenzimidazol-2-one
  1969. 5n4r: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 2-(azepan-1-yl)-1-(1h-indol-3-yl) Propan-1-one
  1970. 5n4o: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule (e)-3-(p-tolyl)acrylic Acid
  1971. 5n4n: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensus Peptide and Fragment like Molecule 3,4-dimethyl-5-(1h-1,2,4-triazol- 3-yl)thiophene-2-carbonitrile
  1972. 5n1v: Crystal Structure of The Protein Kinase Ck2 Catalytic Subunit in Complex with Pyrazolo-pyrimidine Macrocyclic Ligand
  1973. 5mzl: Crystal Structure of Human Pim-1 Kinase in Complex with a Consensuspeptide and Fragment like Molekule N-quinolin-5-ylpyridine- 3-carboxamide
  1974. 5myv: Crystal Structure of Srpk2 in Complex with Compound 1
  1975. 5myc: Crystal Structure of Human 14-3-3 Sigma in Complex with Lrrk2 Peptide Ps910
  1976. 5my9: Crystal Structure of Human 14-3-3 Sigma in Complex with Lrrk2 Peptide Ps935
  1977. 5my8: Crystal Structure of Srpk1 in Complex with Sphinx31
  1978. 5mrd: Human Pdk1-pkciota Kinase Chimera in Complex with Allosteric Compound Ps267 Bound to The Pif-pocket
  1979. 5mqv: Crystal Structure of Human Casein Kinase I Delta in Complex with 4-(2, 5-dimethoxyphenyl)-n-(4-(5-(4-fluorphenyl)-2-(methylthio)-1h- Imidazol-4-yl)-pyridin-2-yl)-1-methyl-1h-pyrrole-2-carboxamide
  1980. 5mpj: 1-(2-chloro-[1,1'-biphenyl]-4-yl)-n-methylethanamine
  1981. 5mp8: Crystal Structure of CK2ALPHA with Zt0432 Bound
  1982. 5mow: Crystal Structure of CK2ALPHA with Zt0432 Bound
  1983. 5mov: Crystal Structure of CK2ALPHA with Zt0633 Bound
  1984. 5mot: Crystal Structure of CK2ALPHA with Zt0627 Bound
  1985. 5moh: Crystal Structure of CK2ALPHA with Zt0583 Bound.
  1986. 5moe: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1987. 5mod: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1988. 5mo8: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1989. 5mo7: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1990. 5mo6: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1991. 5mo5: Crystal Structure of CK2ALPHA with N-(3-(((2-chloro-[1,1'-biphenyl]-4- Yl)methyl)amino)propyl)methanesulfonamide Bound
  1992. 5mmr: Crystal Structure of CK2ALPHA with N-((2-chloro-[1,1'-biphenyl]-4-yl) Methyl)butane-1,4-diamine Bound
  1993. 5mmf: Crystal Structure of CK2ALPHA with Compound 7 Bound
  1994. 5mg2: Crystal Structure of The Second Bromodomain of Human Taf1 in Complex with Bay-299 Chemical Probe
  1995. 5mai: Crystal Structure of Melk in Complex with an Inhibitor
  1996. 5mah: Crystal Structure of Melk in Complex with an Inhibitor
  1997. 5mag: Crystal Structure of Melk in Complex with an Inhibitor
  1998. 5maf: Crystal Structure of Melk in Complex with an Inhibitor
  1999. 5m5a: Crystal Structure of Melk in Complex with an Inhibitor
  2000. 5m57: Nek2 Bound to Arylaminopurine 6
  2001. 5m56: Monoclinic Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA') with The Inhibitor 4'-carboxy-6,8-chloro- Flavonol (flc21)
  2002. 5m55: Nek2 Bound to Arylaminopurine 71
  2003. 5m53: Nek2 Bound to Arylaminopurine Inhibitor 11
  2004. 5m51: Nek2 Bound to Arylaminopurine Compound 8
  2005. 5m4u: Orthorhombic Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit (isoform CK2ALPHA') with The Inhibitor 4'-carboxy-6,8-chloro- Flavonol (flc21)
  2006. 5m4i: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit with The Inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) Crystallized under High-salt Conditions
  2007. 5m4f: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit with The Inhibitor 4'-carboxy-6,8-chloro-flavonol (flc21) Crystallized under Low-salt Conditions
  2008. 5m4c: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit with a Thieno[2,3-d]pyrimidin Inhibitor Crystallized under Low-salt Conditions
  2009. 5m44: Complex Structure of Human Protein Kinase Ck2 Catalytic Subunit with a Thieno[2,3-d]pyrimidin Inhibitor Crystallized under High-salt Conditions
  2010. 5m09: Crystal Structure of Mycobacterium Tuberculosis Pkni Kinase Domain, C20A_R136N Double Mutant
  2011. 5m08: Crystal Structure of Mycobacterium Tuberculosis Pkni Kinase Domain, C20A_R136A Double Mutant
  2012. 5m07: Crystal Structure of Mycobacterium Tuberculosis Pkni Kinase Domain, C20A Mutant
  2013. 5m06: Crystal Structure of Mycobacterium Tuberculosis Pkni Kinase Domain
  2014. 5lxm: Crystal Structure of Aurora-a Bound to a Hydrocarbon-stapled Proteomimetic of Tpx2
  2015. 5lvp: Human Pdk1 Kinase Domain in Complex with an Hm-peptide Bound to The Pif-pocket
  2016. 5lvo: Human Pdk1 Kinase Domain in Complex with Allosteric Compound Pse10 Bound to The Pif-pocket
  2017. 5lvn: Human Pdk1 Kinase Domain in Complex with Adenosine Bound to The Atp- Binding Site
  2018. 5lvm: Human Pdk1 Kinase Domain in Complex with Adenine Bound to The Atp- Binding Site
  2019. 5lvl: Human Pdk1 Kinase Domain in Complex with Compound Ps653 Bound to The Atp-binding Site
  2020. 5luq: Crystal Structure of Human Dna-dependent Protein Kinase Catalytic Subunit (dna-pkcs)
  2021. 5lpz: Crystal Structure of The Bri1 Kinase Domain (865-1196) in Complex with Adp from Arabidopsis Thaliana
  2022. 5lpy: Crystal Structure of The Bri1 Kinase Domain (865-1160) in Complex with Atp from Arabidopsis Thaliana
  2023. 5lpw: Crystal Structure of The Apo-bri1 Kinase Domain (865-1160)
  2024. 5lpv: Crystal Structure of The Bri1 Kinase Domain (865-1160) in Complex with Amppnp and Mn from Arabidopsis Thaliana
  2025. 5lpb: Crystal Structure of The Bri1 Kinase Domain (865-1160) in Complex with Adp from Arabidopsis Thaliana
  2026. 5loh: Kinase Domain of Human Greatwall
  2027. 5lcw: Cryo-em Structure of The Anaphase-promoting Complex/cyclosome, in Complex with The Mitotic Checkpoint Complex (apc/c-mcc) at 4.2 Angstrom Resolution
  2028. 5l9u: Model of Human Anaphase-promoting Complex/cyclosome (apc/c-cdh1) with a cross Linked Ubiquitin VARIANT-SUBSTRATE-UBE2C (ubch10) Complex Representing Key Features of Multiubiquitination
  2029. 5l9t: Model of Human Anaphase-promoting Complex/cyclosome (apc/c-cdh1) with E2 UBE2S Poised for Polyubiquitination Where UBE2S, Apc2, and Apc11 Are Modeled into Low Resolution Density
  2030. 5l8l: Aurora-a Kinase Domain in Complex with Vnar-d01 (crystal Form 1)
  2031. 5l8k: Aurora-a Kinase Domain in Complex with Vnar-d01 (crystal Form 2)
  2032. 5l8j: Aurora-a Kinase Domain in Complex with Vnar-d01 S93R
  2033. 5l6w: Structure of The Limk1-atpgammas-cfl1 Complex
  2034. 5l4q: Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (aak1) in Complex with Lkb1 (aak1 Dual Inhibitor)
  2035. 5l2q: Serine/threonine-protein Kinase 40 (stk40) Kinase Homology Domain
  2036. 5kzi: Crystal Structure of Human Pim-1 Kinase in Complex with an Imidazopyridazine Inhibitor.
  2037. 5kz8: Mark2 Complex with 7-[(1s)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3- Pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one
  2038. 5kz7: Mark2 Complex with 7-[(1s)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3- Pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one
  2039. 5kx8: Irak4-inhibitor Co-structure
  2040. 5kx7: Irak4-inhibitor Co-structure
  2041. 5kwh: Crystal Structure of Ck2
  2042. 5ku8: Crystal Structure of Ck2
  2043. 5kq5: Ampk Bound to Allosteric Activator
  2044. 5kpm: Glycogen Synthase Kinase 3 Beta Complexed with Brd3731
  2045. 5kpl: Glycogen Synthase Kinase 3 Beta Complexed with Brd0705
  2046. 5kpk: Glycogen Synthase Kinase 3 Beta Complexed with Brd0209
  2047. 5kkt: Rock 1 Bound to Azaindole Thiazole Piperazine Inhibitor
  2048. 5kks: Rock 1 Bound to Azaindole Thiazole Inhibitor
  2049. 5kkr: Ksr2:mek1 Complex Bound to The Small Molecule Aps-2-79
  2050. 5khu: Model of Human Anaphase-promoting Complex/cyclosome (apc15 Deletion Mutant), in Complex with The Mitotic Checkpoint Complex (apc/c-cdc20- Mcc) Based on Cryo Em Data at 4.8 Angstrom Resolution
  2051. 5kgk: Crystal Structure of Pim1 with Inhibitor: 3-(4-methoxyphenyl)-1~{h}- Pyrazol-5-amine
  2052. 5kgi: Crystal Structure of Pim1 with Inhibitor 2-[3,4-bis(chloranyl) Phenoxy]ethanamine
  2053. 5kgg: Crystal Structure of Pim1 with Inhibitor: 2-(5-chloranyl-1~{h}-indol- 3-yl)ethanamine
  2054. 5kge: Crystal Structure of Pim1 with Inhibitor: 5-(3,4-dichlorophenyl)- 1~{h}-pyrazol-3-amine
  2055. 5kgd: Crystal Structure of Pim1 with Inhibitor: 2-pyridin-3-yl-1~{h}- Benzimidazole
  2056. 5kcx: Pim-1 Kinase in Complex with a Selective N-substituted 7-azaindole Inhibitor
  2057. 5kcv: Crystal Structure of Allosteric Inhibitor, Arq 092, in Complex with Autoinhibited Form of Akt1
  2058. 5kc2: Negative Stain Structure of Vps15/vps34 Complex
  2059. 5kbr: Pak1 in Complex with 7-azaindole Inhibitor
  2060. 5kbq: Pak1 in Complex with Bis-anilino Pyrimidine Inhibitor
  2061. 5kae: Crystal Structure of Human PI3K-GAMMA in Complex with Quinoline- Containing Inhibitor 5g
  2062. 5k98: Structure of Hipa-hipb-o2-o3 Complex
  2063. 5k7i: Irak4 in Complex with Az3864
  2064. 5k7g: Irak4 in Complex with Az3862
  2065. 5k76: Irak4 in Complex with Compound 28
  2066. 5k75: Irak4 in Complex with Compound 1
  2067. 5k72: Irak4 in Complex with Compound 21
  2068. 5k5n: Crystal Structure of Gsk-3beta Complexed with Pf-04802367, a Highly Selective Brain-penetrant Kinase Inhibitor
  2069. 5k3y: Crystal Structure of Aurorab/incenp in Complex with Bi 811283
  2070. 5k00: Melk in Complex with Nvs-melk5
  2071. 5jzn: Crystal Structure of Dclk1-kd in Complex with Nvp-tae684
  2072. 5jzj: Crystal Structure of Dclk1-kd in Complex with Amppn
  2073. 5jwr: Crystal Structure of Foldswitch-stabilized Kaib in Complex with The N- Terminal Ci Domain of Kaic and a Dimer of Kaia C-terminal Domains from Thermosynechococcus Elongatus
  2074. 5jwq: Crystal Structure of Kaic S431E in Complex with Foldswitch-stabilized Kaib from Thermosynechococcus Elongatus
  2075. 5jwo: Crystal Structure of Foldswitch-stabilized Kaib in Complex with The N- Terminal Ci Domain of Kaic from Thermosynechococcus Elongatus
  2076. 5jt2: BRAFV600E Kinase Domain in Complex with Chemically Linked Vemurafenib Inhibitor Vem-bisamide
  2077. 5jsm: BRAFV600E Kinase Domain in Complex with Chemically Linked Vemurafenib Inhibitor Vem-3-vem
  2078. 5jrq: BRAFV600E Kinase Domain in Complex with Chemically Linked Vemurafenib Inhibitor Vem-6-vem
  2079. 5joe: Crystal Structure of I81 from Titin
  2080. 5jmv: Crystal Structure of Mjkae1-pfupcc1 Complex
  2081. 5jk7: The X-ray Structure of The Ddb1-dcaf1-vpr-ung2 Complex
  2082. 5jja: Crystal Structure of a PP2A B56GAMMA/BUBR1 Complex
  2083. 5jhb: Structure of Phosphoinositide 3-kinase Gamma (PI3K) Bound to The Potent Inhibitor Pikin3
  2084. 5jha: Structure of Phosphoinositide 3-kinase Gamma (PI3K) Bound to The Potent Inhibitor Pikin2
  2085. 5jfk: Crystal Structure of a Tdr Receptor
  2086. 5jfi: Crystal Structure of a Tdif-tdr Complex
  2087. 5jdj: Crystal Structure of Domain I10 from Titin in Space Group P212121
  2088. 5jde: Crystal Structure of I9-i11 Tandem from Titin (p1)
  2089. 5jdd: Crystal Structure of I9-i11 Tandem from Titin (p212121)
  2090. 5jda: Bacillus Cereus Coth Kinase plus Mg2+/amp
  2091. 5j95: MAP4K4 in Complex with Inhibitor
  2092. 5j7b: The Identification and Pharmacological Characterization of 6-(tert- Butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a Highly Potent and Selective Inhibitor of Rip2 Kinase, Gsk583 Complex
  2093. 5j79: The Identification and Pharmacological Characterization of 6-(tert- Butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a Highly Potent and Selective Inhibitor of Rip2 Kinase, Compound 3 Complex
  2094. 5j5t: Glk Co-crystal Structure with Aminopyrrolopyrimidine Inhibitor
  2095. 5j2r: Solution Structure of Ras Binding Domain (rbd) of B-raf
  2096. 5j18: Solution Structure of Ras Binding Domain (rbd) of B-raf Complexed with Rigosertib (complex I)
  2097. 5j17: Solution Structure of Ras Binding Domain (rbd) of B-raf
  2098. 5iyx: Crystal Structure of The Arabidopsis Receptor Kinase Haesa in Complex with The Peptide Hormone Ida and The Co-receptor Serk1
  2099. 5iyv: Crystal Structure of The Arabidopsis Receptor Kinase Haesa Lrr Ectdomain in Complex with The Peptide Hormone Idl1.
  2100. 5ixt: The Crystal Structure of The Arabidopsis Receptor Kinase Haesa Lrr Ectdomain in Complex with a N-terminal Extended Ida Peptide Hormone Ligand.
  2101. 5ixq: Crystal Structure of The Arabidopsis Receptor Kinase Haesa Lrr Ectdomain in Complex with The Peptide Hormone Ida.
  2102. 5ixo: Crystal Structure of The Arabidopsis Receptor Kinase Haesa Lrr Ectdomain (apo Form).
  2103. 5itd: Crystal Structure of PI3K Alpha with PI3K Delta Inhibitor
  2104. 5ita: Crystal Structure of Braf Kinase Domain Bound to Az-vem
  2105. 5iso: Structure of Full Length Human Ampk (non-phosphorylated at T-loop) in Complex with a Small Molecule Activator, a Benzimidazole Derivative (991)
  2106. 5ipj: Crystal Structure of Human Pim-1 Kinase in Complex with a Quinazolinone-pyrrolopyrrolone Inhibitor.
  2107. 5ime: Crystal Structure of P21-activated Kinase 1 (pak1) in Complex with Compound 9
  2108. 5ikw: Crystal Structure of Bmp-2-inducible Kinase in Complex with an Indazole Inhibitor
  2109. 5iis: Design, Synthesis and Structure Activity Relationship of Potent Pan- Pim Kinase Inhibitors Derived from The Pyridyl-amide Scaffold
  2110. 5ihc: Melk in Complex with NVS-MELK12B
  2111. 5iha: Melk in Complex with NVS-MELK8F
  2112. 5ih9: Melk in Complex with NVS-MELK8A
  2113. 5ih8: Melk in Complex with Nvs-melk1
  2114. 5ih6: Human Casein Kinase 1 Isoform Delta (kinase Domain) in Complex with Epiblastin a Derivative
  2115. 5ih5: Human Casein Kinase 1 Isoform Delta (kinase Domain) in Complex with Epiblastin a
  2116. 5ih4: Human Casein Kinase 1 Isoform Delta Apo (kinase Domain)
  2117. 5i3r: Crystal Structure of Bmp-2-inducible Kinase in Complex with an Indazole Inhibitor
  2118. 5i3o: Crystal Structure of Bmp-2-inducible Kinase in Complex with an Indazole Inhibitor
  2119. 5i0b: Structure of Pak4
  2120. 5hz3: Plant Peptide Hormone Receptor Rgfr1 in Complex with Rgfr5
  2121. 5hz1: Plant Peptide Hormone Receptor Rgfr1 in Complex with Rgf3
  2122. 5hz0: Plant Peptide Hormone Receptor Rgfr1 in Complex with Rgf2
  2123. 5hyx: Plant Peptide Hormone Receptor Rgfr1 in Complex with Rgf1
  2124. 5hx6: Crystal Structure of Rip1 Kinase with a Benzo[b][1,4]oxazepin-4-one
  2125. 5hvu: Rho-associated Protein Kinase 1 (rock 1) in Complex with a Pyridine Thiazole Piperidine Inhibitor
  2126. 5hvk: Crystal Structure of Limk1 Mutant D460N in Complex with Full-length Cofilin-1
  2127. 5hvj: Crystal Structure of Limk1 D460N Mutant in Complex with Amp-pnp
  2128. 5htc: Crystal Structure of Haspin (gsg2) in Complex with Bisubstrate Inhibitor Arc-3372
  2129. 5htb: Crystal Structure of Haspin (gsg2) in Complex with Bisubstrate Inhibitor Arc-3353
  2130. 5ho8: Discovery of Novel 7-azaindoles as Pdk1 Inhibitors
  2131. 5ho7: Discovery of Novel 7-azaindoles as Pdk1 Inhibitors
  2132. 5hng: Discovery of Novel 7-azaindoles as Pdk1 Inhibitors
  2133. 5hlp: X-ray Crystal Structure of GSK3B in Complex with Brd3937
  2134. 5hln: X-ray Crystal Structure of GSK3B in Complex with Chir99021
  2135. 5hkm: Discovery of Novel 7-azaindoles as Pdk1 Inhibitors
  2136. 5hie: Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Dabrafenib
  2137. 5hid: Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Az628
  2138. 5hi2: Braf Kinase Domain B3AC Loop Deletion Mutant in Complex with Sorafenib
  2139. 5hgi: Crystal Structure of Apo Human Ire1 Alpha
  2140. 5h8g: Crystal Structure of Ck2 with Compound 7b
  2141. 5h8e: Crystal Structure of Ck2 with Compound 7h
  2142. 5h8b: Crystal Structure of Ck2 with Compound 2
  2143. 5h64: Cryo-em Structure of Mtorc1
  2144. 5gr9: Crystal Structure of Pxy-tdif/cle41
  2145. 5gr8: Crystal Structure of Pepr1-atpep1
  2146. 5gqr: Crystal Structure of Pxy-cle41-serk2
  2147. 5gpg: Co-crystal Structure of The Fk506 Binding Domain of Human Fkbp25, Rapamycin and The Frb Domain of Human Mtor
  2148. 5gij: Crystal Structure of Tdr-tdif Complex
  2149. 5g1x: Crystal Structure of Aurora-a Kinase in Complex with N-myc
  2150. 5g15: Structure Aurora a (122-403) Bound to Activating Monobody Mb1 and Amppcp
  2151. 5g04: Structure of The Human Apc-cdc20-hsl1 Complex
  2152. 5fur: Structure of Human Tfiid-iia Bound to Core Promoter Dna
  2153. 5flc: Architecture of Human Mtor Complex 1 - 5.9 Angstrom Reconstruction
  2154. 5fi4: Discovery of Imidazo[1,2-a]-pyridine Inhibitors of Pan-pi3 Kinases That Are Efficacious in a Mouse Xenograft Model
  2155. 5fd2: B-raf Wild-type Kinase Domain in Complex with a Purinylpyridinylamino- Based Inhibitor
  2156. 5f95: Crystal Structure of GSK3B in Complex with Compound 18: 2- [(cyclopropylcarbonyl)amino]-n-(4-phenylpyridin-3-yl)pyridine-4- Carboxamide
  2157. 5f94: Crystal Structure of GSK3B in Complex with Compound 15: 2- [(cyclopropylcarbonyl)amino]-n-(4-methoxypyridin-3-yl)pyridine-4- Carboxamide
  2158. 5f5p: Molecular Basis for Shroom2 Recognition by Rock1
  2159. 5f4n: Multi-parameter Lead Optimization to Give an Oral Chk1 Inhibitor Clinical Candidate: (r)-5-((4-((morpholin-2-ylmethyl)amino)-5- (trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (cct245737)
  2160. 5ezv: X-ray Crystal Structure of Amp-activated Protein Kinase Alpha-2/alpha- 1 Rim Chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) Beta-1 Gamma-1) Co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3- Yl)-furan-2-phosphonic Acid)
  2161. 5eyk: Crystal Structure of Aurora B in Complex with Bi 847325
  2162. 5ew9: Crystal Structure of Aurora a Kinase Domain Bound to Mk-5108
  2163. 5es1: Crystal Structure of Microtubule Affinity-regulating Kinase 4 Catalytic Domain in Complex with a Pyrazolopyrimidine Inhibitor
  2164. 5ep6: The Crystal Structure of Nap1 in Complex with Tbk1
  2165. 5eol: Crystal Structure of Human Pim-1 Kinase in Complex with a Macrocyclic Quinoxaline-pyrrolodihydropiperidinone Inhibitor
  2166. 5eof: Crystal Structure of Optn Ntd and Tbk1 Ctd Complex
  2167. 5eoa: Crystal Structure of Optn E50K Mutant and Tbk1 Complex
  2168. 5eds: Crystal Structure of Human PI3K-GAMMA in Complex with Benzimidazole Inhibitor 5
  2169. 5eak: Optimization of Microtubule Affinity Regulating Kinase (mark) Inhibitors with Improved Physical Properties
  2170. 5e12: Crystal Structure of Pasta Domains 2, 3 and 4 of Mycobacterium Tuberculosis Protein Kinase B
  2171. 5e10: Crystal Structure of Pasta Domains 1 and 2 of Mycobacterium Tuberculosis Protein Kinase B
  2172. 5e0z: Crystal Structure of Pasta Domains 3 and 4 of Mycobacterium Tuberculosis Protein Kinase B
  2173. 5e0y: Crystal Structure of Pasta Domain 4 of Mycobacterium Tuberculosis Protein Kinase B
  2174. 5dxt: P110ALPHA with Gdc-0326
  2175. 5dxh: P110ALPHA/P85ALPHA with Compound 5
  2176. 5dwr: Identification of N-(4-((1r,3s,5s)-3-amino-5-methylcyclohexyl)pyridin- 3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (pim447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (pim) 1,2 and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies
  2177. 5dt4: Aurora a Kinase in Complex with Aa35 and Atp in Space Group P6122
  2178. 5dt3: Aurora a Kinase in Complex with Atp in Space Group P6122
  2179. 5dt0: Aurora a Kinase in Complex with Jnj-7706621 in Space Group P6122
  2180. 5drd: Aurora a Kinase in Complex with Atp in Space Group P6122
  2181. 5drb: Crystal Structure of Wnk1 in Complex with Wnk463
  2182. 5dr9: Aurora a Kinase in Complex with Aa29 and Jnj-7706621 in Space Group P6122
  2183. 5dr6: Aurora a Kinase in Complex with Aa30 and Jnj-7706621 in Space Group P6122
  2184. 5dr2: Aurora a Kinase in Complex with Aa30 and Atp in Space Group P6122
  2185. 5dpv: Aurora a Kinase in Complex with Aa35 and Jnj-7706621 in Space Group P6122
  2186. 5dos: Aurora a Kinase in Complex with Aa35 and Atp in Space Group P6122
  2187. 5dnr: Aurora a Kinase in Complex with Atp in Space Group P41212
  2188. 5dn3: Aurora a in Complex with Atp and Aa35.
  2189. 5dmz: Structure of Human Bub1 Kinase Domain Phosphorylated at Ser969
  2190. 5dls: Identification of Novel, in Vivo Active Chk1 Inhibitors Utilizing Structure Guided Drug Design
  2191. 5dia: Pim1 in Complex with Cpd36 ((1s,3s)-n1-(6-(5-(pyridin-3-yl)-1h- Pyrazolo[3,4-c]pyridin-3-yl)pyridin-2-yl)cyclohexane-1,3-diamine)
  2192. 5di1: MAP4K4 in Complex with an Inhibitor
  2193. 5dhj: Pim1 in Complex with Cpd4 (3-methyl-5-(pyridin-3-yl)-1h-pyrazolo[3,4- C]pyridine)
  2194. 5dh3: Crystal Structure of Mst2 in Complex with Xmu-mp-1
  2195. 5dgz: Discovery of 3,5-substituted 6-azaindazoles as Potent Pan-pim Inhibitors
  2196. 5dfz: Structure of Vps34 Complex II from S. Cerevisiae.
  2197. 5dfp: Crystal Structure of Pak1 in Complex with an Inhibitor Compound Frax1036
  2198. 5dey: Crystal Structure of Pak1 in Complex with an Inhibitor Compound G-5555
  2199. 5dew: Crystal Structure of Pak1 in Complex with an Inhibitor Compound 5
  2200. 5de2: Structural Mechanism of Nek7 Activation by Nek9-induced Dimerisation
  2201. 5dbx: Crystal Structure of Murine SPAK(T243D) in Complex with Amppnp
  2202. 5d9l: Rsk2 N-terminal Kinase in Complex with Bis-phenol Pyrazole
  2203. 5d9k: Rsk2 N-terminal Kinase in Complex with Bi-d1870
  2204. 5d9h: Crystal Structure of Spak (stk39) Dimer in The Basal Activity State
  2205. 5d7a: Crystal Structure of The Kinase Domain of Traf2 and Nck-interacting Protein Kinase with Ncb-0846
  2206. 5czo: Structure of S. Cerevisiae Hrr25:mam1 Complex, Form 2
  2207. 5cyz: Structure of S. Cerevisiae Hrr25:mam1 Complex, Form 1
  2208. 5cx9: Crystal Structure of CK2ALPHA with (methyl 4-((3-(3-chloro-4-(phenyl) Benzylamino)propyl)amino)-4-oxobutanoate Bound
  2209. 5cwz: Crystal Structure of The Kinase Domain of Human Traf2 and Nck- Interacting Protein Kinase
  2210. 5cvh: Crystal Structure of CK2ALPHA
  2211. 5cvg: Crystal Structure of CK2ALPHA with a Novel Closed Conformation of The ad Loop
  2212. 5cvf: Crystal Structure of CK2ALPHA with Compound 5 Bound
  2213. 5cu6: Crystal Structure of CK2ALPHA
  2214. 5cu4: Crystal Structure of CK2ALPHA with Compound 10 Bound
  2215. 5cu3: Crystal Structure of CK2ALPHA with Compound 10 Bound
  2216. 5cu2: Crystal Structure of CK2ALPHA with 2-hydroxy-5-methylbenzoic Acid and (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4- Oxobutanoat Bound
  2217. 5cu0: Crystal Structure of CK2ALPHA with 2-hydroxy-5-methylbenzoic Acid and N-(3-(3-chloro-4-(phenyl)benzylamino)propyl)acetamide Bound
  2218. 5ctp: Crystal Structure of CK2ALPHA with N-(3-(3-chloro-4-(phenyl) Benzylamino)propyl)acetamide Bound
  2219. 5ct7: Braf in Complex with Raf265
  2220. 5ct0: Crystal Structure of CK2ALPHA with 3-(3-chloro-4-(phenyl)benzylamino) Propan-1-ol Bound
  2221. 5csx: Crystal Structure of B-raf in Complex with Bi 882370
  2222. 5csw: B-raf in Complex with Dabrafenib
  2223. 5csv: Crystal Structure of CK2ALPHA with Compound 6 Bound
  2224. 5csp: Crystal Structure of CK2ALPHA with Compound 5 Bound
  2225. 5csn: S100B-RSK1 Crystal Structure C
  2226. 5csj: S100B-RSK1 Crystal Structure B
  2227. 5csi: S100B-RSK1 Crystal Structure A'
  2228. 5csh: Crystal Structure of CK2ALPHA with Compound 4 Bound
  2229. 5csf: S100B-RSK1 Crystal Structure a
  2230. 5cs6: Crystal Structure of CK2ALPHA with Compound 3 Bound
  2231. 5cqw: Tetragonal Complex Structure of Protein Kinase Ck2 Catalytic Subunit with a Benzotriazole-based Inhibitor Generated by Click-chemistry
  2232. 5cqu: Monoclinic Complex Structure of Protein Kinase Ck2 Catalytic Subunit with a Benzotriazole-based Inhibitor Generated by Click-chemistry
  2233. 5clp: Crystal Structure of CK2ALPHA with 3,4-dichlorophenethylamine Bound
  2234. 5ci7: Structure of Ulk1 Bound to a Selective Inhibitor
  2235. 5c9c: Crystal Structure of BRAF(V600E) in Complex with Ly3009120 Compnd
  2236. 5c1q: Serine/threonine-protein Kinase Pim-1
  2237. 4red: Crystal Structure of Human Ampk Alpha1 Kd-aid with K43A Mutation
  2238. 4rer: Crystal Structure of The Phosphorylated Human Alpha1 Beta2 Gamma1 Holo-ampk Complex Bound to Amp and Cyclodextrin
  2239. 4rew: Crystal Structure of The Non-phosphorylated Human Alpha1 Beta2 Gamma1 Holo-ampk Complex
  2240. 4rlk: Crystal Structure of Z. Mays CK2ALPHA in Complex with The Atp- Competitive Inhibitor 4-[(e)-(fluoren-9-ylidenehydrazinylidene)- Methyl] Benzoate
  2241. 4rll: Crystal Structure of Human CK2ALPHA in Complex with The Atp- Competitive Inhibitor 4-[(e)-(fluoren-9-ylidenehydrazinylidene)- Methyl] Benzoate
  2242. 4rqk: Crystal Structure of Pdk1 in Complex with Atp and The Pif-pocket Ligand Rs1
  2243. 4rqv: Crystal Structure of Pdk1 in Complex with Atp and The Pif-pocket Ligand Rs2
  2244. 4rrv: Crystal Structure of Pdk1 in Complex with Atp and Piftide
  2245. 4uow: Crystal Structure of The Titin M10-obscurin Ig Domain 1 Complex
  2246. 4wwn: Crystal Structure of Human PI3K-GAMMA in Complex with (s)-n-(1-(7- Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine Amg319 Inhibitor
  2247. 4wwo: Crystal Structure of Human PI3K-GAMMA in Complex with Phenylquinoline Inhibitor N-{(1s)-1-[8-chloro-2-(3-fluorophenyl)quinolin-3-yl]ethyl}- 9h-purin-6-amine
  2248. 4wwp: Crystal Structure of Human PI3K-GAMMA in Complex with Pyridinylquinoline Inhibitor N-{(1s)-1-[8-chloro-2-(2-methylpyridin- 3-yl)quinolin-3-yl]ethyl}-9h-purin-6-amine
  2249. 4o00: Crystal Structure of The Titin A-band Domain A3
  2250. 6ntc: Crystal Structure of G12V Hras-gppnhp Bound in Complex with The Engineered Rbd Variant 1 of Craf Kinase Protein
  2251. 3wow: Crystal Structure of Human CK2A with Amppnp
  2252. 4mta: Crystal Structure of Pim-1 Kinase Domain in Complex with 2-methyl-5- Phenylfuran-3-carboxylic Acid
  2253. 4ow8: Crystal Structure of Kinase Domain of Pkna from Mtb
  2254. 5bs0: Mage-a3 Reactive Tcr in Complex with Titin Epitope in Hla-a1
  2255. 5brm: Structural Basis for Mob1-dependent Activation of The Core Mst-lats Kinase Cascade in Hippo Signaling
  2256. 5brk: Pmob1-lats1 Complex
  2257. 5bms: Crystal Structure of P21-activated Kinase 4 in Complex with an Inhibitor Compound 29
  2258. 5bml: Rock 1 Bound to a Pyridine Thiazole Inhibitor
  2259. 5b6b: Complex of Lats1 and Phosphomimetic MOB1B
  2260. 5b5w: Crystal Structure of Mob1-lats1 Ntr Domain Complex
  2261. 5b0x: Crystal Structure of The CK2A/BENZOIC Acid Derivative Complex
  2262. 5ax9: Crystal Structure of The Kinase Domain of Human Traf2 and Nck- Interacting Protein Kinase in Complex with Compund 9
  2263. 5av4: Crystal Structure of Dapk1-genistein Complex in The Presence of Bromide Ions.
  2264. 5av3: Crystal Structure of Dapk1-kaempferol Complex in The Presence of Iodide Ions.
  2265. 5av2: Crystal Structure of Dapk1-kaempferol Complex in The Presence of Bromide Ions.
  2266. 5av1: Crystal Structure of Dapk1 in The Presence of Bromide Ions.
  2267. 5av0: Crystal Structure of Dapk1 in Complex with 7,3',4'- Trihydroxyisoflavone.
  2268. 5auz: Crystal Structure of Dapk1 in Complex with Genistein.
  2269. 5auy: Crystal Structure of Dapk1 in Complex with Morin.
  2270. 5aux: Crystal Structure of Dapk1 in Complex with Kaempferol.
  2271. 5auw: Crystal Structure of Dapk1 in Complex with Quercetin.
  2272. 5auv: Crystal Structure of Dapk1 in Complex with Apigenin.
  2273. 5auu: Crystal Structure of Dapk1 in Complex with Luteolin.
  2274. 5aut: Crystal Structure of Dapk1 in Complex with Ans.
  2275. 5ar8: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Biphenylsulfonamide
  2276. 5ar7: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Biaryl Urea
  2277. 5ar5: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Benzimidazole
  2278. 5ar4: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Sb-203580
  2279. 5ar3: Rip2 Kinase Catalytic Domain (1 - 310) Complex with Amp-pcp
  2280. 5ar2: Rip2 Kinase Catalytic Domain (1 - 310)
  2281. 5ack: Human Pdk1 Kinase Domain in Complex with Allosteric Compound 7 Bound to The Pif-pocket
  2282. 4rlo: Human P70S6K1 with Ruthenium-based Inhibitor Em5
  2283. 5aag: Aurora a Kinase Bound to an Imidazopyridine Inhibitor (14b)
  2284. 5aaf: Aurora a Kinase Bound to an Imidazopyridine Inhibitor (14a)
  2285. 5aae: Aurora a Kinase Bound to an Imidazopyridine Inhibitor (14d)
  2286. 4rlp: Human P70S6K1 with Ruthenium-based Inhibitor Fl772
  2287. 5aad: Aurora a Kinase Bound to an Imidazopyridine Inhibitor (7a)
  2288. 4rpv: Co-crystal Structure of Pim1 with Compound 3
  2289. 5a6o: Crystal Structure of The Apo Form of The Unphosphorylated Human Death Associated Protein Kinase 3 (dapk3)
  2290. 5a6n: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with Compound 2
  2291. 4ty1: Crystal Structure of Human Pim-1 Kinase in Complex with an Aminooxadiazole-indole Inhibitor.
  2292. 4waf: Crystal Structure of a Novel Tetrahydropyrazolo[1,5-a]pyrazine in an Engineered PI3K Alpha
  2293. 4wno: Structure of Ulk1 Bound to an Inhibitor
  2294. 4wnp: Structure of Ulk1 Bound to a Potent Inhibitor
  2295. 5a14: Human Cdk2 with Type II Inhibitor
  2296. 4wrs: Crystal Structure of Human Pim-1 Kinase in Complex with an Azaspiro Pyrazinyl-indazole Inhibitor.
  2297. 4wsy: Crystal Structure of Human Pim-1 Kinase in Complex with a Thiazolamine-indazole Inhibitor.
  2298. 4wt6: Crystal Structure of Human Pim-1 Kinase in Complex with a Thiadiazolamine-indole Inhibitor.
  2299. 4x3f: Crystal Structure of The Intracellular Domain of The M. Tuberculosis Ser/thr Kinase Pkna
  2300. 4zy6: Crystal Structure of P21-activated Kinase 1 in Complex with an Inhibitor Compound 29
  2301. 4zy5: Crystal Structure of P21-activated Kinase 1 in Complex with an Inhibitor Compound 17
  2302. 4zy4: Crystal Structure of P21 Activated Kinase 1 in Complex with an Inhibitor Compound 4
  2303. 4x7h: Co-crystal Structure of Perk Bound to N-{5-[(6,7-dimethoxyquinolin-4- Yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3- Dihydro-1h-pyrazole-4-carboxamide Inhibitor
  2304. 4x7j: Co-crystal Structure of Perk with 2-amino-n-[4-methoxy-3- (trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6- Yl]benzamide Inhibitor
  2305. 4x7k: Co-crystal Structure of Perk Bound to 4-{2-amino-3-[5-fluoro-2- (methylamino)quinazolin-6-yl]-4-methylbenzoyl}-1-methyl-2,5-diphenyl- 1,2-dihydro-3h-pyrazol-3-one Inhibitor
  2306. 4x7l: Co-crystal Structure of Perk Bound to 4-{2-amino-4-methyl-3-[2- (methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1, 2-dihydro-3h-pyrazol-3-one Inhibitor
  2307. 4x7n: Co-crystal Structure of Perk Bound to 4-[2-amino-4-methyl-3-(2- Methylquinolin-6-yl)benzoyl]-1-methyl-2,5-diphenyl-1,2-dihydro-3h- Pyrazol-3-one Inhibitor
  2308. 4x7o: Co-crystal Structure of Perk Bound to 1-[5-(4-amino-2,7-dimethyl-7h- Pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1h-indol-1-yl]-2-[3-fluoro- 5-(trifluoromethyl)phenyl]ethanone Inhibitor
  2309. 4x7q: Pim2 Kinase in Complex with Compound 1s
  2310. 4xhk: Pim1 Kinase in Complex with Compound 1s
  2311. 4zts: Human Aurora a Catalytic Domain Bound to Fk1142
  2312. 4ztr: Human Aurora a Catalytic Domain Bound to Fk1141
  2313. 4ztq: Human Aurora a Catalytic Domain Bound to Fk932
  2314. 4ztn: Irak4-inhibitor Co-structure
  2315. 4ztm: Irak4-inhibitor Co-structure
  2316. 4ztl: Irak4-inhibitor Co-structure
  2317. 4zs0: Human Aurora a Catalytic Domain Bound to Sb-6-oh
  2318. 4zp5: MAP4K4 in Complex with Inhibitor
  2319. 4zop: Co-crystal Structure of Lipid Kinase PI3K Alpha with a Selective Phosphatidylinositol-3 Kinase Alpha Inhibitor
  2320. 4zlo: Serine/threonine-protein Kinase Pak1 Complexed with a Dibenzodiazepine: Identification of an Allosteric Site on Pak1
  2321. 4zk5: MAP4K4 in Complex with Inhibitor Gne-495
  2322. 4zjj: Pak1 in Complex with (s)-n-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro- Dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide
  2323. 4zji: Pak1 in Complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin- 1-yl)-dibenzodiazepine
  2324. 4zhx: Novel Binding Site for Allosteric Activation of Ampk
  2325. 5aik: Human DYRK1A in Complex with Ldn-211898
  2326. 4z8l: Crystal Structure of Dcaf1/siv-mnd Vpx/mnd Samhd1 Ntd Ternary Complex
  2327. 4z64: The Plant Peptide Hormone Receptor Complex in Arabidopsis
  2328. 4z63: The Plant Peptide Hormone Receptor in Arabidopsis
  2329. 4z62: The Plant Peptide Hormone Free Receptor
  2330. 4z61: The Plant Peptide Hormone Receptor Complex
  2331. 4z5w: The Plant Peptide Hormone Receptor
  2332. 4yzd: Crystal Structure of Human Phosphorylated IRE1ALPHA in Complex with Adp-mg
  2333. 4yzc: Crystal Structure of PIRE1ALPHA in Complex with Staurosporine
  2334. 4yz9: Crystal Structure of Human Phosphorylated IRE1ALPHA in Complex with a Type III Kinase Inhibitor (GSK2850163A)
  2335. 5ajq: Human Lok (stk10) in Complex with Bosutinib
  2336. 4rbl: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  2337. 4rc2: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  2338. 4rc3: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  2339. 4rc4: Crystal Structure of Ser/thr Kinase Pim1 in Complex with Mitoxantrone Derivatives
  2340. 4u8z: Crystal Structure of Mst3 with a Pyrrolopyrimidine Inhibitor (pf- 06447475)
  2341. 4w8d: Crystal Structure of Mst3 with a Pyrrolopyrimidine Inhibitor (pf- 06454589).
  2342. 4w8e: Structure of Mst3 with a Pyrrolopyrimidine Inhibitor (pf-06645342)
  2343. 4ww5: Crystal Structure of Binary Complex Bud32-cgi121 in Complex with Ampp
  2344. 4ww7: Crystal Structure of Binary Complex Bud32-cgi121 in Complex with Amp
  2345. 4ww9: Crystal Structure of Binary Complex Bud32-cgi121 in Complex with Adp
  2346. 4wwa: Crystal Structure of Binary Complex Bud32-cgi121
  2347. 5air: Structural Analysis of Mouse GSK3BETA Fused with Lrp6 Peptide.
  2348. 4ptc: Structure of a Carboxamide Compound (3) (2-{2-[(cyclopropylcarbonyl) Amino]pyridin-4-yl}-4-oxo-4h-1lambda~4~,3-thiazole-5-carboxamide) to GSK3B
  2349. 4pte: Structure of a Carvoxamide Compound (15) (n-[4-(isoquinolin-7-yl) Pyridin-2-yl]cyclopropanecarboxamide) to GSK3B
  2350. 4ptg: Structure of a Carboxamine Compound (26) (2-{2-[(cyclopropylcarbonyl) Amino]pyridin-4-yl}-4-methoxypyrimidine-5-carboxamide) to GSK3B
  2351. 4yve: Rock 1 Bound to Methoxyphenyl Thiazole Inhibitor
  2352. 4yvc: Rock 1 Bound to Thiazole Inhibitor
  2353. 4y8d: Crystal Structure of Cyclin-g Associated Kinase (gak) Complexed with Selective 12i Inhibitor
  2354. 4ykn: PI3K Alpha Lipid Kinase with Active Site Inhibitor
  2355. 4yht: Braf Complexed with an Inhibitor
  2356. 4yg7: Structure of Fl Autorepression Promoter Complex
  2357. 4yfi: TNNI3K Complexed with Inhibitor 1
  2358. 4yff: TNNI3K Complexed with Inhibitor 2
  2359. 4rvt: MAP4K4 in Complex with a Pyridin-2(1h)-one Derivative
  2360. 4wot: Rock2 in Complex with 1426382-07-1
  2361. 4xs2: Irak4-inhibitor Co-structure
  2362. 4y0x: Crystal Structure of The S/t Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Adp
  2363. 4y12: Crystal Structure of The S/t Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Ags
  2364. 4y73: Crystal Structure of Irak4 Kinase Domain with Inhibitor
  2365. 4yo4: Crystal Structure of Dapk1 Catalytic Domain in Complex with The Hinge Binding Fragment Phthalazine
  2366. 4yo6: Irak4-inhibitor Co-structure
  2367. 4yp8: Irak4-inhibitor Co-structure
  2368. 4ypd: Crystal Structure of Dapk1 Catalytic Domain in Complex with The Hinge Binding Fragment 4-methylpyridazine
  2369. 4yzm: Humanized Roco4 Bound to Lrrk2-in1
  2370. 4yzn: Humanized Roco4 Bound to Compound 19
  2371. 4yzs: Crystal Structures Reveal Transient Perk Luminal Domain Tetramerization in Er Stress Signaling
  2372. 4yzy: Crystal Structures Reveal Transient Perk Luminal Domain Tetramerization in Er Stress Signaling
  2373. 4z7g: Crystal Structure of Human Ire1 Cytoplasmic Kinase-rnase Region - Apo
  2374. 4z7h: Crystal Structure of Human Ire1 Cytoplasmic Kinase-rnase Region - Complex with Imidazopyridine Compound 3
  2375. 5aja: Crystal Structure of Mandrill Samhd1 (amino Acid Residues 1-114) Bound to Vpx Isolated from Mandrill and Human Dcaf1 (amino Acid Residues 1058-1396)
  2376. 2mwc: Solution Structure of Human Obscurin Ig58
  2377. 2n56: Ig59 Domain of Human Obscurin a
  2378. 2n7z: Solution Structure of Rip2 Card
  2379. 2n83: P75NTR Dd:rip2 Card
  2380. 3jbz: Crystal Structure of Mtor Docked into Em Map of Dimeric Atm Kinase
  2381. 3wws: Crystal Structure of Serine/threonine-protein Kinase 3
  2382. 4qeg: Crystal Structure of Domain I10 from Titin (space Group P41)
  2383. 4qml: Mst3 in Complex with Amp-pnp
  2384. 4qmm: Mst3 in Complex with At-9283, 4-[(2-{4-[(cyclopropylcarbamoyl)amino]- 1h-pyrazol-3-yl}-1h-benzimidazol-6-yl)methyl]morpholin-4-ium
  2385. 4qmn: Mst3 in Complex with Bosutinib
  2386. 4qmo: Mst3 in Complex with Imidazolo-oxindole Pkr Inhibitor C16
  2387. 4qmp: Mst3 in Complex with Cdk1/2 Inhibitor Iii, 5-amino-3-{[4- (aminosulfonyl)phenyl]amino}-n-(2,6-difluorophenyl)-1h-1,2,4- Triazole-1-carbothioamide
  2388. 4qmq: Mst3 in Complex with Cp-673451
  2389. 4qms: Mst3 in Complex with Dasatinib
  2390. 4qmt: Mst3 in Complex with Hesperadin
  2391. 4qmu: Mst3 in Complex with Jnj-7706621, 4-({5-amino-1-[(2,6-difluorophenyl) Carbonyl]-1h-1,2,4-triazol-3-yl}amino)benzenesulfonamide
  2392. 4qmv: Mst3 in Complex with Pf-03814735, N-{2-[(1s,4r)-6-{[4- (cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-1,2,3,4- Tetrahydro-1,4-epiminonaphthalen-9-yl]-2-oxoethyl}acetamide
  2393. 4qmw: Mst3 in Complex with Pp-121, 1-cyclopentyl-3-(1h-pyrrolo[2,3- B]pyridin-5-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine
  2394. 4qmx: Mst3 in Complex with Saracatinib
  2395. 4qmy: Mst3 in Complex with Staurosporine
  2396. 4qmz: Mst3 in Complex with Sunitinib
  2397. 4qna: Mst3 in Complex with 2-(4,6-diamino-1,3,5-triazin-2-yl)phenol
  2398. 4qo9: Mst3 in Complex with Danusertib
  2399. 4r5y: The Complex Structure of Braf V600E Kinase Domain with a Novel Braf Inhibitor
  2400. 4rmz: Crystal Structure of Irak-4
  2401. 4rsv: Human Obscurin Ig58 Domain
  2402. 4rvk: Chk1 Kinase Domain with Diazacarbazole Compound 8: N-[3-(6-cyano-9h- Pyrrolo[2,3-b:5,4-c']dipyridin-3-yl)phenyl]acetamide
  2403. 4rvl: Chk1 Kinase Domain with Diazacarbazole Compound 7: 3-(2- Hydroxyphenyl)-9h-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile
  2404. 4rvm: Chk1 Kinase Domain with Diazacarbazole Compound 19
  2405. 4rzv: Crystal Structure of The Braf (R509H) Kinase Domain Monomer Bound to Vemurafenib
  2406. 4rzw: Crystal Structure of Braf (R509H) Kinase Domain Bound to Az628
  2407. 4tl0: Crystal Structure of Death-associated Protein Kinase 1 with a Crucial Phosphomimicking Mutation
  2408. 4tl6: Crystal Structure of N-terminal Domain of Kaic
  2409. 4tl7: Crystal Structure of N-terminal C1 Domain of Kaic
  2410. 4tl8: Crystal Structure of N-terminal C1 Domain of Kaic
  2411. 4tl9: Crystal Structure of N-terminal C1 Domain of Kaic
  2412. 4tla: Crystal Structure of N-terminal C1 Domain of Kaic
  2413. 4tlb: Crystal Structure of N-terminal C1 Domain of Kaic
  2414. 4tlc: Crystal Structure of N-terminal C1 Domain of Kaic
  2415. 4tld: Crystal Structure of N-terminal C1 Domain of Kaic
  2416. 4tle: Crystal Structure of N-terminal C1 Domain of Kaic
  2417. 4tn6: CK1D in Complex with Inhibitor
  2418. 4tyh: Ternary Complex of P38 and Mk2 with a P38 Inhibitor
  2419. 4u3y: Apo Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4)
  2420. 4u3z: Apo MAP4K4 T181E Phosphomimetic Mutant
  2421. 4u40: Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Bound to Amppnp
  2422. 4u41: MAP4K4 Bound to Inhibitor Compound 1
  2423. 4u42: MAP4K4 T181E Mutant Bound to Inhibitor Compound 1
  2424. 4ub7: High-salt Structure of Protein Kinase Ck2 Catalytic Subunit with 4'- Carboxy-6,8-bromo-flavonol (flc26) Showing an Extreme Distortion of The Atp-binding Loop Combined with a Pi-halogen Bond
  2425. 4uba: Low-salt Structure of Protein Kinase Ck2 Catalytic Subunit with 4'- Carboxy-6,8-bromo-flavonol (flc26)
  2426. 4usd: Human Stk10 (lok) with Sb-633825
  2427. 4use: Human Stk10 (lok) with Sb-633825
  2428. 4usf: Human Slk with Sb-440719
  2429. 4uv0: Structure of a Semisynthetic Phosphorylated Dapk
  2430. 4wua: Crystal Structure of Human Srpk1 Complexed to an Inhibitor Srpin340
  2431. 4wzx: Ulk3 Regulates Cytokinetic Abscission by Phosphorylating Escrt-iii Proteins
  2432. 4xbr: In Cellulo Crystal Structure of Pak4 in Complex with Inka
  2433. 4xbu: In Vitro Crystal Structure of Pak4 in Complex with Inka Peptide
  2434. 4xh0: Structure of C. Glabrata Hrr25 Bound to Adp (so4 Condition)
  2435. 4xh6: Crystal Structure of Proto-oncogene Kinase Pim1 Bound to Hispidulin
  2436. 4xhl: Structure of S. Cerevisiae Hrr25 1-394 (K38R Mutant)
  2437. 4xv1: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx7904
  2438. 4xv2: B-raf Kinase V600E Oncogenic Mutant in Complex with Dabrafenib
  2439. 4xv3: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx7922
  2440. 4xv9: B-raf Kinase Domain in Complex with Plx5568
  2441. 4xx5: Structure of PI3K Gamma in Complex with an Inhibitor
  2442. 4xx9: Crystal Structure of Pdk1 in Complex with Atp and The Pif-pocket Ligand Rf4
  2443. 4xz4: Structure of PI3K Gamma in Complex with an Inhibitor
© Copyright 2008-2009 by enzymes.me.uk